HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 6.06 MAC1. 14NOV23:08:03:1614NOV23:08:03:16 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS DM_2 SASDATA 6.06 14NOV23:08:03:1614NOV23:08:03:16 Demographics HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000002600000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier SUBJID Subject Identifier for the Study RFSTDTC Subject Reference Start Date/Time ( RFENDTC Subject Reference End Date/Time ;RFXSTDTCDate/Time of First Study Treatment ERFXENDTCDate/Time of Last Study Treatment X RFICDTC Date/Time of Informed Consent k RFPENDTCDate/Time of End of Participation u DTHDTC Date/Time of Death  DTHFL Subject Death Flag  SITEID Study Site Identifier INVID Investigator Identifier INVNAM Investigator Name BRTHDTC Date/Time of Birth AGE Age BEST  AGEU Age Units SEX Sex )RACE Race ETHNIC Ethnicity  ARMCD Planned Arm Code ARM Description of Planned Arm  ACTARMCDActual Arm Code ACTARM Description of Actual Arm 'COUNTRY Country B HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001DMC4591001 1005 10051317100513172020-10-20T09:35:002021-05-132020-10-20T09:35:002020-11-12T09:06:002020-10-202021-05-13 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051328100513282020-10-20T12:31:002021-05-132020-10-20T12:31:002020-11-11T11:04:002020-10-202021-05-13 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051339100513392020-10-21T11:41:002021-07-072020-10-21T11:41:002021-06-09T02:05:002020-10-212021-07-07 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051410100514102020-12-09T16:46:002021-07-072020-12-09T16:46:002021-06-09T15:18:002020-12-092021-07-07 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051412100514122020-12-14T09:49:002021-06-302020-12-14T09:49:002021-01-05T09:17:002020-12-142021-06-30 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051413100514132020-12-14T09:32:002021-07-262020-12-14T09:32:002021-01-04T09:45:002020-12-142021-07-26 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051414100514142020-12-14T11:36:002021-07-232020-12-14T11:36:002021-06-25T11:17:002020-12-142021-07-23 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051415100514152020-12-14T16:26:002021-07-082020-12-14T16:26:002021-06-10T15:33:002020-12-142021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051417100514172020-12-16T12:25:002021-08-142020-12-16T12:25:002021-08-13T10:53:002020-12-16 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051418100514182020-12-16T12:30:002021-07-162020-12-16T12:30:002021-01-06T10:19:002020-12-162021-07-16 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051419100514192020-12-16T15:57:002021-06-022020-12-16T15:57:002021-03-17T15:18:002020-12-16 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051420100514202020-12-16T15:50:002021-07-192020-12-16T15:50:002021-01-04T12:13:002020-12-162021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051421100514212020-12-17T15:48:002021-07-192020-12-17T15:48:002021-06-09T15:03:002020-12-172021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051422100514222020-12-17T15:56:002021-07-192020-12-17T15:56:002021-06-09T15:02:002020-12-172021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051424100514242020-12-18T09:36:002021-07-122020-12-18T09:36:002021-01-08T09:03:002020-12-182021-07-12 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051425100514252020-12-18T12:13:002021-07-082020-12-18T12:13:002021-01-08T12:13:002020-12-182021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051427100514272020-12-21T11:11:002021-07-082020-12-21T11:11:002021-06-07T12:18:002020-12-212021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051428100514282020-12-21T14:37:002021-07-142020-12-21T14:37:002021-01-13T09:21:002020-12-212021-07-14 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051429100514292020-12-21T15:09:002021-07-162020-12-21T15:09:002021-01-11T16:16:002020-12-212021-07-16 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051430100514302020-12-22T08:48:002021-07-192020-12-22T08:48:002021-05-13T10:36:002020-12-222021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051431100514312020-12-22T09:40:002021-07-202020-12-22T09:40:002021-01-12T11:52:002020-12-222021-07-20 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051436100514362020-12-22T12:26:002021-07-082020-12-22T12:26:002021-01-12T14:25:002020-12-222021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051437100514372020-12-22T12:20:002021-07-192020-12-22T12:20:002021-06-17T10:57:002020-12-222021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051438100514382020-12-22T12:13:002021-07-262020-12-22T12:13:002021-06-17T10:55:002020-12-222021-07-26 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051439100514392020-12-22T15:07:002021-07-122020-12-22T15:07:002021-01-11T15:13:002020-12-222021-07-12 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051440100514402020-12-22T15:10:002021-07-072020-12-22T15:10:002021-06-09T13:58:002020-12-222021-07-07 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051441100514412020-12-22T15:00:002021-08-052020-12-22T15:00:002021-01-12T14:14:002020-12-222021-08-05 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051444100514442020-12-22T16:23:002021-07-262020-12-22T16:23:002021-06-10T03:28:002020-12-22 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051445100514452020-12-22T16:50:002021-07-152020-12-22T16:50:002021-06-16T09:01:002020-12-222021-07-15 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051447100514472021-01-11T10:48:002021-07-262021-01-11T10:48:002021-02-01T10:07:002021-01-112021-07-26 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051448100514482021-01-11T12:59:002021-07-192021-01-11T12:59:002021-06-16T13:48:002021-01-112021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051449100514492021-01-11T12:48:002021-08-022021-01-11T12:48:002021-02-01T11:21:002021-01-112021-08-02 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051450100514502021-01-11T14:54:002021-07-192021-01-11T14:54:002021-06-14T15:30:002021-01-112021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051451100514512021-01-12T14:32:002021-08-092021-01-12T14:32:002021-02-03T12:57:002021-01-122021-08-09 100579828 Davis, Matthew Gilruth (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061183100611832020-11-30T09:24:002021-07-122020-11-30T09:24:002021-06-08T09:15:002020-11-302021-07-12 100682785 Peterson, James Todd (b)(6)AYEARSMMULTIPLE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061184100611842020-11-30T12:03:002021-06-142020-11-30T12:03:002020-12-21T11:05:002020-11-302021-06-14 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061188100611882020-12-01T17:24:002021-07-122020-12-01T17:24:002021-06-07T17:03:002020-12-012021-07-12 100682785 Peterson, James Todd (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061189100611892020-12-01T17:24:002021-06-152020-12-01T17:24:002020-12-22T16:59:002020-12-012021-06-15 100682785 Peterson, James Todd (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061190100611902020-12-02T08:52:002021-06-172020-12-02T08:52:002020-12-22T10:26:002020-12-022021-06-17 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061191100611912020-12-02T11:09:002021-06-182020-12-02T11:09:002020-12-22T10:47:002020-12-022021-06-18 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061196100611962020-12-02T18:00:002021-07-062020-12-02T18:00:002021-06-08T12:03:002020-12-022021-07-06 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061200100612002020-12-03T14:59:002021-08-262020-12-03T14:59:002021-04-07T10:44:002020-12-032021-08-26 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061201100612012020-12-03T14:58:002021-07-072020-12-03T14:58:002020-12-24T10:12:002020-12-032021-07-07 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061203100612032020-12-03T17:14:002021-06-172020-12-03T17:14:002020-12-22T12:02:002020-12-032021-06-17 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061206100612062020-12-04T09:16:002021-05-182020-12-04T09:16:002020-12-23T09:03:002020-12-042021-05-18 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061207100612072020-12-04T09:17:002021-05-182020-12-04T09:17:002020-12-23T09:02:002020-12-042021-05-18 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061209100612092020-12-04T12:09:002021-06-222020-12-04T12:09:002020-12-23T11:18:002020-12-042021-06-22 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061212100612122020-12-04T14:24:002021-07-082020-12-04T14:24:002021-06-08T13:53:002020-12-042021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061213100612132020-12-04T14:23:002021-06-162020-12-04T14:23:002020-12-23T09:52:002020-12-042021-06-16 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061214100612142020-12-04T15:54:002021-07-192020-12-04T15:54:002021-06-21T15:11:002020-12-042021-07-19 100682785 Peterson, James Todd (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061219100612192020-12-07T09:55:002021-09-012020-12-07T09:55:002021-07-30T15:35:002020-12-072021-09-01 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061220100612202020-12-07T10:58:002021-06-232020-12-07T10:58:002020-12-28T10:02:002020-12-07 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061221100612212020-12-07T12:09:002021-08-022020-12-07T12:09:002020-12-28T11:47:002020-12-072021-08-02 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061223100612232020-12-07T13:48:002021-07-082020-12-07T13:48:002021-06-08T11:11:002020-12-072021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061224100612242020-12-07T15:10:002021-07-082020-12-07T15:10:002020-12-28T09:50:002020-12-072021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061226100612262020-12-07T16:29:002021-07-082020-12-07T16:29:002021-06-04T10:56:002020-12-072021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061227100612272020-12-07T16:30:002021-06-212020-12-07T16:30:002020-12-28T17:30:002020-12-072021-06-21 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061228100612282020-12-08T10:56:002021-07-082020-12-08T10:56:002021-06-04T14:27:002020-12-082021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061229100612292020-12-08T13:00:002021-06-232020-12-08T13:00:002021-03-11T16:32:002020-12-082021-06-23 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061230100612302020-12-08T17:08:002021-08-102020-12-08T17:08:002020-12-31T12:36:002020-12-082021-08-10 100682785 Peterson, James Todd (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061231100612312020-12-08T17:33:002021-08-162020-12-08T17:33:002020-12-28T10:09:002020-12-082021-08-16 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061232100612322020-12-08T17:56:002021-07-082020-12-08T17:56:002021-06-08T17:37:002020-12-082021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061233100612332020-12-08T17:51:002021-07-082020-12-08T17:51:002021-06-08T17:38:002020-12-082021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061234100612342020-12-09T08:59:002021-06-232020-12-09T08:59:002020-12-30T08:54:002020-12-092021-06-23 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061235100612352020-12-09T09:00:002021-07-142020-12-09T09:00:002021-06-08T09:00:002020-12-092021-07-14 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061236100612362020-12-09T11:20:002021-06-212020-12-09T11:20:002020-12-28T14:16:002020-12-092021-06-21 100682785 Peterson, James Todd (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061237100612372020-12-09T11:39:002021-06-302020-12-09T11:39:002021-06-02T13:45:002020-12-09 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061239100612392020-12-09T12:26:002021-07-092020-12-09T12:26:002021-06-09T17:42:002020-12-092021-07-09 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061241100612412020-12-09T14:21:002021-06-222020-12-09T14:21:002020-12-28T14:56:002020-12-09 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061242100612422020-12-09T16:24:002021-07-062020-12-09T16:24:002020-12-28T08:59:002020-12-092021-07-06 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061243100612432020-12-10T10:07:002021-06-292020-12-10T10:07:002020-12-29T08:59:002020-12-10 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061244100612442020-12-10T12:10:002021-06-222020-12-10T12:10:002020-12-29T11:36:002020-12-102021-06-22 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061245100612452020-12-10T12:11:002021-07-082020-12-10T12:11:002021-06-09T15:02:002020-12-102021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061247100612472020-12-10T18:19:002021-07-122020-12-10T18:19:002021-06-04T17:01:002020-12-102021-07-12 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061248100612482020-12-11T09:11:002021-07-092020-12-11T09:11:002021-06-09T09:56:002020-12-112021-07-09 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061249100612492020-12-11T11:00:002021-06-252020-12-11T11:00:002020-12-31T11:04:002020-12-112021-06-25 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061250100612502020-12-11T11:03:002021-07-272020-12-11T11:03:002021-06-28T17:28:002020-12-112021-07-27 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061252100612522020-12-11T12:42:002021-07-122020-12-11T12:42:002020-12-31T12:15:002020-12-112021-07-12 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061253100612532020-12-11T14:15:002021-07-082020-12-11T14:15:002021-06-08T10:52:002020-12-112021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061254100612542020-12-11T14:00:002021-07-062020-12-11T14:00:002020-12-30T14:11:002020-12-112021-07-06 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061256100612562020-12-11T17:55:002021-07-072020-12-11T17:55:002020-12-30T16:57:002020-12-112021-07-07 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061257100612572020-12-11T17:50:002021-04-092020-12-11T17:50:002021-03-12T14:03:002020-12-11 100682785 Peterson, James Todd (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061258100612582020-12-14T09:15:002021-07-092020-12-14T09:15:002021-01-05T08:57:002020-12-142021-07-09 100682785 Peterson, James Todd (b)(6)AYEARSMNATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERNOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061259100612592020-12-14T10:42:002021-05-112020-12-14T10:42:002021-04-13T09:25:002020-12-142021-05-11 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061260100612602020-12-14T10:44:002021-07-092020-12-14T10:44:002021-06-07T10:58:002020-12-142021-07-09 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061261100612612020-12-14T15:52:002021-06-302020-12-14T15:52:002021-01-05T10:15:002020-12-142021-06-30 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061262100612622020-12-14T17:40:002021-09-012020-12-14T17:40:002021-07-07T10:33:002020-12-142021-09-01 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061263100612632020-12-14T17:30:002021-07-072020-12-14T17:30:002021-01-04T16:57:002020-12-142021-07-07 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061264100612642020-12-14T18:00:002021-07-062020-12-14T18:00:002021-01-04T17:30:002020-12-142021-07-06 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061265100612652020-12-18T10:00:002021-05-142020-12-18T10:00:002021-01-06T08:45:002020-12-152021-05-14 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061266100612662020-12-15T11:15:002021-04-142020-12-15T11:15:002021-03-17T10:59:002020-12-15 100682785 Peterson, James Todd (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061267100612672020-12-15T13:25:002021-08-132020-12-15T13:25:002021-08-13T15:46:002020-12-15 100682785 Peterson, James Todd (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061269100612692020-12-15T17:36:002021-06-292020-12-15T17:36:002021-01-06T16:21:002020-12-152021-06-29 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061270100612702020-12-16T10:56:002021-04-092020-12-16T10:56:002021-03-11T16:30:002020-12-16 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061271100612712020-12-16T11:47:002021-07-072020-12-16T11:47:002021-01-05T14:26:002020-12-162021-07-07 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061272100612722020-12-16T12:07:002021-08-122020-12-16T12:07:002021-05-17T16:41:002020-12-162021-08-12 100682785 Peterson, James Todd (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061273100612732020-12-16T16:05:002021-07-082020-12-16T16:05:002021-06-10T17:01:002020-12-162021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061274100612742020-12-16T17:48:002021-07-072020-12-16T17:48:002021-01-08T10:56:002020-12-162021-07-07 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061276100612762020-12-17T12:52:002021-07-202020-12-17T12:52:002021-06-22T10:30:002020-12-172021-07-20 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061277100612772020-12-17T15:30:002021-08-232020-12-17T15:30:002021-06-07T15:52:002020-12-172021-08-23 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061278100612782020-12-17T17:11:002021-07-022020-12-17T17:11:002021-01-05T12:12:002020-12-172021-07-02 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061279100612792020-12-17T17:31:002021-08-112020-12-17T17:31:002021-06-07T17:12:002020-12-172021-08-11 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061280100612802020-12-17T17:41:002021-08-022020-12-17T17:41:002021-01-07T17:03:002020-12-172021-08-02 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061282100612822020-12-18T11:37:002021-07-022020-12-18T11:37:002021-01-08T10:59:002020-12-182021-07-02 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061283100612832020-12-18T12:28:002021-07-082020-12-18T12:28:002021-06-10T14:03:002020-12-182021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061284100612842020-12-18T17:36:002021-08-312020-12-18T17:36:002021-06-15T15:57:002020-12-182021-08-31 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061285100612852020-12-21T11:59:002021-07-272020-12-21T11:59:002021-06-22T13:55:002020-12-21 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061286100612862020-12-21T14:26:002021-07-122020-12-21T14:26:002021-01-11T16:51:002020-12-212021-07-12 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061287100612872020-12-21T16:08:002021-05-252020-12-21T16:08:002021-01-11T17:38:002020-12-212021-05-25 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061288100612882020-12-21T16:09:002021-08-022020-12-21T16:09:002021-01-11T17:37:002020-12-212021-08-02 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061289100612892020-12-22T09:18:002021-08-192020-12-22T09:18:002021-01-13T16:49:002020-12-222021-08-19 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061290100612902020-12-22T09:19:002021-08-242020-12-22T09:19:002021-01-13T16:50:002020-12-222021-08-24 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061291100612912020-12-22T09:20:002021-07-132020-12-22T09:20:002021-06-14T16:42:002020-12-222021-07-13 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061292100612922020-12-22T13:53:002021-06-302020-12-22T13:53:002021-06-02T09:06:002020-12-222021-06-30 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061293100612932020-12-22T13:52:002021-07-142020-12-22T13:52:002021-01-12T09:18:002020-12-22 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061294100612942020-12-22T16:43:002021-07-082020-12-22T16:43:002021-06-08T16:28:002020-12-222021-07-08 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061295100612952020-12-24T10:21:002021-06-302020-12-24T10:21:002021-06-02T09:07:002020-12-242021-06-30 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061296100612962020-12-29T09:54:002021-05-272020-12-29T09:54:002021-01-19T16:04:002020-12-292021-05-27 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061297100612972020-12-29T09:55:002021-05-272020-12-29T09:55:002021-01-19T16:03:002020-12-292021-05-27 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061298100612982020-12-29T14:51:002021-07-092020-12-29T14:51:002021-06-09T09:48:002020-12-29 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061299100612992020-12-31T11:41:002021-07-262020-12-31T11:41:002021-01-22T17:07:002020-12-312021-07-26 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061300100613002021-01-07T16:41:002021-07-222021-01-07T16:41:002021-01-28T16:33:002021-01-072021-07-22 100682785 Peterson, James Todd (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071409100714092020-10-22T11:29:002021-07-012020-10-22T11:29:002021-05-27T10:40:002020-10-222021-07-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071414100714142020-10-22T12:17:002021-07-122020-10-22T12:17:002021-06-14T14:38:002020-10-222021-07-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071415100714152020-10-22T12:57:002021-06-072020-10-22T12:57:002020-12-10T09:13:002020-10-222021-06-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071417100714172020-10-22T13:32:002021-05-062020-10-22T13:32:002020-11-12T12:35:002020-10-222021-05-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071428100714282020-10-22T16:20:002021-05-132020-10-22T16:20:002020-11-12T16:26:002020-10-222021-05-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071429100714292020-10-22T16:34:002021-07-242020-10-22T16:34:002020-11-12T16:40:002020-10-222021-07-24 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071467100714672020-11-30T10:26:002021-06-142020-11-30T10:26:002020-12-21T09:59:002020-11-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071469100714692020-11-30T11:22:002021-06-212020-11-30T11:22:002020-12-21T11:22:002020-11-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071471100714712020-11-30T12:25:002021-06-142020-11-30T12:25:002020-12-21T11:32:002020-11-302021-06-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071472100714722020-11-30T13:57:002021-07-122020-11-30T13:57:002021-06-07T15:02:002020-11-302021-07-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071475100714752020-11-30T15:02:002021-06-142020-11-30T15:02:002020-12-21T14:39:002020-11-302021-06-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071476100714762020-11-30T17:18:002021-06-142020-11-30T17:18:002020-12-21T11:47:002020-11-302021-06-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071478100714782020-11-30T17:02:002021-07-132020-11-30T17:02:002021-06-09T14:01:002020-11-302021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071480100714802020-11-30T17:21:002021-07-132020-11-30T17:21:002021-06-08T11:19:002020-11-302021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071481100714812020-12-01T09:43:002021-08-012020-12-01T09:43:002021-06-28T09:46:002020-12-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071482100714822020-12-01T10:05:002021-07-152020-12-01T10:05:002020-12-22T10:32:002020-12-012021-07-15 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071483100714832020-12-01T11:20:002021-05-182020-12-01T11:20:002021-04-20T15:35:002020-12-012021-05-18 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071484100714842020-12-01T11:16:002021-07-072020-12-01T11:16:002021-06-09T15:52:002020-12-012021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071485100714852020-12-01T14:04:002021-06-152020-12-01T14:04:002020-12-21T15:01:002020-12-012021-06-15 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071488100714882020-12-01T15:56:002021-06-152020-12-01T15:56:002020-12-22T12:00:002020-12-012021-06-15 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071490100714902020-12-01T16:54:002021-06-162020-12-01T16:54:002020-12-22T11:58:002020-12-012021-06-16 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071492100714922020-12-01T17:22:002021-06-242020-12-01T17:22:002020-12-21T15:45:002020-12-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071494100714942020-12-02T11:29:002021-06-212020-12-02T11:29:002020-12-21T15:09:002020-12-022021-06-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071495100714952020-12-02T15:13:002021-07-132020-12-02T15:13:002021-06-14T12:03:002020-12-022021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071496100714962020-12-02T17:12:002021-07-122020-12-02T17:12:002021-06-14T13:30:002020-12-022021-07-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071497100714972020-12-02T17:22:002021-06-162020-12-02T17:22:002020-12-22T09:50:002020-12-022021-06-16 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071499100714992020-12-03T16:21:002021-06-282020-12-03T16:21:002020-12-22T15:18:002020-12-032021-06-28 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071500100715002020-12-03T16:54:002021-06-222020-12-03T16:54:002020-12-22T10:26:002020-12-032021-06-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071504100715042020-12-07T09:41:002021-06-232020-12-07T09:41:002020-12-30T10:35:002020-12-072021-06-23 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071505100715052020-12-07T10:16:002021-07-222020-12-07T10:16:002021-06-23T13:50:002020-12-072021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071506100715062020-12-07T10:42:002021-06-212020-12-07T10:42:002020-12-28T16:05:002020-12-072021-06-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071507100715072020-12-07T12:07:002021-07-092020-12-07T12:07:002021-06-10T14:10:002020-12-072021-07-09 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071508100715082020-12-07T13:47:002021-06-212020-12-07T13:47:002020-12-28T13:46:002020-12-072021-06-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071509100715092020-12-07T14:42:002021-07-072020-12-07T14:42:002021-06-09T12:16:002020-12-072021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071511100715112020-12-07T16:50:002021-07-132020-12-07T16:50:002021-06-08T10:01:002020-12-072021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071512100715122020-12-07T17:14:002021-08-102020-12-07T17:14:002020-12-28T16:46:002020-12-072021-08-10 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071514100715142020-12-07T17:11:002021-06-212020-12-07T17:11:002020-12-28T14:39:002020-12-072021-06-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071515100715152020-12-08T09:50:002021-06-242020-12-08T09:50:002020-12-29T10:14:002020-12-082021-06-24 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071516100715162020-12-08T09:43:002021-07-132020-12-08T09:43:002021-06-08T10:37:002020-12-082021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071517100715172020-12-08T10:45:002021-06-222020-12-08T10:45:002020-12-29T15:55:002020-12-082021-06-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071518100715182020-12-08T11:20:002021-07-012020-12-08T11:20:002020-12-29T09:38:002020-12-082021-07-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071519100715192020-12-08T11:58:002021-06-092020-12-08T11:58:002021-04-21T14:11:002020-12-082021-06-09 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071520100715202020-12-08T12:03:002021-08-012020-12-08T12:03:002021-07-01T09:58:002020-12-082021-08-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071521100715212020-12-08T13:50:002021-07-192020-12-08T13:50:002020-12-29T14:53:002020-12-082021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071522100715222020-12-08T15:38:002021-07-162020-12-08T15:38:002021-06-16T15:04:002020-12-082021-07-16 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071523100715232020-12-08T15:30:002021-08-252020-12-08T15:30:002020-12-29T11:40:002020-12-082021-08-25 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071524100715242020-12-08T16:55:002021-04-202020-12-08T16:55:002021-03-18T16:09:002020-12-08 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071525100715252020-12-08T16:48:002021-06-242020-12-08T16:48:002020-12-29T11:28:002020-12-082021-06-24 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071526100715262020-12-08T17:18:002021-07-262020-12-08T17:18:002020-12-29T13:58:002020-12-082021-07-26 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071527100715272020-12-08T17:09:002021-07-212020-12-08T17:09:002021-06-22T14:12:002020-12-082021-07-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071528100715282020-12-09T09:40:002021-06-232020-12-09T09:40:002020-12-30T13:36:002020-12-092021-06-23 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071529100715292020-12-09T10:28:002021-06-292020-12-09T10:28:002020-12-30T10:22:002020-12-092021-06-29 100713351 Frenck, Robert Wilson (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071530100715302020-12-09T10:40:002021-07-132020-12-09T10:40:002020-12-29T16:26:002020-12-092021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071531100715312020-12-09T10:46:002021-07-282020-12-09T10:46:002021-06-22T09:29:002020-12-092021-07-28 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071533100715332020-12-09T11:46:002021-07-192020-12-09T11:46:002021-06-16T11:03:002020-12-092021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071535100715352020-12-09T11:57:002021-08-272020-12-09T11:57:002020-12-30T12:49:002020-12-092021-08-27 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071536100715362020-12-09T12:48:002021-06-172020-12-09T12:48:002020-12-29T15:54:002020-12-092021-06-17 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071537100715372020-12-09T14:12:002021-06-232020-12-09T14:12:002020-12-30T16:25:002020-12-092021-06-23 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071539100715392020-12-09T15:23:002021-08-302020-12-09T15:23:002021-06-23T14:29:002020-12-092021-08-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071540100715402020-12-09T15:30:002021-08-302020-12-09T15:30:002021-06-23T14:14:002020-12-092021-08-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071541100715412020-12-09T16:50:002021-08-242020-12-09T16:50:002021-03-02T15:14:002020-12-092021-08-24 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071542100715422020-12-09T17:04:002021-06-232020-12-09T17:04:002020-12-30T16:28:002020-12-092021-06-23 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071543100715432020-12-09T17:05:002021-08-162020-12-09T17:05:002020-12-30T14:06:002020-12-092021-08-16 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071544100715442020-12-09T17:09:002021-08-162020-12-09T17:09:002020-12-30T14:13:002020-12-092021-08-16 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071546100715462020-12-10T09:54:002021-06-232020-12-10T09:54:002020-12-30T10:40:002020-12-102021-06-23 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071547100715472020-12-10T10:59:002021-07-132020-12-10T10:59:002021-06-10T11:04:002020-12-102021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071550100715502020-12-10T15:20:002021-06-242020-12-10T15:20:002020-12-30T15:13:002020-12-10 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071551100715512020-12-10T15:08:002021-08-302020-12-10T15:08:002021-06-14T14:49:002020-12-102021-08-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071552100715522020-12-10T16:40:002021-07-162020-12-10T16:40:002021-06-16T14:54:002020-12-102021-07-16 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071554100715542020-12-10T16:55:002021-08-042020-12-10T16:55:002020-12-30T15:29:002020-12-102021-08-04 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071555100715552020-12-10T16:36:002021-06-222020-12-10T16:36:002020-12-29T15:48:002020-12-10 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071557100715572020-12-14T09:42:002021-08-102020-12-14T09:42:002021-01-04T11:06:002020-12-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071558100715582020-12-14T09:53:002021-06-282020-12-14T09:53:002021-01-04T09:33:002020-12-142021-06-28 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071559100715592020-12-14T11:52:002021-08-302020-12-14T11:52:002021-06-17T11:48:002020-12-142021-08-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071560100715602020-12-14T14:21:002021-07-062020-12-14T14:21:002021-06-07T14:56:002020-12-142021-07-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071561100715612020-12-14T15:08:002021-08-192020-12-14T15:08:002021-01-04T15:04:002020-12-142021-08-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071562100715622020-12-14T16:30:002021-07-062020-12-14T16:30:002021-06-07T12:26:002020-12-142021-07-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071563100715632020-12-14T16:21:002021-07-062020-12-14T16:21:002021-06-07T12:31:002020-12-142021-07-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071564100715642020-12-14T17:10:002021-06-302020-12-14T17:10:002021-01-06T15:38:002020-12-142021-06-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071565100715652020-12-14T17:22:002021-06-302020-12-14T17:22:002021-01-06T15:44:002020-12-142021-06-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071566100715662020-12-14T17:14:002021-07-072020-12-14T17:14:002021-01-04T16:35:002020-12-142021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071567100715672020-12-15T10:06:002021-06-292020-12-15T10:06:002021-01-05T09:14:002020-12-152021-06-29 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071568100715682020-12-15T10:16:002021-07-222020-12-15T10:16:002021-06-22T09:29:002020-12-152021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071569100715692020-12-15T11:10:002021-07-222020-12-15T11:10:002021-06-23T10:21:002020-12-152021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071570100715702020-12-15T11:24:002021-07-222020-12-15T11:24:002021-06-23T10:28:002020-12-152021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071571100715712020-12-15T13:46:002021-06-302020-12-15T13:46:002021-01-06T16:32:002020-12-152021-06-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071572100715722020-12-15T17:05:002021-07-062020-12-15T17:05:002021-01-05T16:03:002020-12-152021-07-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071573100715732020-12-15T17:14:002021-06-302020-12-15T17:14:002021-01-04T15:13:002020-12-152021-06-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071574100715742020-12-16T10:00:002021-08-242020-12-16T10:00:002021-01-06T13:30:002020-12-162021-08-24 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071575100715752020-12-16T15:11:002021-06-302020-12-16T15:11:002021-01-06T14:56:002020-12-162021-06-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071576100715762020-12-16T15:31:002021-07-012020-12-16T15:31:002021-06-03T16:26:002020-12-162021-07-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071577100715772020-12-16T17:32:002021-06-082020-12-16T17:32:002021-05-11T10:09:002020-12-162021-06-08 100713351 Frenck, Robert Wilson (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071578100715782020-12-16T17:26:002021-07-122020-12-16T17:26:002021-06-14T13:56:002020-12-162021-07-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071579100715792020-12-16T17:36:002021-07-072020-12-16T17:36:002021-01-06T14:56:002020-12-162021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071580100715802020-12-16T17:44:002021-06-302020-12-16T17:44:002021-01-06T16:45:002020-12-162021-06-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071581100715812020-12-17T15:49:002021-07-132020-12-17T15:49:002021-06-14T11:23:002020-12-172021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071582100715822020-12-17T15:59:002021-07-082020-12-17T15:59:002021-01-07T15:43:002020-12-172021-07-08 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071583100715832020-12-17T16:41:002021-07-092020-12-17T16:41:002021-06-09T13:54:002020-12-172021-07-09 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071584100715842020-12-17T16:25:002021-08-272020-12-17T16:25:002021-01-07T16:12:002020-12-172021-08-27 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071585100715852020-12-17T16:27:002021-07-062020-12-17T16:27:002021-06-08T13:48:002020-12-172021-07-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071586100715862020-12-17T16:34:002021-07-212020-12-17T16:34:002021-06-22T09:49:002020-12-172021-07-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071587100715872020-12-17T16:47:002021-07-012020-12-17T16:47:002021-01-07T16:16:002020-12-172021-07-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071588100715882020-12-28T10:19:002021-07-272020-12-28T10:19:002021-01-20T09:20:002020-12-282021-07-27 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071589100715892020-12-28T11:25:002021-07-072020-12-28T11:25:002021-06-09T14:12:002020-12-282021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071590100715902020-12-28T12:21:002021-07-142020-12-28T12:21:002021-01-20T15:49:002020-12-282021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071591100715912020-12-28T12:56:002021-07-222020-12-28T12:56:002021-06-23T09:23:002020-12-282021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071592100715922020-12-28T12:50:002021-07-132020-12-28T12:50:002021-01-19T09:29:002020-12-282021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071593100715932020-12-28T12:57:002021-02-122020-12-28T12:57:002020-12-28T12:57:002020-12-282021-02-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071594100715942020-12-28T14:21:002021-07-192020-12-28T14:21:002021-01-19T16:55:002020-12-282021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071595100715952020-12-28T14:50:002021-08-042020-12-28T14:50:002021-06-10T10:57:002020-12-282021-08-04 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071596100715962020-12-28T15:26:002021-07-122020-12-28T15:26:002021-06-14T11:31:002020-12-282021-07-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071597100715972020-12-28T15:35:002021-07-152020-12-28T15:35:002021-01-19T16:10:002020-12-282021-07-15 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071599100715992020-12-28T16:40:002021-07-132020-12-28T16:40:002021-01-19T12:06:002020-12-282021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071600100716002020-12-28T16:44:002021-08-122020-12-28T16:44:002021-07-14T11:34:002020-12-28 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071601100716012020-12-28T16:54:002021-07-292020-12-28T16:54:002021-01-19T15:31:002020-12-282021-07-29 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071602100716022020-12-28T17:02:002021-07-202020-12-28T17:02:002021-01-19T16:56:002020-12-282021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071603100716032020-12-29T10:08:002021-07-202020-12-29T10:08:002021-01-19T16:45:002020-12-292021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071604100716042020-12-29T09:40:002021-07-142020-12-29T09:40:002021-01-19T16:37:002020-12-292021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071605100716052020-12-29T10:33:002021-07-132020-12-29T10:33:002021-01-19T10:01:002020-12-292021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071606100716062020-12-29T12:15:002021-07-192020-12-29T12:15:002021-01-19T16:36:002020-12-292021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071607100716072020-12-29T14:27:002021-08-312020-12-29T14:27:002021-06-10T14:10:002020-12-292021-08-31 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071608100716082020-12-29T14:21:002021-07-132020-12-29T14:21:002021-06-10T14:05:002020-12-29 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071609100716092020-12-29T14:49:002021-07-192020-12-29T14:49:002021-01-19T16:46:002020-12-29 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071610100716102020-12-29T15:05:002021-07-222020-12-29T15:05:002021-01-21T16:00:002020-12-292021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071612100716122020-12-29T15:00:002021-07-132020-12-29T15:00:002021-01-19T16:12:002020-12-292021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071613100716132020-12-29T16:13:002021-07-132020-12-29T16:13:002021-06-15T09:36:002020-12-292021-07-13 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071614100716142020-12-29T16:40:002021-08-262020-12-29T16:40:002021-06-28T14:09:002020-12-292021-08-26 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071615100716152020-12-29T16:12:002021-08-302020-12-29T16:12:002021-01-19T16:34:002020-12-292021-08-30 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071616100716162020-12-29T16:31:002021-07-282020-12-29T16:31:002021-01-19T13:55:002020-12-292021-07-28 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071617100716172020-12-29T17:14:002021-06-092020-12-29T17:14:002021-05-10T17:03:002020-12-292021-06-09 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071618100716182020-12-29T17:13:002021-07-262020-12-29T17:13:002021-01-19T09:24:002020-12-292021-07-26 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071619100716192020-12-30T09:45:002021-07-142020-12-30T09:45:002021-01-20T09:09:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071620100716202020-12-30T10:26:002021-07-142020-12-30T10:26:002021-01-20T16:30:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071621100716212020-12-30T10:45:002021-07-142020-12-30T10:45:002021-01-20T16:33:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071622100716222020-12-30T10:39:002021-07-142020-12-30T10:39:002020-12-30T10:39:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071623100716232020-12-30T10:59:002021-07-202020-12-30T10:59:002021-06-22T14:13:002020-12-302021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071624100716242020-12-30T12:08:002021-07-072020-12-30T12:08:002021-06-07T14:27:002020-12-302021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071625100716252020-12-30T12:17:002021-07-072020-12-30T12:17:002021-06-07T14:21:002020-12-302021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071626100716262020-12-30T14:05:002021-07-142020-12-30T14:05:002021-01-20T09:30:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071627100716272020-12-30T14:33:002021-07-212020-12-30T14:33:002021-01-20T09:00:002020-12-302021-07-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071628100716282020-12-30T16:10:002021-08-022020-12-30T16:10:002021-01-20T14:07:002020-12-302021-08-02 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071629100716292020-12-30T15:45:002021-07-202020-12-30T15:45:002021-06-22T12:31:002020-12-302021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071630100716302020-12-30T15:39:002021-07-202020-12-30T15:39:002021-06-22T12:38:002020-12-302021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071631100716312020-12-30T16:26:002021-07-152020-12-30T16:26:002021-01-21T16:04:002020-12-302021-07-15 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071632100716322020-12-30T16:45:002021-07-072020-12-30T16:45:002021-06-08T10:08:002020-12-302021-07-07 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071633100716332020-12-30T16:41:002021-07-152020-12-30T16:41:002021-01-21T16:17:002020-12-302021-07-15 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071634100716342021-01-04T10:34:002021-07-192021-01-04T10:34:002021-01-25T11:01:002021-01-042021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071635100716352021-01-04T10:09:002021-05-122021-01-04T10:09:002021-01-25T14:04:002021-01-042021-05-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071636100716362021-01-04T11:21:002021-07-192021-01-04T11:21:002021-01-25T10:00:002021-01-042021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071638100716382021-01-04T11:45:002021-08-022021-01-04T11:45:002021-01-25T09:32:002021-01-042021-08-02 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071639100716392021-01-04T12:10:002021-06-012021-01-04T12:10:002021-01-25T09:07:002021-01-042021-06-01 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071640100716402021-01-04T13:30:002021-07-212021-01-04T13:30:002021-06-22T13:58:002021-01-042021-07-21 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071641100716412021-01-04T14:14:002021-08-092021-01-04T14:14:002021-01-26T15:34:002021-01-042021-08-09 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071642100716422021-01-04T15:01:002021-08-092021-01-04T15:01:002021-05-27T14:42:002021-01-042021-08-09 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071643100716432021-01-04T14:55:002021-08-292021-01-04T14:55:002021-06-24T11:12:002021-01-042021-08-29 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071644100716442021-01-04T16:36:002021-07-192021-01-04T16:36:002021-01-25T15:34:002021-01-04 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071645100716452021-01-04T16:22:002021-07-142021-01-04T16:22:002021-06-16T10:23:002021-01-042021-07-14 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071646100716462021-01-04T17:09:002021-07-202021-01-04T17:09:002021-06-22T15:23:002021-01-042021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071647100716472021-01-04T17:19:002021-07-192021-01-04T17:19:002021-01-25T15:17:002021-01-042021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071648100716482021-01-05T09:27:002021-06-082021-01-05T09:27:002021-05-11T12:00:002021-01-052021-06-08 100713351 Frenck, Robert Wilson (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071649100716492021-01-05T09:55:002021-07-202021-01-05T09:55:002021-01-26T15:17:002021-01-052021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071650100716502021-01-05T11:09:002021-08-162021-01-05T11:09:002021-06-15T14:35:002021-01-05 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071651100716512021-01-05T10:55:002021-07-222021-01-05T10:55:002021-01-26T10:48:002021-01-052021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071652100716522021-01-05T11:17:002021-07-192021-01-05T11:17:002021-06-21T11:17:002021-01-052021-07-19 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071653100716532021-01-05T14:25:002021-07-202021-01-05T14:25:002021-01-26T14:42:002021-01-052021-07-20 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071654100716542021-01-05T14:14:002021-07-222021-01-05T14:14:002021-01-26T14:47:002021-01-052021-07-22 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071655100716552021-01-06T09:35:002021-07-062021-01-06T09:35:002021-06-07T16:06:002021-01-062021-07-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071656100716562021-01-06T10:14:002021-07-272021-01-06T10:14:002021-01-27T14:56:002021-01-062021-07-27 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071658100716582021-01-06T17:12:002021-07-122021-01-06T17:12:002021-06-07T15:08:002021-01-062021-07-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071659100716592021-01-06T16:57:002021-07-212021-01-06T16:57:002021-01-27T15:56:002021-01-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071660100716602021-01-06T16:53:002021-07-222021-01-06T16:53:002021-06-24T14:31:002021-01-06 100713351 Frenck, Robert Wilson (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071661100716612021-01-07T15:30:002021-08-172021-01-07T15:30:002021-01-28T16:06:002021-01-072021-08-17 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071662100716622021-01-07T16:07:002021-08-122021-01-07T16:07:002021-01-28T09:33:002021-01-072021-08-12 100713351 Frenck, Robert Wilson (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081751100817512020-12-01T11:04:002021-07-022020-12-01T11:04:002021-06-04T10:07:002020-12-012021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081752100817522020-12-01T15:26:002021-07-022020-12-01T15:26:002021-06-04T13:50:002020-12-012021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081753100817532020-12-01T15:27:002021-06-172020-12-01T15:27:002020-12-22T15:05:002020-12-012021-06-17 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081754100817542020-12-02T13:50:002021-06-162020-12-02T13:50:002020-12-22T08:50:002020-12-022021-06-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081755100817552020-12-02T13:57:002021-06-172020-12-02T13:57:002020-12-23T11:00:002020-12-022021-06-17 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081756100817562020-12-02T14:25:002021-06-142020-12-02T14:25:002021-05-12T15:08:002020-12-022021-06-14 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081757100817572020-12-02T14:22:002021-07-072020-12-02T14:22:002021-06-07T11:27:002020-12-022021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081758100817582020-12-02T15:05:002021-08-022020-12-02T15:05:002020-12-23T10:35:002020-12-022021-08-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081760100817602020-12-07T15:53:002021-07-062020-12-07T15:53:002020-12-28T11:11:002020-12-072021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081761100817612020-12-07T15:00:002021-05-252020-12-07T15:00:002021-04-27T14:56:002020-12-072021-05-25 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081763100817632020-12-07T16:28:002021-07-082020-12-07T16:28:002021-06-09T13:43:002020-12-072021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081764100817642020-12-07T16:23:002021-06-252020-12-07T16:23:002020-12-30T11:26:002020-12-072021-06-25 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081767100817672020-12-08T14:35:002021-07-012020-12-08T14:35:002021-06-03T13:25:002020-12-082021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081768100817682020-12-08T14:52:002021-06-292020-12-08T14:52:002020-12-29T13:29:002020-12-082021-06-29 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081769100817692020-12-08T15:08:002021-08-092020-12-08T15:08:002020-12-29T10:39:002020-12-082021-08-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081770100817702020-12-09T10:57:002021-06-232020-12-09T10:57:002020-12-30T11:35:002020-12-092021-06-23 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081771100817712020-12-09T10:50:002021-06-232020-12-09T10:50:002020-12-30T11:38:002020-12-092021-06-23 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081773100817732020-12-09T14:14:002021-07-022020-12-09T14:14:002021-06-04T11:18:002020-12-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081774100817742020-12-09T15:00:002021-06-302020-12-09T15:00:002020-12-28T12:06:002020-12-092021-06-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081775100817752020-12-09T14:57:002021-07-162020-12-09T14:57:002021-06-18T14:38:002020-12-092021-07-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081777100817772020-12-10T11:22:002021-06-282020-12-10T11:22:002020-12-31T09:27:002020-12-102021-06-28 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081780100817802020-12-10T14:55:002021-07-072020-12-10T14:55:002021-06-07T09:42:002020-12-102021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081781100817812020-12-10T15:02:002021-07-072020-12-10T15:02:002021-06-09T10:06:002020-12-102021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081785100817852020-12-11T14:37:002021-06-252020-12-11T14:37:002020-12-30T10:33:002020-12-112021-06-25 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081788100817882020-12-14T10:17:002021-07-012020-12-14T10:17:002021-06-03T14:53:002020-12-142021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081789100817892020-12-14T10:23:002021-07-082020-12-14T10:23:002021-01-04T13:06:002020-12-142021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081790100817902020-12-14T14:22:002021-08-102020-12-14T14:22:002021-06-03T13:16:002020-12-142021-08-10 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081791100817912020-12-14T15:11:002021-07-022020-12-14T15:11:002021-01-04T12:46:002020-12-142021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081792100817922020-12-14T15:15:002021-07-022020-12-14T15:15:002021-01-04T12:44:002020-12-142021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081793100817932020-12-14T15:21:002021-07-012020-12-14T15:21:002021-06-03T14:08:002020-12-142021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081794100817942020-12-14T15:26:002021-07-012020-12-14T15:26:002021-06-03T14:09:002020-12-142021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081795100817952020-12-15T11:41:002021-07-062020-12-15T11:41:002021-01-07T12:27:002020-12-152021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081796100817962020-12-15T14:07:002021-07-062020-12-15T14:07:002021-06-03T11:23:002020-12-152021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081797100817972020-12-15T15:08:002021-07-062020-12-15T15:08:002021-01-05T15:36:002020-12-152021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081798100817982020-12-15T15:16:002021-07-122020-12-15T15:16:002021-06-04T14:02:002020-12-152021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081799100817992020-12-15T15:21:002021-07-122020-12-15T15:21:002021-01-05T10:22:002020-12-152021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081800100818002020-12-16T11:20:002021-07-072020-12-16T11:20:002021-01-06T13:19:002020-12-162021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081801100818012020-12-17T11:02:002021-07-062020-12-17T11:02:002021-06-07T13:41:002020-12-172021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081802100818022020-12-17T14:04:002021-08-132020-12-17T14:04:002021-01-07T09:42:002020-12-172021-08-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081803100818032020-12-17T14:13:002021-05-112020-12-17T14:13:002021-04-09T13:54:002020-12-172021-05-11 1008424439 Jennings, Timothy W. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081804100818042020-12-17T14:42:002021-07-012020-12-17T14:42:002021-06-03T14:17:002020-12-172021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081805100818052020-12-17T15:33:002021-07-022020-12-17T15:33:002021-01-07T15:32:002020-12-172021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081806100818062020-12-17T15:45:002021-07-092020-12-17T15:45:002021-01-07T15:05:002020-12-17 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081807100818072020-12-18T10:25:002021-07-062020-12-18T10:25:002021-06-04T09:39:002020-12-182021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081808100818082020-12-18T10:40:002021-07-062020-12-18T10:40:002021-06-07T09:48:002020-12-182021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081809100818092020-12-18T11:36:002021-07-142020-12-18T11:36:002021-06-03T12:09:002020-12-182021-07-14 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081810100818102020-12-18T11:56:002021-07-022020-12-18T11:56:002021-01-08T11:19:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081811100818112020-12-18T11:49:002021-07-022020-12-18T11:49:002021-01-08T11:16:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081812100818122020-12-18T14:20:002021-07-022020-12-18T14:20:002021-06-04T09:43:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081813100818132020-12-18T14:42:002021-07-122020-12-18T14:42:002021-01-08T11:45:002020-12-182021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081814100818142020-12-18T15:12:002021-07-022020-12-18T15:12:002021-01-08T15:12:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081815100818152020-12-18T15:22:002021-07-082020-12-18T15:22:002021-06-10T09:27:002020-12-182021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081816100818162020-12-18T15:19:002021-07-022020-12-18T15:19:002021-01-08T14:52:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081817100818172020-12-18T15:42:002021-07-022020-12-18T15:42:002021-06-04T11:58:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081818100818182020-12-18T15:50:002021-07-082020-12-18T15:50:002021-01-08T14:28:002020-12-182021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081819100818192020-12-21T10:12:002021-07-062020-12-21T10:12:002021-06-08T09:28:002020-12-212021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081820100818202020-12-21T10:18:002021-07-132020-12-21T10:18:002021-06-15T13:17:002020-12-212021-07-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081821100818212020-12-21T10:49:002021-07-092020-12-21T10:49:002021-01-12T15:03:002020-12-212021-07-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081822100818222020-12-21T11:05:002021-07-062020-12-21T11:05:002021-06-04T10:11:002020-12-212021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081823100818232020-12-21T11:10:002021-08-242020-12-21T11:10:002021-01-11T08:55:002020-12-212021-08-24 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081824100818242020-12-21T11:45:002021-07-162020-12-21T11:45:002021-01-11T09:36:002020-12-212021-07-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081825100818252020-12-21T14:07:002021-07-012020-12-21T14:07:002021-06-03T11:15:002020-12-212021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081826100818262020-12-21T14:13:002021-07-282020-12-21T14:13:002021-01-12T13:37:002020-12-212021-07-28 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081827100818272020-12-21T15:07:002021-07-072020-12-21T15:07:002021-01-11T14:52:002020-12-212021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081828100818282020-12-21T14:56:002021-07-072020-12-21T14:56:002021-06-08T13:57:002020-12-212021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081829100818292020-12-22T09:56:002021-05-132020-12-22T09:56:002021-01-12T15:09:002020-12-222021-05-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081830100818302020-12-22T10:02:002021-07-072020-12-22T10:02:002021-06-09T11:27:002020-12-222021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081831100818312020-12-22T10:46:002021-07-062020-12-22T10:46:002021-01-12T08:48:002020-12-222021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081832100818322020-12-22T11:06:002021-08-202020-12-22T11:06:002021-01-12T09:17:002020-12-222021-08-20 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081833100818332020-12-22T11:01:002021-07-022020-12-22T11:01:002021-06-04T10:15:002020-12-222021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081834100818342020-12-22T12:50:002021-05-132020-12-22T12:50:002021-01-13T14:52:002020-12-222021-05-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081835100818352020-12-22T14:18:002021-07-062020-12-22T14:18:002021-01-12T14:58:002020-12-222021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081836100818362020-12-22T14:59:002021-07-022020-12-22T14:59:002021-06-04T10:42:002020-12-222021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081837100818372020-12-22T15:40:002021-09-012020-12-22T15:40:002021-06-09T13:47:002020-12-222021-09-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081838100818382020-12-22T15:44:002021-07-082020-12-22T15:44:002021-01-12T15:23:002020-12-222021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081839100818392020-12-22T15:50:002021-07-192020-12-22T15:50:002021-01-12T14:28:002020-12-222021-07-19 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081840100818402020-12-23T09:40:002021-07-022020-12-23T09:40:002021-06-04T13:52:002020-12-232021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081841100818412020-12-23T09:44:002021-07-132020-12-23T09:44:002021-01-13T14:26:002020-12-232021-07-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081842100818422020-12-23T09:48:002021-07-082020-12-23T09:48:002021-06-09T13:39:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081843100818432020-12-23T10:09:002021-07-072020-12-23T10:09:002021-01-13T15:03:002020-12-232021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081844100818442020-12-23T10:13:002021-07-082020-12-23T10:13:002021-06-09T15:18:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081845100818452020-12-23T11:15:002021-08-112020-12-23T11:15:002021-06-08T09:45:002020-12-232021-08-11 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081846100818462020-12-23T11:24:002021-07-082020-12-23T11:24:002021-01-11T09:18:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081847100818472020-12-23T11:09:002021-07-082020-12-23T11:09:002021-01-13T13:51:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081848100818482020-12-23T11:31:002021-09-012020-12-23T11:31:002021-01-14T15:08:002020-12-232021-09-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081849100818492020-12-23T11:37:002021-07-022020-12-23T11:37:002021-06-04T11:57:002020-12-232021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081850100818502020-12-23T11:58:002021-07-122020-12-23T11:58:002021-01-14T14:17:002020-12-232021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081851100818512020-12-23T12:43:002021-07-062020-12-23T12:43:002021-06-08T09:18:002020-12-232021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081852100818522020-12-23T12:47:002021-07-062020-12-23T12:47:002021-06-08T09:20:002020-12-232021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081853100818532020-12-28T10:18:002021-07-062020-12-28T10:18:002021-06-07T13:44:002020-12-282021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081854100818542020-12-28T11:05:002021-07-092020-12-28T11:05:002021-01-18T09:55:002020-12-282021-07-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081855100818552020-12-28T11:26:002021-07-262020-12-28T11:26:002021-01-18T14:56:002020-12-282021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081856100818562020-12-28T11:39:002021-08-032020-12-28T11:39:002021-06-09T10:09:002020-12-282021-08-03 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081857100818572020-12-28T15:03:002021-07-132020-12-28T15:03:002021-01-19T15:21:002020-12-282021-07-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081858100818582020-12-28T15:00:002021-09-012020-12-28T15:00:002021-03-08T14:50:002020-12-282021-09-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081859100818592020-12-28T15:10:002021-07-122020-12-28T15:10:002021-01-18T11:47:002020-12-282021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081860100818602020-12-28T15:16:002021-07-192020-12-28T15:16:002021-01-18T14:05:002020-12-28 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081861100818612020-12-29T10:25:002021-06-302020-12-29T10:25:002021-06-02T14:02:002020-12-292021-06-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081862100818622020-12-29T11:15:002021-08-062020-12-29T11:15:002021-01-20T10:12:002020-12-292021-08-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081863100818632020-12-29T11:24:002021-07-062020-12-29T11:24:002021-06-07T09:46:002020-12-292021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081864100818642020-12-29T11:29:002021-07-262020-12-29T11:29:002021-01-18T11:12:002020-12-292021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081865100818652020-12-29T11:35:002021-08-092020-12-29T11:35:002021-01-19T14:50:002020-12-292021-08-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081866100818662020-12-29T14:47:002021-07-022020-12-29T14:47:002021-06-04T09:48:002020-12-292021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081867100818672020-12-29T14:51:002021-07-222020-12-29T14:51:002021-06-04T09:49:002020-12-292021-07-22 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081868100818682020-12-29T14:56:002021-07-142020-12-29T14:56:002021-01-19T13:47:002020-12-292021-07-14 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081869100818692020-12-29T15:13:002021-06-302020-12-29T15:13:002021-06-02T11:30:002020-12-292021-06-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081870100818702020-12-29T15:33:002021-07-092020-12-29T15:33:002021-01-18T12:16:002020-12-292021-07-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081871100818712020-12-30T10:40:002021-07-022020-12-30T10:40:002021-06-03T13:19:002020-12-302021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081872100818722020-12-30T11:12:002021-06-012020-12-30T11:12:002021-04-28T14:51:002020-12-302021-06-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081873100818732020-12-30T11:16:002021-07-302020-12-30T11:16:002021-01-18T09:19:002020-12-302021-07-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081874100818742020-12-30T11:45:002021-07-142020-12-30T11:45:002021-01-20T10:18:002020-12-302021-07-14 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081875100818752020-12-30T11:49:002021-07-012020-12-30T11:49:002021-06-03T09:11:002020-12-302021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081876100818762020-12-30T14:22:002021-07-212020-12-30T14:22:002021-01-20T13:19:002020-12-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081877100818772020-12-30T14:36:002021-07-072020-12-30T14:36:002021-06-07T13:27:002020-12-302021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081878100818782020-12-30T14:42:002021-07-162020-12-30T14:42:002021-01-20T14:31:002020-12-302021-07-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081879100818792020-12-30T14:47:002021-07-162020-12-30T14:47:002021-01-20T10:48:002020-12-302021-07-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081880100818802020-12-30T15:08:002021-07-062020-12-30T15:08:002021-06-08T14:27:002020-12-302021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081881100818812020-12-30T15:12:002021-07-062020-12-30T15:12:002021-06-08T14:28:002020-12-302021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081882100818822020-12-31T10:50:002021-08-162020-12-31T10:50:002021-01-21T15:00:002020-12-312021-08-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081883100818832020-12-31T10:55:002021-07-162020-12-31T10:55:002021-01-21T14:57:002020-12-312021-07-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081884100818842020-12-31T11:30:002021-07-092020-12-31T11:30:002021-06-03T13:13:002020-12-312021-07-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081885100818852020-12-31T11:51:002021-07-292020-12-31T11:51:002021-01-21T09:45:002020-12-312021-07-29 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081886100818862020-12-31T11:54:002021-07-212020-12-31T11:54:002021-01-21T09:48:002020-12-312021-07-21 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081887100818872021-01-04T10:31:002021-07-012021-01-04T10:31:002021-06-03T09:07:002021-01-042021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081888100818882021-01-04T10:40:002021-07-012021-01-04T10:40:002021-06-03T14:05:002021-01-042021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081889100818892021-01-04T11:24:002021-07-262021-01-04T11:24:002021-01-25T09:08:002021-01-042021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081890100818902021-01-04T11:21:002021-07-262021-01-04T11:21:002021-01-25T08:56:002021-01-042021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081891100818912021-01-04T11:31:002021-07-062021-01-04T11:31:002021-06-08T08:50:002021-01-042021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081892100818922021-01-04T14:32:002021-07-132021-01-04T14:32:002021-06-15T08:50:002021-01-042021-07-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSMAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081893100818932021-01-04T14:37:002021-07-262021-01-04T14:37:002021-01-25T14:15:002021-01-042021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081894100818942021-01-04T15:21:002021-07-212021-01-04T15:21:002021-01-27T10:06:002021-01-042021-07-21 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081895100818952021-01-04T15:28:002021-07-192021-01-04T15:28:002021-01-25T14:45:002021-01-042021-07-19 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081896100818962021-01-04T15:26:002021-07-062021-01-04T15:26:002021-06-04T12:58:002021-01-042021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081897100818972021-01-05T10:54:002021-08-302021-01-05T10:54:002021-01-26T10:00:002021-01-052021-08-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081898100818982021-01-05T11:05:002021-07-012021-01-05T11:05:002021-06-02T13:36:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081899100818992021-01-05T11:07:002021-07-012021-01-05T11:07:002021-06-02T13:35:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081900100819002021-01-05T14:44:002021-08-112021-01-05T14:44:002021-01-26T14:48:002021-01-052021-08-11 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081901100819012021-01-05T14:50:002021-08-312021-01-05T14:50:002021-03-08T14:02:002021-01-052021-08-31 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081902100819022021-01-05T15:02:002021-07-012021-01-05T15:02:002021-06-03T14:57:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081903100819032021-01-05T15:07:002021-07-162021-01-05T15:07:002021-01-26T09:50:002021-01-052021-07-16 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081904100819042021-01-05T15:25:002021-07-012021-01-05T15:25:002021-06-03T14:13:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081905100819052021-01-06T10:28:002021-07-292021-01-06T10:28:002021-01-29T14:33:002021-01-062021-07-29 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081906100819062021-01-06T10:58:002021-07-212021-01-06T10:58:002021-01-27T10:37:002021-01-062021-07-21 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081907100819072021-01-06T11:22:002021-07-022021-01-06T11:22:002021-06-04T14:05:002021-01-062021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081908100819082021-01-06T11:18:002021-07-212021-01-06T11:18:002021-01-27T10:20:002021-01-062021-07-21 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081909100819092021-01-06T11:28:002021-07-072021-01-06T11:28:002021-06-07T12:05:002021-01-062021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081910100819102021-01-06T14:46:002021-07-282021-01-06T14:46:002021-01-27T13:21:002021-01-062021-07-28 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081911100819112021-01-06T14:52:002021-07-022021-01-06T14:52:002021-06-04T09:45:002021-01-062021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081912100819122021-01-06T15:31:002021-08-022021-01-06T15:31:002021-01-28T15:01:002021-01-062021-08-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081913100819132021-01-06T15:20:002021-07-062021-01-06T15:20:002021-06-07T13:37:002021-01-062021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081914100819142021-01-06T15:15:002021-06-302021-01-06T15:15:002021-06-02T13:31:002021-01-062021-06-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081915100819152021-01-07T10:57:002021-07-222021-01-07T10:57:002021-01-28T10:25:002021-01-072021-07-22 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081916100819162021-01-07T11:13:002021-07-222021-01-07T11:13:002021-01-28T14:35:002021-01-072021-07-22 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081917100819172021-01-07T11:06:002021-07-092021-01-07T11:06:002021-06-10T08:47:002021-01-072021-07-09 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081918100819182021-01-07T14:45:002021-07-222021-01-07T14:45:002021-01-28T14:07:002021-01-072021-07-22 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081919100819192021-01-07T14:57:002021-07-082021-01-07T14:57:002021-06-10T13:21:002021-01-072021-07-08 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081920100819202021-01-07T15:17:002021-07-262021-01-07T15:17:002021-01-28T14:00:002021-01-072021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081921100819212021-01-07T15:42:002021-07-122021-01-07T15:42:002021-05-17T14:37:002021-01-072021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081922100819222021-01-08T10:28:002021-07-232021-01-08T10:28:002021-01-29T14:42:002021-01-082021-07-23 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081923100819232021-01-08T10:36:002021-07-012021-01-08T10:36:002021-06-03T11:43:002021-01-082021-07-01 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081924100819242021-01-08T10:49:002021-07-062021-01-08T10:49:002021-06-04T11:54:002021-01-082021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081925100819252021-01-08T11:27:002021-07-282021-01-08T11:27:002021-01-29T14:57:002021-01-082021-07-28 1008424439 Jennings, Timothy W. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081926100819262021-01-08T15:13:002021-07-072021-01-08T15:13:002021-06-04T13:47:002021-01-082021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081927100819272021-01-08T14:44:002021-08-022021-01-08T14:44:002021-01-29T13:18:002021-01-082021-08-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081928100819282021-01-08T15:23:002021-07-302021-01-08T15:23:002021-01-29T14:26:002021-01-082021-07-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081929100819292021-01-08T15:37:002021-07-272021-01-08T15:37:002021-01-29T14:37:002021-01-082021-07-27 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081930100819302021-01-11T10:41:002021-07-062021-01-11T10:41:002021-06-04T11:56:002021-01-112021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081931100819312021-01-11T10:48:002021-07-122021-01-11T10:48:002021-06-09T10:01:002021-01-112021-07-12 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081932100819322021-01-11T10:52:002021-07-072021-01-11T10:52:002021-06-09T10:03:002021-01-112021-07-07 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081933100819332021-01-11T13:49:002021-07-062021-01-11T13:49:002021-06-07T14:07:002021-01-112021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081934100819342021-01-11T14:27:002021-07-272021-01-11T14:27:002021-02-01T14:54:002021-01-112021-07-27 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081935100819352021-01-11T14:57:002021-08-132021-01-11T14:57:002021-02-03T14:14:002021-01-112021-08-13 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081936100819362021-01-11T15:06:002021-06-302021-01-11T15:06:002021-06-02T10:04:002021-01-112021-06-30 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081937100819372021-01-11T15:27:002021-07-262021-01-11T15:27:002021-02-01T14:49:002021-01-112021-07-26 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081938100819382021-01-11T15:36:002021-07-062021-01-11T15:36:002021-06-07T11:23:002021-01-112021-07-06 1008424439 Jennings, Timothy W. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081940100819402021-01-12T11:49:002021-07-272021-01-12T11:49:002021-02-02T09:30:002021-01-122021-07-27 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081941100819412021-01-12T14:34:002021-07-022021-01-12T14:34:002021-06-04T13:56:002021-01-122021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081942100819422021-01-12T14:35:002021-07-022021-01-12T14:35:002021-06-04T13:54:002021-01-122021-07-02 1008424439 Jennings, Timothy W. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081943100819432021-01-12T14:40:002021-08-042021-01-12T14:40:002021-02-02T14:59:002021-01-122021-08-04 1008424439 Jennings, Timothy W. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091204100912042020-10-15T10:10:002021-08-232020-10-15T10:10:002021-08-23T15:54:002020-10-15 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091205100912052020-10-15T12:58:002021-06-102020-10-15T12:58:002020-11-06T16:45:002020-10-152021-06-10 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091208100912082020-10-15T13:24:002021-04-232020-10-15T13:24:002021-03-25T16:02:002020-10-15 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091209100912092020-10-15T16:52:002021-05-212020-10-15T16:52:002020-11-04T16:25:002020-10-152021-05-21 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091212100912122020-10-16T09:45:002021-07-082020-10-16T09:45:002021-06-10T15:29:002020-10-162021-07-08 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091213100912132020-10-16T10:21:002021-04-162020-10-16T10:21:002021-03-16T09:05:002020-10-16 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091216100912162020-10-16T11:58:002021-05-142020-10-16T11:58:002020-11-06T11:38:002020-10-162021-05-14 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091218100912182020-10-16T12:03:002021-05-142020-10-16T12:03:002020-11-06T11:44:002020-10-162021-05-14 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091220100912202020-10-19T13:53:002021-08-182020-10-19T13:53:002020-11-07T11:12:002020-10-192021-08-18 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091221100912212020-10-19T13:58:002021-05-142020-10-19T13:58:002020-11-07T11:10:002020-10-192021-05-14 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091223100912232020-10-19T14:11:002021-05-142020-10-19T14:11:002020-11-10T14:11:002020-10-192021-05-14 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091226100912262020-10-20T13:13:002021-07-142020-10-20T13:13:002021-06-11T11:06:002020-10-202021-07-14 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091227100912272020-10-20T16:49:002021-07-262020-10-20T16:49:002020-11-10T16:16:002020-10-202021-07-26 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091229100912292020-10-20T17:21:002021-07-132020-10-20T17:21:002021-06-11T15:48:002020-10-202021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091231100912312020-10-20T18:16:002021-05-192020-10-20T18:16:002020-11-09T15:56:002020-10-202021-05-19 100933285 Christensen, Shane Glade (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091233100912332020-10-21T10:46:002021-07-222020-10-21T10:46:002021-06-23T11:54:002020-10-212021-07-22 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091234100912342020-10-21T14:40:002021-09-012020-10-21T14:40:002020-11-11T14:00:002020-10-212021-09-01 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091237100912372020-10-21T15:47:002021-08-302020-10-21T15:47:002020-11-12T14:11:002020-10-21 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091238100912382020-10-21T17:23:002021-06-212020-10-21T17:23:002021-05-17T13:07:002020-10-212021-06-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091240100912402020-10-21T17:42:002021-05-172020-10-21T17:42:002020-11-09T17:40:002020-10-212021-05-17 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091246100912462020-10-22T16:02:002021-07-082020-10-22T16:02:002021-06-08T15:48:002020-10-222021-07-08 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091247100912472020-10-22T16:31:002021-05-192020-10-22T16:31:002020-11-11T17:05:002020-10-222021-05-19 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091249100912492020-10-22T19:44:002021-07-132020-10-22T19:44:002021-06-09T15:30:002020-10-222021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091250100912502020-10-22T19:46:002021-05-182020-10-22T19:46:002020-11-13T12:47:002020-10-222021-05-18 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091265100912652020-12-01T14:57:002021-06-292020-12-01T14:57:002020-12-22T09:16:002020-12-012021-06-29 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091266100912662020-12-01T11:28:002021-04-202020-12-01T11:28:002021-03-23T12:02:002020-12-01 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091267100912672020-12-01T13:17:002021-07-122020-12-01T13:17:002021-06-07T11:08:002020-12-012021-07-12 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091269100912692020-12-01T18:04:002021-06-172020-12-01T18:04:002020-12-23T18:02:002020-12-012021-06-17 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091270100912702020-12-01T18:06:002021-06-172020-12-01T18:06:002020-12-23T18:07:002020-12-012021-06-17 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091272100912722020-12-02T13:33:002021-08-102020-12-02T13:33:002020-12-22T12:47:002020-12-022021-08-10 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091273100912732020-12-02T13:35:002021-07-152020-12-02T13:35:002021-06-11T15:00:002020-12-022021-07-15 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091274100912742020-12-02T17:52:002021-08-232020-12-02T17:52:002021-07-21T08:37:002020-12-022021-08-23 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091275100912752020-12-02T17:50:002021-08-232020-12-02T17:50:002021-07-21T08:38:002020-12-022021-08-23 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091277100912772020-12-03T15:24:002021-07-302020-12-03T15:24:002021-06-28T14:16:002020-12-032021-07-30 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091280100912802020-12-03T19:31:002021-06-232020-12-03T19:31:002020-12-22T10:27:002020-12-032021-06-23 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091281100912812020-12-03T17:20:002021-06-182020-12-03T17:20:002020-12-22T10:31:002020-12-032021-06-18 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091282100912822020-12-03T17:13:002021-08-092020-12-03T17:13:002021-07-12T14:01:002020-12-032021-08-09 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091283100912832020-12-03T17:40:002021-08-132020-12-03T17:40:002021-07-15T10:16:002020-12-03 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091284100912842020-12-03T17:43:002021-06-212020-12-03T17:43:002020-12-23T10:10:002020-12-032021-06-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091287100912872020-12-04T13:29:002021-08-042020-12-04T13:29:002020-12-23T13:41:002020-12-042021-08-04 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091288100912882020-12-04T13:31:002021-06-212020-12-04T13:31:002020-12-23T13:40:002020-12-042021-06-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091289100912892020-12-04T14:55:002021-06-222020-12-04T14:55:002020-12-23T11:18:002020-12-042021-06-22 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091292100912922020-12-04T15:36:002021-05-282020-12-04T15:36:002021-04-23T16:21:002020-12-042021-05-28 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091293100912932020-12-04T17:49:002021-08-062020-12-04T17:49:002021-06-10T15:20:002020-12-042021-08-06 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091294100912942020-12-07T11:38:002021-07-272020-12-07T11:38:002021-04-28T09:35:002020-12-072021-07-27 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091295100912952020-12-07T14:43:002021-06-232020-12-07T14:43:002020-12-29T13:58:002020-12-072021-06-23 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091296100912962020-12-07T14:41:002021-08-192020-12-07T14:41:002021-07-16T08:55:002020-12-07 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091297100912972020-12-07T15:30:002021-08-112020-12-07T15:30:002020-12-28T12:40:002020-12-072021-08-11 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091298100912982020-12-07T16:33:002021-08-102020-12-07T16:33:002020-12-28T15:33:002020-12-072021-08-10 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091300100913002020-12-07T18:07:002021-06-212020-12-07T18:07:002020-12-28T14:36:002020-12-072021-06-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091301100913012020-12-07T18:05:002021-08-262020-12-07T18:05:002021-06-21T16:22:002020-12-072021-08-26 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091303100913032020-12-08T12:52:002021-08-132020-12-08T12:52:002021-07-12T12:59:002020-12-082021-08-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091304100913042020-12-08T16:51:002021-06-282020-12-08T16:51:002020-12-29T17:00:002020-12-082021-06-28 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091305100913052020-12-08T18:00:002021-09-022020-12-08T18:00:002021-04-09T12:15:002020-12-082021-09-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091306100913062020-12-08T17:58:002021-09-022020-12-08T17:58:002021-06-02T09:44:002020-12-082021-09-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091307100913072020-12-09T09:38:002021-08-312020-12-09T09:38:002020-12-30T09:18:002020-12-092021-08-31 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091308100913082020-12-09T09:40:002021-08-312020-12-09T09:40:002020-12-30T09:17:002020-12-092021-08-31 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091309100913092020-12-09T11:42:002021-06-222020-12-09T11:42:002020-12-29T15:04:002020-12-092021-06-22 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091310100913102020-12-09T11:50:002021-06-242020-12-09T11:50:002020-12-29T14:07:002020-12-092021-06-24 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091311100913112020-12-09T13:52:002021-07-132020-12-09T13:52:002021-06-08T12:50:002020-12-092021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091312100913122020-12-09T15:37:002021-07-282020-12-09T15:37:002021-06-25T14:02:002020-12-092021-07-28 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091313100913132020-12-09T15:34:002021-06-302020-12-09T15:34:002020-12-29T12:03:002020-12-09 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091314100913142020-12-09T16:33:002021-08-022020-12-09T16:33:002021-08-02T10:45:002020-12-09 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091315100913152020-12-09T18:30:002021-06-212020-12-09T18:30:002020-12-28T11:13:002020-12-092021-06-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091316100913162020-12-09T18:27:002021-05-072020-12-09T18:27:002021-04-08T10:30:002020-12-092021-05-07 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091317100913172020-12-10T11:23:002021-08-132020-12-10T11:23:002021-07-15T11:06:002020-12-102021-08-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091318100913182020-12-10T13:07:002021-06-232020-12-10T13:07:002020-12-29T12:40:002020-12-10 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091319100913192020-12-10T14:27:002021-06-222020-12-10T14:27:002020-12-29T09:02:002020-12-10 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091320100913202020-12-10T14:35:002021-08-252020-12-10T14:35:002021-06-28T11:48:002020-12-102021-08-25 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091321100913212020-12-10T15:32:002021-06-242020-12-10T15:32:002020-12-30T13:59:002020-12-10 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091322100913222020-12-10T16:25:002021-08-312020-12-10T16:25:002020-12-30T16:32:002020-12-102021-08-31 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091323100913232020-12-10T16:28:002021-08-232020-12-10T16:28:002021-07-26T09:54:002020-12-102021-08-23 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091324100913242020-12-11T10:44:002021-08-182020-12-11T10:44:002021-08-18T16:48:002020-12-11 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091325100913252020-12-11T10:47:002021-06-302020-12-11T10:47:002020-12-31T09:55:002020-12-112021-06-30 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091326100913262020-12-11T10:58:002021-07-282020-12-11T10:58:002021-06-25T15:59:002020-12-112021-07-28 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091328100913282020-12-11T13:47:002021-07-022020-12-11T13:47:002020-12-30T11:24:002020-12-112021-07-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091329100913292020-12-11T13:45:002021-07-202020-12-11T13:45:002021-06-17T15:22:002020-12-11 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091330100913302020-12-11T13:43:002021-08-302020-12-11T13:43:002021-07-28T10:42:002020-12-112021-08-30 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091331100913312020-12-11T15:00:002021-07-092020-12-11T15:00:002020-12-30T11:59:002020-12-112021-07-09 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091332100913322020-12-11T15:04:002021-08-022020-12-11T15:04:002020-12-30T12:01:002020-12-112021-08-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091333100913332020-12-11T15:30:002021-06-242020-12-11T15:30:002020-12-30T13:15:002020-12-112021-06-24 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091334100913342020-12-11T19:06:002021-07-122020-12-11T19:06:002021-06-08T16:57:002020-12-112021-07-12 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091335100913352020-12-11T18:08:002021-06-292020-12-11T18:08:002020-12-31T10:48:002020-12-112021-06-29 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091336100913362020-12-11T18:10:002021-08-052020-12-11T18:10:002021-08-05T16:58:002020-12-11 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091337100913372020-12-14T11:11:002021-09-012020-12-14T11:11:002021-06-08T13:09:002020-12-142021-09-01 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091338100913382020-12-14T13:57:002021-08-102020-12-14T13:57:002021-08-10T10:15:002020-12-14 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091339100913392020-12-14T13:59:002021-07-202020-12-14T13:59:002021-01-18T10:58:002020-12-142021-07-20 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091340100913402020-12-14T16:37:002021-07-012020-12-14T16:37:002021-01-04T16:15:002020-12-142021-07-01 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091341100913412020-12-14T18:27:002021-08-232020-12-14T18:27:002021-07-21T08:58:002020-12-142021-08-23 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091342100913422020-12-14T18:25:002021-06-302020-12-14T18:25:002021-01-04T17:11:002020-12-142021-06-30 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091343100913432020-12-15T12:50:002021-07-062020-12-15T12:50:002021-01-05T11:21:002020-12-152021-07-06 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091344100913442020-12-15T12:47:002021-07-302020-12-15T12:47:002021-03-23T15:58:002020-12-15 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091345100913452020-12-15T15:16:002021-08-302020-12-15T15:16:002021-01-05T15:00:002020-12-152021-08-30 100933285 Christensen, Shane Glade (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091346100913462020-12-15T15:14:002021-05-042020-12-15T15:14:002021-04-06T16:10:002020-12-152021-05-04 100933285 Christensen, Shane Glade (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091347100913472020-12-15T15:31:002021-08-052020-12-15T15:31:002021-08-05T16:17:002020-12-15 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091348100913482020-12-15T15:33:002021-07-022020-12-15T15:33:002021-01-06T11:09:002020-12-152021-07-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091349100913492020-12-15T17:50:002021-08-192020-12-15T17:50:002021-06-07T17:03:002020-12-152021-08-19 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091350100913502020-12-16T10:57:002021-08-042020-12-16T10:57:002021-08-04T16:39:002020-12-16 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091351100913512020-12-16T12:58:002021-07-012020-12-16T12:58:002021-01-06T13:55:002020-12-162021-07-01 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091353100913532020-12-16T13:19:002021-07-132020-12-16T13:19:002021-01-06T17:22:002020-12-162021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091354100913542020-12-16T14:45:002021-07-082020-12-16T14:45:002021-01-07T10:03:002020-12-162021-07-08 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091355100913552020-12-16T16:41:002021-08-242020-12-16T16:41:002021-01-08T15:59:002020-12-162021-08-24 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091356100913562020-12-16T17:29:002021-07-092020-12-16T17:29:002021-06-07T08:31:002020-12-162021-07-09 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091357100913572020-12-17T10:40:002021-05-042020-12-17T10:40:002021-04-05T10:10:002020-12-17 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091358100913582020-12-17T10:37:002021-08-252020-12-17T10:37:002021-01-06T09:14:002020-12-172021-08-25 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091359100913592020-12-17T13:02:002021-08-022020-12-17T13:02:002021-06-07T13:45:002020-12-172021-08-02 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091360100913602020-12-17T13:05:002021-07-122020-12-17T13:05:002021-01-06T14:33:002020-12-172021-07-12 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091361100913612020-12-17T14:13:002021-07-192020-12-17T14:13:002021-06-07T12:10:002020-12-172021-07-19 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091362100913622020-12-17T16:21:002021-07-192020-12-17T16:21:002021-01-11T15:44:002020-12-172021-07-19 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091363100913632020-12-17T16:19:002021-08-272020-12-17T16:19:002021-08-27T16:04:002020-12-172021-08-27 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091364100913642020-12-17T16:47:002021-07-222020-12-17T16:47:002021-01-19T15:20:002020-12-172021-07-22 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091365100913652020-12-17T16:50:002021-08-192020-12-17T16:50:002021-08-19T15:57:002020-12-17 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091366100913662020-12-17T17:05:002021-08-302020-12-17T17:05:002021-08-30T08:52:002020-12-172021-08-30 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091369100913692020-12-18T11:00:002021-07-142020-12-18T11:00:002021-06-09T09:45:002020-12-182021-07-14 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091370100913702020-12-18T11:25:002021-08-242020-12-18T11:25:002021-01-08T12:58:002020-12-182021-08-24 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091371100913712020-12-18T13:39:002021-07-212020-12-18T13:39:002021-01-08T12:05:002020-12-182021-07-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091372100913722020-12-18T15:10:002021-07-022020-12-18T15:10:002021-01-08T14:14:002020-12-182021-07-02 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091373100913732020-12-18T15:57:002021-08-062020-12-18T15:57:002021-08-06T15:40:002020-12-18 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091374100913742020-12-21T11:58:002021-07-162020-12-21T11:58:002021-06-14T12:35:002020-12-212021-07-16 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091375100913752020-12-21T12:00:002021-07-122020-12-21T12:00:002021-01-11T17:49:002020-12-212021-07-12 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091376100913762020-12-21T14:00:002021-07-082020-12-21T14:00:002021-01-11T15:46:002020-12-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091377100913772020-12-21T15:50:002021-07-122020-12-21T15:50:002021-01-12T10:23:002020-12-212021-07-12 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091378100913782020-12-21T15:52:002021-08-182020-12-21T15:52:002021-08-18T16:45:002020-12-21 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091379100913792020-12-22T14:19:002021-07-132020-12-22T14:19:002021-06-09T09:25:002020-12-222021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091380100913802020-12-29T16:31:002021-08-182020-12-29T16:31:002021-07-12T12:55:002020-12-292021-08-18 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091381100913812020-12-31T11:28:002021-07-132020-12-31T11:28:002021-01-19T08:35:002020-12-312021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091382100913822021-01-04T16:30:002021-07-022021-01-04T16:30:002021-06-02T09:54:002021-01-042021-07-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091383100913832021-01-05T13:39:002021-08-052021-01-05T13:39:002021-01-25T12:36:002021-01-052021-08-05 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091384100913842021-01-05T13:37:002021-04-202021-01-05T13:37:002021-03-16T10:06:002021-01-05 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091385100913852021-01-05T14:05:002021-07-132021-01-05T14:05:002021-06-15T12:52:002021-01-052021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091386100913862021-01-06T12:40:002021-07-212021-01-06T12:40:002021-01-25T09:54:002021-01-062021-07-21 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091387100913872021-01-06T14:12:002021-07-302021-01-06T14:12:002021-01-28T17:01:002021-01-062021-07-30 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091388100913882021-01-06T16:25:002021-07-122021-01-06T16:25:002021-06-07T13:02:002021-01-062021-07-12 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091389100913892021-01-06T16:53:002021-07-282021-01-06T16:53:002021-01-25T17:11:002021-01-062021-07-28 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091390100913902021-01-07T13:02:002021-08-232021-01-07T13:02:002021-08-23T16:55:002021-01-07 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091391100913912021-01-07T14:34:002021-08-022021-01-07T14:34:002021-01-29T13:10:002021-01-072021-08-02 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091392100913922021-01-07T14:36:002021-08-192021-01-07T14:36:002021-07-22T13:04:002021-01-072021-08-19 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091393100913932021-01-07T14:30:002021-07-272021-01-07T14:30:002021-01-27T12:51:002021-01-072021-07-27 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091394100913942021-01-07T15:46:002021-08-042021-01-07T15:46:002021-01-27T14:01:002021-01-072021-08-04 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091395100913952021-01-07T15:43:002021-07-162021-01-07T15:43:002021-06-14T10:59:002021-01-072021-07-16 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091396100913962021-01-07T16:30:002021-08-112021-01-07T16:30:002021-01-26T16:00:002021-01-072021-08-11 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091398100913982021-01-07T17:42:002021-08-262021-01-07T17:42:002021-01-28T17:21:002021-01-072021-08-26 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091399100913992021-01-08T12:00:002021-08-202021-01-08T12:00:002021-08-20T16:28:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091400100914002021-01-08T13:28:002021-08-302021-01-08T13:28:002021-08-30T16:38:002021-01-082021-08-30 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091401100914012021-01-08T14:50:002021-08-232021-01-08T14:50:002021-08-23T16:22:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091402100914022021-01-08T14:48:002021-07-272021-01-08T14:48:002021-01-29T15:55:002021-01-082021-07-27 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091403100914032021-01-08T15:41:002021-04-192021-01-08T15:41:002021-03-19T13:53:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091404100914042021-01-08T16:49:002021-07-272021-01-08T16:49:002021-01-29T09:33:002021-01-082021-07-27 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091405100914052021-01-08T18:16:002021-08-192021-01-08T18:16:002021-08-19T16:13:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091406100914062021-01-08T18:14:002021-08-192021-01-08T18:14:002021-08-19T16:12:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091407100914072021-01-11T12:55:002021-08-042021-01-11T12:55:002021-02-01T12:11:002021-01-112021-08-04 100933285 Christensen, Shane Glade (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091408100914082021-01-11T17:38:002021-08-112021-01-11T17:38:002021-02-02T17:31:002021-01-112021-08-11 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091409100914092021-01-11T17:36:002021-08-112021-01-11T17:36:002021-02-02T17:29:002021-01-112021-08-11 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091410100914102021-01-12T09:48:002021-07-262021-01-12T09:48:002021-02-01T16:42:002021-01-122021-07-26 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091411100914112021-01-12T10:37:002021-07-132021-01-12T10:37:002021-06-08T11:08:002021-01-122021-07-13 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091412100914122021-01-12T15:29:002021-08-202021-01-12T15:29:002021-08-20T15:05:002021-01-12 100933285 Christensen, Shane Glade (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091413100914132021-01-12T15:50:002021-08-092021-01-12T15:50:002021-02-03T16:20:002021-01-122021-08-09 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091414100914142021-01-12T16:59:002021-08-022021-01-12T16:59:002021-02-04T16:33:002021-01-122021-08-02 100933285 Christensen, Shane Glade (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131821101318212020-11-30T13:28:002021-06-212020-11-30T13:28:002020-12-21T15:45:002020-11-302021-06-21 1013347220 Dever, Michael Edward (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131822101318222020-11-30T13:25:002021-08-262020-11-30T13:25:002020-12-21T15:42:002020-11-302021-08-26 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131823101318232020-12-01T13:05:002021-08-102020-12-01T13:05:002021-07-13T16:10:002020-12-01 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131824101318242020-12-01T13:08:002021-08-032020-12-01T13:08:002020-12-22T14:50:002020-12-01 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131826101318262020-12-01T16:29:002021-07-192020-12-01T16:29:002021-06-21T15:42:002020-12-012021-07-19 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131828101318282020-12-02T10:32:002021-06-092020-12-02T10:32:002020-12-30T15:10:002020-12-022021-06-09 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131830101318302020-12-02T10:42:002021-05-122020-12-02T10:42:002020-12-23T15:20:002020-12-022021-05-12 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131835101318352020-12-02T12:40:002021-07-192020-12-02T12:40:002021-06-15T14:14:002020-12-022021-07-19 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131836101318362020-12-02T12:42:002021-06-152020-12-02T12:42:002020-12-22T14:17:002020-12-022021-06-15 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131839101318392020-12-02T13:15:002021-07-142020-12-02T13:15:002020-12-23T14:48:002020-12-022021-07-14 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131841101318412020-12-02T16:50:002021-06-172020-12-02T16:50:002020-12-22T15:31:002020-12-022021-06-17 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131842101318422020-12-02T16:52:002021-07-202020-12-02T16:52:002021-07-20T16:00:002020-12-022021-07-20 1013347220 Dever, Michael Edward (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131843101318432020-12-02T17:02:002021-08-032020-12-02T17:02:002020-12-22T16:05:002020-12-022021-08-03 1013347220 Dever, Michael Edward (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131844101318442020-12-02T17:00:002021-08-162020-12-02T17:00:002021-07-15T16:42:002020-12-022021-08-16 1013347220 Dever, Michael Edward (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131845101318452020-12-03T10:00:002021-06-212020-12-03T10:00:002020-12-23T14:15:002020-12-032021-06-21 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131846101318462020-12-03T11:48:002021-05-142020-12-03T11:48:002020-12-22T15:55:002020-12-032021-05-14 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131848101318482020-12-03T11:50:002021-05-142020-12-03T11:50:002020-12-22T15:38:002020-12-032021-05-14 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131850101318502020-12-03T13:05:002021-06-212020-12-03T13:05:002020-12-23T15:25:002020-12-032021-06-21 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131851101318512020-12-07T11:15:002021-08-312020-12-07T11:15:002021-07-26T14:22:002020-12-072021-08-31 1013347220 Dever, Michael Edward (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131852101318522020-12-07T11:50:002021-07-212020-12-07T11:50:002021-06-22T14:17:002020-12-072021-07-21 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131855101318552020-12-08T11:25:002021-06-232020-12-08T11:25:002020-12-29T16:22:002020-12-082021-06-23 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131856101318562020-12-09T12:48:002021-05-112020-12-09T12:48:002020-12-30T15:58:002020-12-092021-05-11 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131858101318582020-12-09T12:42:002021-08-312020-12-09T12:42:002021-06-15T15:20:002020-12-092021-08-31 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131859101318592020-12-09T12:36:002021-06-302020-12-09T12:36:002020-12-31T09:30:002020-12-092021-06-30 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131860101318602020-12-09T14:58:002021-07-152020-12-09T14:58:002021-06-15T15:25:002020-12-092021-07-15 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131861101318612020-12-10T10:42:002021-08-252020-12-10T10:42:002021-01-04T14:10:002020-12-102021-08-25 1013347220 Dever, Michael Edward (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131862101318622020-12-10T12:27:002021-08-172020-12-10T12:27:002020-12-29T14:50:002020-12-102021-08-17 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131863101318632020-12-10T16:30:002021-07-132020-12-10T16:30:002021-06-14T14:15:002020-12-102021-07-13 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131865101318652020-12-14T11:03:002021-07-082020-12-14T11:03:002021-01-06T15:56:002020-12-142021-07-08 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131866101318662020-12-14T11:00:002021-07-082020-12-14T11:00:002021-01-06T15:54:002020-12-142021-07-08 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131867101318672020-12-17T12:32:002021-08-022020-12-17T12:32:002021-06-30T16:32:002020-12-172021-08-02 1013347220 Dever, Michael Edward (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131868101318682020-12-21T11:04:002021-05-182020-12-21T11:04:002021-01-12T14:55:002020-12-212021-05-18 1013347220 Dever, Michael Edward (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131869101318692020-12-21T12:05:002021-06-022020-12-21T12:05:002021-01-13T15:59:002020-12-212021-06-02 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131870101318702020-12-21T12:08:002021-04-222020-12-21T12:08:002021-01-13T15:58:002020-12-212021-04-22 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131871101318712020-12-21T13:28:002021-07-062020-12-21T13:28:002021-01-11T16:00:002020-12-212021-07-06 1013347220 Dever, Michael Edward (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131872101318722020-12-21T13:25:002021-08-112020-12-21T13:25:002021-01-11T15:55:002020-12-21 1013347220 Dever, Michael Edward (b)(6)AYEARSMMULTIPLE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131873101318732020-12-22T13:02:002021-07-202020-12-22T13:02:002021-01-13T14:07:002020-12-222021-07-20 1013347220 Dever, Michael Edward (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131874101318742020-12-22T12:14:002021-08-112020-12-22T12:14:002021-08-11T13:55:002020-12-22 1013347220 Dever, Michael Edward (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131875101318752020-12-22T12:17:002021-07-192020-12-22T12:17:002021-06-14T14:18:002020-12-222021-07-19 1013347220 Dever, Michael Edward (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131876101318762020-12-22T13:06:002021-07-122020-12-22T13:06:002021-01-12T14:08:002020-12-222021-07-12 1013347220 Dever, Michael Edward (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131877101318772020-12-23T09:50:002021-07-132020-12-23T09:50:002021-01-13T16:09:002020-12-232021-07-13 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131878101318782020-12-23T10:20:002021-05-252020-12-23T10:20:002021-01-13T15:50:002020-12-232021-05-25 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131879101318792020-12-23T10:14:002021-06-162020-12-23T10:14:002021-05-19T15:41:002020-12-232021-06-16 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131880101318802020-12-23T10:07:002021-07-062020-12-23T10:07:002021-01-11T16:20:002020-12-232021-07-06 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131881101318812020-12-28T11:45:002021-07-152020-12-28T11:45:002021-01-20T15:06:002020-12-282021-07-15 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131882101318822020-12-30T10:55:002021-07-092020-12-30T10:55:002021-06-07T16:19:002020-12-302021-07-09 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131883101318832020-12-31T11:00:002021-07-082020-12-31T11:00:002021-06-10T16:07:002020-12-312021-07-08 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131884101318842021-01-07T10:05:002021-08-182021-01-07T10:05:002021-01-28T16:37:002021-01-072021-08-18 1013347220 Dever, Michael Edward (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131885101318852021-01-07T10:10:002021-07-132021-01-07T10:10:002021-06-15T14:18:002021-01-072021-07-13 1013347220 Dever, Michael Edward (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131886101318862021-01-07T12:20:002021-07-092021-01-07T12:20:002021-06-10T16:03:002021-01-072021-07-09 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161307101613072020-10-15T12:18:002021-08-302020-10-15T12:18:002021-06-10T11:00:002020-10-152021-08-30 101680863 Finn, Daniel J. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161308101613082020-10-15T12:24:002021-07-122020-10-15T12:24:002021-06-14T09:16:002020-10-152021-07-12 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161309101613092020-10-15T14:54:002021-08-262020-10-15T14:54:002020-11-12T11:39:002020-10-152021-08-26 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161310101613102020-10-15T15:07:002021-05-252020-10-15T15:07:002020-11-04T09:24:002020-10-152021-05-25 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161311101613112020-10-15T15:32:002021-05-282020-10-15T15:32:002020-11-03T14:22:002020-10-15 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161314101613142020-10-16T11:13:002021-05-262020-10-16T11:13:002020-11-05T09:58:002020-10-162021-05-26 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161315101613152020-10-16T15:01:002021-07-072020-10-16T15:01:002021-06-09T15:50:002020-10-162021-07-07 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161316101613162020-10-16T15:10:002021-04-132020-10-16T15:10:002021-03-16T14:33:002020-10-16 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161318101613182020-10-16T15:39:002021-07-272020-10-16T15:39:002021-06-29T14:51:002020-10-162021-07-27 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161319101613192020-10-16T15:53:002021-07-122020-10-16T15:53:002021-06-14T15:13:002020-10-16 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161320101613202020-10-21T11:07:002021-05-172020-10-21T11:07:002020-11-09T10:08:002020-10-192021-05-17 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161322101613222020-10-19T11:52:002021-05-132020-10-19T11:52:002020-11-09T10:26:002020-10-192021-05-13 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161323101613232020-10-19T14:04:002021-05-132020-10-19T14:04:002020-11-09T11:42:002020-10-192021-05-13 101680863 Finn, Daniel J. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161324101613242020-10-19T14:02:002021-07-152020-10-19T14:02:002021-06-17T14:21:002020-10-192021-07-15 101680863 Finn, Daniel J. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161325101613252020-10-19T14:58:002021-08-302020-10-19T14:58:002020-11-10T15:54:002020-10-192021-08-30 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161326101613262020-10-20T09:46:002021-05-132020-10-20T09:46:002020-11-10T10:48:002020-10-202021-05-13 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161327101613272020-10-20T09:46:002021-07-202020-10-20T09:46:002021-06-22T09:22:002020-10-20 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161329101613292020-10-20T09:53:002021-07-172020-10-20T09:53:002021-06-09T15:53:002020-10-20 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161330101613302020-10-20T14:59:002021-05-132020-10-20T14:59:002020-11-11T16:07:002020-10-202021-05-13 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161331101613312020-10-20T14:54:002021-08-092020-10-20T14:54:002021-06-14T11:56:002020-10-202021-08-09 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161332101613322020-10-21T14:35:002021-05-132020-10-21T14:35:002020-11-09T11:39:002020-10-212021-05-13 101680863 Finn, Daniel J. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161334101613342020-10-21T14:59:002021-07-142020-10-21T14:59:002021-06-15T09:39:002020-10-212021-07-14 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161335101613352020-10-21T16:51:002021-08-202020-10-21T16:51:002020-11-11T10:28:002020-10-21 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161336101613362020-10-21T16:53:002021-08-232020-10-21T16:53:002021-07-26T11:54:002020-10-212021-08-23 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161337101613372020-10-21T16:31:002021-06-082020-10-21T16:31:002021-05-10T16:25:002020-10-212021-06-08 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161338101613382020-10-22T10:10:002021-05-142020-10-22T10:10:002020-11-10T11:06:002020-10-222021-05-14 101680863 Finn, Daniel J. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161339101613392020-10-22T11:02:002021-05-182020-10-22T11:02:002020-11-10T10:16:002020-10-222021-05-18 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161340101613402020-10-22T11:03:002021-07-192020-10-22T11:03:002021-06-15T09:35:002020-10-222021-07-19 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161343101613432020-10-22T16:39:002021-05-142020-10-22T16:39:002020-11-13T14:08:002020-10-222021-05-14 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161344101613442020-10-22T16:44:002021-07-052020-10-22T16:44:002021-06-07T16:20:002020-10-222021-07-05 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161350101613502020-11-30T10:30:002021-08-092020-11-30T10:30:002020-12-21T11:25:002020-11-302021-08-09 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161351101613512020-11-30T10:23:002021-08-092020-11-30T10:23:002021-07-12T09:28:002020-11-302021-08-09 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161352101613522020-11-30T15:49:002021-07-192020-11-30T15:49:002021-06-21T11:57:002020-11-302021-07-19 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161353101613532020-11-30T16:33:002021-07-122020-11-30T16:33:002021-06-14T10:45:002020-11-302021-07-12 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161354101613542020-12-02T10:08:002021-06-242020-12-02T10:08:002020-12-23T09:44:002020-12-02 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161356101613562020-12-02T11:02:002021-06-172020-12-02T11:02:002020-12-22T10:12:002020-12-022021-06-17 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161357101613572020-12-02T11:32:002021-06-152020-12-02T11:32:002020-12-22T10:37:002020-12-022021-06-15 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161358101613582020-12-03T09:45:002021-06-222020-12-03T09:45:002020-12-22T14:24:002020-12-032021-06-22 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161361101613612020-12-04T10:29:002021-07-052020-12-04T10:29:002021-06-07T14:48:002020-12-042021-07-05 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161362101613622020-12-04T15:38:002021-06-232020-12-04T15:38:002020-12-28T14:38:002020-12-042021-06-23 101680863 Finn, Daniel J. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161363101613632020-12-08T16:07:002021-06-232020-12-08T16:07:002020-12-28T15:15:002020-12-082021-06-23 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161364101613642020-12-09T15:34:002021-06-282020-12-09T15:34:002020-12-31T11:10:002020-12-092021-06-28 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161365101613652020-12-10T11:42:002021-07-082020-12-10T11:42:002021-06-10T10:17:002020-12-102021-07-08 101680863 Finn, Daniel J. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161366101613662020-12-15T15:38:002021-08-102020-12-15T15:38:002021-07-07T15:28:002020-12-15 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161367101613672020-12-29T10:57:002021-07-122020-12-29T10:57:002021-06-14T12:10:002020-12-292021-07-12 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161368101613682020-12-30T16:02:002021-08-312020-12-30T16:02:002021-06-09T16:33:002020-12-30 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161369101613692020-12-30T16:18:002021-08-232020-12-30T16:18:002021-01-27T16:02:002020-12-30 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161370101613702021-01-04T11:37:002021-07-282021-01-04T11:37:002021-01-25T16:34:002021-01-042021-07-28 101680863 Finn, Daniel J. (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161371101613712021-01-04T15:34:002021-07-122021-01-04T15:34:002021-06-14T16:22:002021-01-042021-07-12 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161372101613722021-01-05T15:51:002021-07-012021-01-05T15:51:002021-06-03T15:50:002021-01-052021-07-01 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161373101613732021-01-05T16:26:002021-07-212021-01-05T16:26:002021-01-27T10:02:002021-01-052021-07-21 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161374101613742021-01-06T12:28:002021-08-042021-01-06T12:28:002021-01-28T11:45:002021-01-06 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161375101613752021-01-06T16:08:002021-07-062021-01-06T16:08:002021-06-07T11:00:002021-01-062021-07-06 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161376101613762021-01-07T12:04:002021-07-262021-01-07T12:04:002021-01-26T11:30:002021-01-072021-07-26 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161377101613772021-01-07T12:05:002021-07-262021-01-07T12:05:002021-01-26T11:32:002021-01-072021-07-26 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161378101613782021-01-07T16:06:002021-08-252021-01-07T16:06:002021-08-25T16:25:002021-01-07 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161379101613792021-01-07T16:49:002021-07-282021-01-07T16:49:002021-06-28T10:30:002021-01-072021-07-28 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161381101613812021-01-08T10:40:002021-09-012021-01-08T10:40:002021-01-28T11:21:002021-01-082021-09-01 101680863 Finn, Daniel J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161382101613822021-01-08T10:59:002021-07-262021-01-08T10:59:002021-01-28T15:35:002021-01-082021-07-26 101680863 Finn, Daniel J. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161383101613832021-01-08T10:56:002021-06-302021-01-08T10:56:002021-06-01T11:00:002021-01-082021-06-30 101680863 Finn, Daniel J. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161384101613842021-01-08T11:23:002021-07-262021-01-08T11:23:002021-01-27T16:32:002021-01-082021-07-26 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161385101613852021-01-08T15:00:002021-08-022021-01-08T15:00:002021-01-29T09:26:002021-01-082021-08-02 101680863 Finn, Daniel J. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161386101613862021-01-08T15:25:002021-07-232021-01-08T15:25:002021-06-01T14:20:002021-01-082021-07-23 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161387101613872021-01-08T16:06:002021-07-212021-01-08T16:06:002021-01-27T15:08:002021-01-082021-07-21 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161388101613882021-01-11T16:14:002021-06-212021-01-11T16:14:002021-05-24T10:05:002021-01-112021-06-21 101680863 Finn, Daniel J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391246103912462020-12-01T08:59:002021-04-152020-12-01T08:59:002021-03-18T11:00:002020-12-01 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391247103912472020-12-01T09:09:002021-06-142020-12-01T09:09:002020-12-21T09:17:002020-12-012021-06-14 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391250103912502020-12-04T09:34:002021-07-062020-12-04T09:34:002020-12-28T08:28:002020-12-042021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391251103912512020-12-07T08:11:002021-08-202020-12-07T08:11:002021-02-25T07:44:002020-12-072021-08-20 1039406048 Crook, Gretchen (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391252103912522020-12-07T08:32:002021-05-142020-12-07T08:32:002021-04-15T13:53:002020-12-072021-05-14 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391253103912532020-12-07T09:11:002021-08-092020-12-07T09:11:002020-12-28T11:15:002020-12-072021-08-09 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391255103912552020-12-07T12:04:002021-07-212020-12-07T12:04:002020-12-29T11:27:002020-12-072021-07-21 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391256103912562020-12-07T12:49:002021-07-212020-12-07T12:49:002021-06-03T12:30:002020-12-072021-07-21 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391258103912582020-12-07T12:40:002021-07-062020-12-07T12:40:002021-06-01T12:02:002020-12-072021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391259103912592020-12-07T13:39:002021-07-022020-12-07T13:39:002021-06-04T13:11:002020-12-072021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391260103912602020-12-07T14:21:002021-07-282020-12-07T14:21:002020-12-28T14:02:002020-12-072021-07-28 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391262103912622020-12-08T08:19:002021-06-222020-12-08T08:19:002020-12-29T08:03:002020-12-082021-06-22 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391263103912632020-12-08T08:36:002021-08-042020-12-08T08:36:002020-12-29T07:58:002020-12-082021-08-04 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391264103912642020-12-08T11:55:002021-06-082020-12-08T11:55:002021-05-24T13:58:002020-12-082021-06-08 1039406048 Crook, Gretchen (b)(6)AYEARSFASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391265103912652020-12-08T12:10:002021-06-292020-12-08T12:10:002020-12-29T12:26:002020-12-082021-06-29 1039406048 Crook, Gretchen (b)(6)AYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391266103912662020-12-08T13:16:002021-07-082020-12-08T13:16:002021-06-03T14:04:002020-12-082021-07-08 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391267103912672020-12-08T13:54:002021-07-022020-12-08T13:54:002020-12-28T08:48:002020-12-082021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391268103912682020-12-08T13:30:002021-07-022020-12-08T13:30:002021-06-04T13:09:002020-12-082021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391269103912692020-12-08T13:42:002021-07-022020-12-08T13:42:002020-12-28T08:02:002020-12-082021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391270103912702020-12-09T11:31:002021-07-012020-12-09T11:31:002021-06-03T08:47:002020-12-092021-07-01 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391271103912712020-12-09T13:56:002021-07-012020-12-09T13:56:002021-06-03T12:14:002020-12-092021-07-01 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391272103912722020-12-09T12:57:002021-06-302020-12-09T12:57:002020-12-28T12:46:002020-12-092021-06-30 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391273103912732020-12-09T13:58:002021-07-012020-12-09T13:58:002021-06-03T12:14:002020-12-092021-07-01 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391274103912742020-12-16T08:47:002021-07-062020-12-16T08:47:002021-06-04T08:06:002020-12-162021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391275103912752020-12-16T08:35:002021-06-282020-12-16T08:35:002021-01-04T13:08:002020-12-162021-06-28 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391276103912762020-12-16T10:35:002021-06-292020-12-16T10:35:002021-01-05T09:56:002020-12-162021-06-29 1039406048 Crook, Gretchen (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391277103912772020-12-16T10:49:002021-07-062020-12-16T10:49:002021-06-04T11:26:002020-12-162021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391278103912782020-12-16T11:58:002021-07-022020-12-16T11:58:002021-01-05T09:48:002020-12-162021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391279103912792020-12-16T12:28:002021-07-062020-12-16T12:28:002021-06-07T10:41:002020-12-162021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391280103912802020-12-17T09:27:002021-08-132020-12-17T09:27:002021-06-04T14:15:002020-12-172021-08-13 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391281103912812020-12-17T13:54:002021-07-232020-12-17T13:54:002021-01-05T14:30:002020-12-172021-07-23 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391282103912822020-12-18T08:44:002021-07-142020-12-18T08:44:002021-01-08T13:25:002020-12-182021-07-14 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391283103912832020-12-18T09:17:002021-07-012020-12-18T09:17:002021-06-03T13:23:002020-12-182021-07-01 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391284103912842020-12-18T09:27:002021-09-022020-12-18T09:27:002021-01-07T07:50:002020-12-182021-09-02 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391285103912852020-12-18T09:59:002021-07-262020-12-18T09:59:002021-06-04T08:16:002020-12-182021-07-26 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391286103912862020-12-18T10:11:002021-07-162020-12-18T10:11:002021-01-08T08:50:002020-12-182021-07-16 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391287103912872020-12-18T10:54:002021-07-062020-12-18T10:54:002021-06-03T09:34:002020-12-182021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391289103912892020-12-18T11:42:002021-08-292020-12-18T11:42:002021-01-08T12:41:002020-12-182021-08-29 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391290103912902020-12-18T12:58:002021-07-132020-12-18T12:58:002021-01-08T09:43:002020-12-182021-07-13 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391291103912912020-12-18T14:04:002021-05-142020-12-18T14:04:002021-04-16T08:37:002020-12-182021-05-14 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391292103912922020-12-18T13:42:002021-07-062020-12-18T13:42:002021-06-04T08:27:002020-12-182021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391293103912932020-12-21T12:33:002021-07-152020-12-21T12:33:002021-01-11T12:29:002020-12-21 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391294103912942020-12-21T12:43:002021-07-072020-12-21T12:43:002021-06-04T10:02:002020-12-212021-07-07 1039406048 Crook, Gretchen (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391295103912952020-12-29T08:32:002021-09-012020-12-29T08:32:002021-01-19T11:56:002020-12-292021-09-01 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391296103912962020-12-29T09:16:002021-08-182020-12-29T09:16:002021-06-04T09:52:002020-12-29 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT REPORTED PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391297103912972020-12-29T09:38:002021-07-202020-12-29T09:38:002021-01-19T07:37:002020-12-292021-07-20 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391298103912982020-12-29T09:50:002021-07-132020-12-29T09:50:002021-01-19T09:44:002020-12-29 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391299103912992020-12-29T10:05:002021-07-022020-12-29T10:05:002021-06-04T10:12:002020-12-292021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391300103913002020-12-29T12:06:002021-07-222020-12-29T12:06:002021-01-21T08:12:002020-12-292021-07-22 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391301103913012020-12-29T12:03:002021-07-142020-12-29T12:03:002021-06-04T13:29:002020-12-292021-07-14 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391302103913022020-12-29T12:36:002021-08-192020-12-29T12:36:002021-01-18T12:41:002020-12-292021-08-19 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391303103913032020-12-29T13:39:002021-07-062020-12-29T13:39:002021-06-04T08:08:002020-12-292021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391304103913042020-12-29T13:51:002021-07-132020-12-29T13:51:002021-01-19T11:58:002020-12-292021-07-13 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391305103913052021-01-06T13:27:002021-07-122021-01-06T13:27:002021-06-04T13:13:002021-01-062021-07-12 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391306103913062021-01-06T13:29:002021-07-282021-01-06T13:29:002021-01-25T08:14:002021-01-062021-07-28 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391307103913072021-01-06T14:08:002021-07-022021-01-06T14:08:002021-06-04T10:43:002021-01-062021-07-02 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391308103913082021-01-06T14:09:002021-07-222021-01-06T14:09:002021-01-27T12:52:002021-01-062021-07-22 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391309103913092021-01-07T08:10:002021-07-202021-01-07T08:10:002021-06-08T13:08:002021-01-072021-07-20 1039406048 Crook, Gretchen (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391310103913102021-01-07T08:45:002021-07-062021-01-07T08:45:002021-06-07T10:50:002021-01-072021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391311103913112021-01-07T10:22:002021-07-212021-01-07T10:22:002021-01-29T09:27:002021-01-072021-07-21 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391312103913122021-01-07T10:10:002021-08-102021-01-07T10:10:002021-01-28T09:05:002021-01-072021-08-10 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391313103913132021-01-07T11:29:002021-07-062021-01-07T11:29:002021-06-03T10:35:002021-01-07 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391314103913142021-01-07T11:57:002021-07-062021-01-07T11:57:002021-06-07T08:06:002021-01-072021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391315103913152021-01-07T13:55:002021-07-222021-01-07T13:55:002021-01-27T13:58:002021-01-072021-07-22 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391316103913162021-01-07T13:57:002021-07-222021-01-07T13:57:002021-01-27T13:57:002021-01-072021-07-22 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391317103913172021-01-07T13:59:002021-07-012021-01-07T13:59:002021-06-03T08:09:002021-01-072021-07-01 1039406048 Crook, Gretchen (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391318103913182021-01-07T15:07:002021-08-232021-01-07T15:07:002021-01-29T13:58:002021-01-072021-08-23 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391319103913192021-01-08T08:20:002021-07-092021-01-08T08:20:002021-06-11T14:08:002021-01-082021-07-09 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391320103913202021-01-08T10:19:002021-08-232021-01-08T10:19:002021-01-29T10:23:002021-01-082021-08-23 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391321103913212021-01-08T10:00:002021-07-132021-01-08T10:00:002021-06-08T13:50:002021-01-082021-07-13 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391322103913222021-01-08T12:59:002021-07-232021-01-08T12:59:002021-01-29T11:31:002021-01-082021-07-23 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391323103913232021-01-08T13:17:002021-07-232021-01-08T13:17:002021-01-29T13:20:002021-01-082021-07-23 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391324103913242021-01-08T15:42:002021-08-292021-01-08T15:42:002021-01-29T13:28:002021-01-082021-08-29 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391325103913252021-01-11T12:51:002021-07-062021-01-11T12:51:002021-06-03T08:34:002021-01-112021-07-06 1039406048 Crook, Gretchen (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391326103913262021-01-11T12:50:002021-08-092021-01-11T12:50:002021-02-01T08:31:002021-01-112021-08-09 1039406048 Crook, Gretchen (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391327103913272021-01-11T13:08:002021-07-282021-01-11T13:08:002021-02-01T08:44:002021-01-11 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391328103913282021-01-11T13:15:002021-07-082021-01-11T13:15:002021-06-04T13:05:002021-01-112021-07-08 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391329103913292021-01-11T15:06:002021-07-092021-01-11T15:06:002021-06-10T13:29:002021-01-112021-07-09 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391330103913302021-01-11T14:59:002021-08-102021-01-11T14:59:002021-02-02T13:34:002021-01-112021-08-10 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391331103913312021-01-12T08:08:002021-07-262021-01-12T08:08:002021-02-01T08:33:002021-01-122021-07-26 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391332103913322021-01-12T08:52:002021-06-102021-01-12T08:52:002021-02-02T08:00:002021-01-122021-06-10 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391333103913332021-01-12T09:36:002021-07-092021-01-12T09:36:002021-06-11T14:11:002021-01-122021-07-09 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391334103913342021-01-12T09:40:002021-07-092021-01-12T09:40:002021-06-11T14:10:002021-01-122021-07-09 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391335103913352021-01-12T11:36:002021-08-102021-01-12T11:36:002021-02-02T08:52:002021-01-122021-08-10 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391336103913362021-01-12T11:34:002021-08-102021-01-12T11:34:002021-02-02T08:51:002021-01-12 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391337103913372021-01-12T12:09:002021-07-022021-01-12T12:09:002021-06-04T11:21:002021-01-12 1039406048 Crook, Gretchen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391338103913382021-01-12T14:50:002021-08-032021-01-12T14:50:002021-02-03T08:30:002021-01-12 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391339103913392021-01-12T14:52:002021-08-022021-01-12T14:52:002021-06-07T08:09:002021-01-122021-08-02 1039406048 Crook, Gretchen (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441251104412512020-11-30T14:59:002021-06-232020-11-30T14:59:002020-12-22T11:53:002020-11-302021-06-23 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441252104412522020-11-30T16:14:002021-07-062020-11-30T16:14:002021-06-07T11:12:002020-11-302021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441253104412532020-11-30T17:42:002021-06-292020-11-30T17:42:002020-12-21T11:54:002020-11-302021-06-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441255104412552020-12-01T11:34:002021-06-252020-12-01T11:34:002020-12-21T13:55:002020-12-012021-06-25 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441256104412562020-12-01T11:35:002021-07-072020-12-01T11:35:002021-06-09T10:45:002020-12-012021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441257104412572020-12-01T15:23:002021-06-302020-12-01T15:23:002020-12-23T16:03:002020-12-012021-06-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441259104412592020-12-01T16:49:002021-06-172020-12-01T16:49:002020-12-22T11:45:002020-12-012021-06-17 1044374169 Hartman, Aaron N. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441260104412602020-12-01T17:43:002021-07-012020-12-01T17:43:002021-06-03T16:03:002020-12-012021-07-01 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441261104412612020-12-01T17:46:002021-07-022020-12-01T17:46:002021-06-04T16:17:002020-12-012021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441263104412632020-12-07T15:04:002021-06-222020-12-07T15:04:002020-12-28T14:06:002020-12-072021-06-22 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441264104412642020-12-07T16:55:002021-08-232020-12-07T16:55:002021-08-23T10:39:002020-12-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441265104412652020-12-07T17:32:002021-07-082020-12-07T17:32:002021-06-09T14:12:002020-12-072021-07-08 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441266104412662020-12-08T11:34:002021-06-282020-12-08T11:34:002020-12-28T13:19:002020-12-082021-06-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441267104412672020-12-08T12:04:002021-07-122020-12-08T12:04:002021-06-09T12:22:002020-12-082021-07-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441268104412682020-12-08T12:52:002021-07-022020-12-08T12:52:002020-12-28T15:50:002020-12-082021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441270104412702020-12-08T15:26:002021-07-012020-12-08T15:26:002020-12-31T11:25:002020-12-082021-07-01 1044374169 Hartman, Aaron N. (b)(6)AYEARSFNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441271104412712020-12-08T18:10:002021-06-262020-12-08T18:10:002020-12-28T15:25:002020-12-08 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441273104412732020-12-08T19:15:002021-07-062020-12-08T19:15:002020-12-28T14:35:002020-12-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441274104412742020-12-08T19:14:002021-04-092020-12-08T19:14:002021-03-12T14:39:002020-12-08 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441275104412752020-12-09T10:43:002021-07-072020-12-09T10:43:002021-06-09T10:12:002020-12-092021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441276104412762020-12-09T12:07:002021-06-282020-12-09T12:07:002020-12-29T11:20:002020-12-092021-06-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441277104412772020-12-09T14:09:002021-07-062020-12-09T14:09:002021-06-08T09:30:002020-12-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441278104412782020-12-09T14:06:002021-06-302020-12-09T14:06:002020-12-29T15:52:002020-12-092021-06-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441279104412792020-12-09T17:59:002021-07-062020-12-09T17:59:002020-12-29T10:34:002020-12-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441280104412802020-12-09T17:58:002021-08-112020-12-09T17:58:002021-02-17T14:35:002020-12-09 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441281104412812020-12-09T18:38:002021-07-012020-12-09T18:38:002020-12-29T12:20:002020-12-092021-07-01 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441282104412822020-12-09T18:31:002021-04-212020-12-09T18:31:002021-03-24T13:43:002020-12-09 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441283104412832020-12-10T10:49:002021-06-302020-12-10T10:49:002020-12-29T12:22:002020-12-102021-06-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441284104412842020-12-10T15:17:002021-07-012020-12-10T15:17:002021-06-03T14:53:002020-12-102021-07-01 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441285104412852020-12-10T16:14:002021-07-022020-12-10T16:14:002020-12-30T10:25:002020-12-102021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441286104412862020-12-11T11:01:002021-07-072020-12-11T11:01:002021-06-07T11:52:002020-12-112021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441288104412882020-12-16T11:29:002021-06-172020-12-16T11:29:002021-01-06T13:56:002020-12-162021-06-17 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441289104412892020-12-16T15:34:002021-08-182020-12-16T15:34:002021-01-11T14:56:002020-12-162021-08-18 100682785 Peterson, James Todd (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441290104412902021-01-08T13:51:002021-07-292021-01-08T13:51:002021-01-29T13:56:002020-12-162021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441291104412912020-12-17T14:00:002021-07-022020-12-17T14:00:002021-01-06T16:40:002020-12-172021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441292104412922020-12-17T14:39:002021-05-032020-12-17T14:39:002021-04-01T13:03:002020-12-17 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441293104412932020-12-17T18:27:002021-06-212020-12-17T18:27:002021-05-14T16:28:002020-12-172021-06-21 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441294104412942020-12-17T18:28:002021-07-022020-12-17T18:28:002021-05-14T16:27:002020-12-172021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441295104412952020-12-18T09:44:002021-07-262020-12-18T09:44:002021-01-08T10:13:002020-12-182021-07-26 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441296104412962020-12-22T14:05:002021-07-122020-12-22T14:05:002021-01-11T10:50:002020-12-222021-07-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441297104412972020-12-23T09:44:002021-07-152020-12-23T09:44:002021-01-13T15:25:002020-12-232021-07-15 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441298104412982020-12-23T11:53:002021-07-302020-12-23T11:53:002021-06-18T13:47:002020-12-232021-07-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441299104412992020-12-28T16:24:002021-07-062020-12-28T16:24:002021-06-04T14:57:002020-12-282021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441300104413002020-12-28T17:48:002021-09-012020-12-28T17:48:002021-01-18T12:21:002020-12-282021-09-01 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441301104413012020-12-29T14:58:002021-07-122020-12-29T14:58:002021-01-18T11:33:002020-12-292021-07-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441302104413022020-12-29T16:55:002021-07-062020-12-29T16:55:002021-06-07T10:24:002020-12-292021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441303104413032020-12-29T16:57:002021-06-142020-12-29T16:57:002021-05-13T10:23:002020-12-292021-06-14 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441304104413042020-12-29T17:54:002021-07-142020-12-29T17:54:002021-01-19T15:04:002020-12-292021-07-14 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441306104413062020-12-30T12:00:002021-07-122020-12-30T12:00:002021-01-18T10:20:002020-12-302021-07-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441307104413072020-12-30T12:01:002021-08-172020-12-30T12:01:002021-08-17T10:16:002020-12-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441308104413082020-12-30T12:24:002021-07-072020-12-30T12:24:002021-06-09T13:54:002020-12-302021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441309104413092020-12-30T13:13:002021-07-162020-12-30T13:13:002021-01-18T13:49:002020-12-302021-07-16 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441310104413102020-12-30T14:40:002021-07-212020-12-30T14:40:002021-01-18T14:21:002020-12-302021-07-21 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441311104413112021-01-04T10:45:002021-07-202021-01-04T10:45:002021-01-25T10:23:002021-01-042021-07-20 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441312104413122021-01-04T10:51:002021-06-302021-01-04T10:51:002021-06-02T11:26:002021-01-042021-06-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441313104413132021-01-04T11:53:002021-08-172021-01-04T11:53:002021-08-17T10:08:002021-01-04 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441314104413142021-01-04T14:15:002021-08-022021-01-04T14:15:002021-01-25T15:40:002021-01-042021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441315104413152021-01-04T14:14:002021-07-062021-01-04T14:14:002021-06-08T10:04:002021-01-042021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441316104413162021-01-04T15:38:002021-07-202021-01-04T15:38:002021-01-25T12:52:002021-01-042021-07-20 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441317104413172021-01-04T16:07:002021-07-092021-01-04T16:07:002021-06-09T13:06:002021-01-042021-07-09 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441318104413182021-01-05T10:48:002021-07-062021-01-05T10:48:002021-06-04T14:32:002021-01-052021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441319104413192021-01-05T10:49:002021-08-022021-01-05T10:49:002021-01-25T10:33:002021-01-052021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441320104413202021-01-05T12:56:002021-07-022021-01-05T12:56:002021-06-04T13:57:002021-01-052021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441321104413212021-01-05T13:37:002021-08-032021-01-05T13:37:002021-01-26T14:07:002021-01-052021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441322104413222021-01-05T15:31:002021-05-132021-01-05T15:31:002021-01-27T16:39:002021-01-052021-05-13 1044374169 Hartman, Aaron N. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441323104413232021-01-05T17:17:002021-07-062021-01-05T17:17:002021-06-08T10:05:002021-01-052021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441324104413242021-01-05T18:39:002021-07-062021-01-05T18:39:002021-06-03T10:23:002021-01-052021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441325104413252021-01-05T18:43:002021-07-262021-01-05T18:43:002021-01-26T16:39:002021-01-052021-07-26 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441326104413262021-01-06T10:31:002021-07-122021-01-06T10:31:002021-06-09T14:01:002021-01-062021-07-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441327104413272021-01-06T10:32:002021-07-122021-01-06T10:32:002021-06-09T14:02:002021-01-062021-07-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441328104413282021-01-06T11:52:002021-08-032021-01-06T11:52:002021-01-26T10:20:002021-01-062021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441329104413292021-01-06T13:54:002021-08-102021-01-06T13:54:002021-01-27T15:58:002021-01-062021-08-10 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441330104413302021-01-06T15:27:002021-09-012021-01-06T15:27:002021-06-08T14:30:002021-01-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441331104413312021-01-06T17:42:002021-07-262021-01-06T17:42:002021-01-27T16:41:002021-01-062021-07-26 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441332104413322021-01-06T17:43:002021-07-062021-01-06T17:43:002021-06-04T16:14:002021-01-062021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441333104413332021-01-06T18:48:002021-08-022021-01-06T18:48:002021-01-27T14:35:002021-01-062021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441334104413342021-01-07T10:24:002021-08-032021-01-07T10:24:002021-01-26T10:10:002021-01-072021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441335104413352021-01-07T15:29:002021-07-082021-01-07T15:29:002021-06-07T16:22:002021-01-072021-07-08 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441336104413362021-01-07T16:35:002021-07-272021-01-07T16:35:002021-01-28T16:15:002021-01-072021-07-27 1044374169 Hartman, Aaron N. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441337104413372021-01-08T10:15:002021-07-062021-01-08T10:15:002021-06-07T11:50:002021-01-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441338104413382021-01-08T10:15:002021-07-282021-01-08T10:15:002021-01-29T11:32:002021-01-082021-07-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441339104413392021-01-08T16:02:002021-08-032021-01-08T16:02:002021-01-29T15:47:002021-01-082021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441340104413402021-01-08T16:06:002021-07-062021-01-08T16:06:002021-06-01T11:49:002021-01-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441341104413412021-01-08T16:07:002021-07-062021-01-08T16:07:002021-06-01T11:50:002021-01-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441342104413422021-01-09T10:20:002021-07-222021-01-09T10:20:002021-01-28T15:33:002021-01-092021-07-22 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441343104413432021-01-09T10:24:002021-07-292021-01-09T10:24:002021-01-29T15:26:002021-01-092021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441344104413442021-01-09T10:23:002021-04-132021-01-09T10:23:002021-03-16T10:34:002021-01-09 1044374169 Hartman, Aaron N. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441345104413452021-01-09T11:35:002021-07-062021-01-09T11:35:002021-06-07T10:28:002021-01-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441346104413462021-01-09T11:33:002021-07-262021-01-09T11:33:002021-01-28T10:13:002021-01-092021-07-26 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441347104413472021-01-09T11:38:002021-05-282021-01-09T11:38:002021-01-29T13:04:002021-01-092021-05-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441348104413482021-01-09T12:16:002021-07-062021-01-09T12:16:002021-06-08T15:57:002021-01-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441349104413492021-01-09T12:19:002021-08-022021-01-09T12:19:002021-01-29T10:26:002021-01-092021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441350104413502021-01-09T12:48:002021-07-272021-01-09T12:48:002021-01-29T12:35:002021-01-092021-07-27 1044374169 Hartman, Aaron N. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441351104413512021-01-10T10:09:002021-08-232021-01-10T10:09:002021-08-23T15:52:002021-01-10 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441352104413522021-01-10T10:16:002021-08-052021-01-10T10:16:002021-01-29T13:00:002021-01-102021-08-05 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441353104413532021-01-10T10:19:002021-07-292021-01-10T10:19:002021-02-01T15:33:002021-01-102021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441354104413542021-01-10T11:33:002021-07-092021-01-10T11:33:002021-06-09T10:14:002021-01-10 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441355104413552021-01-10T11:34:002021-07-282021-01-10T11:34:002021-01-29T12:42:002021-01-102021-07-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441356104413562021-01-10T11:38:002021-07-292021-01-10T11:38:002021-02-02T17:25:002021-01-102021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441357104413572021-01-10T12:34:002021-07-072021-01-10T12:34:002021-06-07T16:23:002021-01-102021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441358104413582021-01-10T12:31:002021-08-092021-01-10T12:31:002021-02-01T13:25:002021-01-102021-08-09 1044374169 Hartman, Aaron N. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441359104413592021-01-11T10:05:002021-08-232021-01-11T10:05:002021-02-25T16:55:002021-01-112021-08-23 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441360104413602021-01-11T10:04:002021-07-072021-01-11T10:04:002021-06-07T16:42:002021-01-112021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441361104413612021-01-11T12:43:002021-07-282021-01-11T12:43:002021-02-03T12:57:002021-01-112021-07-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441362104413622021-01-11T13:51:002021-07-022021-01-11T13:51:002021-06-04T14:52:002021-01-112021-07-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441363104413632021-01-11T14:43:002021-07-062021-01-11T14:43:002021-06-04T15:43:002021-01-112021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441364104413642021-01-11T15:16:002021-08-042021-01-11T15:16:002021-02-03T15:34:002021-01-112021-08-04 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441365104413652021-01-11T15:42:002021-07-062021-01-11T15:42:002021-06-02T10:33:002021-01-112021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441366104413662021-01-11T15:40:002021-08-022021-01-11T15:40:002021-02-02T15:20:002021-01-112021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441367104413672021-01-11T16:56:002021-07-282021-01-11T16:56:002021-02-03T11:59:002021-01-112021-07-28 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441368104413682021-01-11T17:28:002021-04-272021-01-11T17:28:002021-03-30T15:23:002021-01-11 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441369104413692021-01-11T17:45:002021-08-032021-01-11T17:45:002021-02-02T16:54:002021-01-112021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441370104413702021-01-11T17:44:002021-07-202021-01-11T17:44:002021-06-21T11:19:002021-01-112021-07-20 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441371104413712021-01-11T18:41:002021-08-032021-01-11T18:41:002021-02-02T14:08:002021-01-112021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441372104413722021-01-11T18:40:002021-08-032021-01-11T18:40:002021-02-02T14:07:002021-01-112021-08-03 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441373104413732021-01-12T10:33:002021-07-072021-01-12T10:33:002021-06-08T09:37:002021-01-122021-07-07 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441374104413742021-01-12T11:36:002021-08-202021-01-12T11:36:002021-08-20T11:24:002021-01-12 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441375104413752021-01-12T12:42:002021-07-292021-01-12T12:42:002021-02-02T11:30:002021-01-122021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441376104413762021-01-12T12:43:002021-07-292021-01-12T12:43:002021-02-02T11:29:002021-01-122021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441377104413772021-02-01T13:29:002021-08-252021-02-01T13:29:002021-02-22T15:40:002021-01-122021-08-25 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441378104413782021-01-12T14:31:002021-08-022021-01-12T14:31:002021-02-04T15:57:002021-01-122021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441379104413792021-01-12T14:32:002021-08-022021-01-12T14:32:002021-02-04T15:58:002021-01-122021-08-02 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441380104413802021-01-12T16:15:002021-07-012021-01-12T16:15:002021-06-03T15:48:002021-01-122021-07-01 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441381104413812021-01-12T16:20:002021-07-092021-01-12T16:20:002021-06-11T14:54:002021-01-122021-07-09 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441382104413822021-01-12T17:46:002021-06-302021-01-12T17:46:002021-06-02T15:37:002021-01-122021-06-30 1044374169 Hartman, Aaron N. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441383104413832021-01-12T17:45:002021-07-292021-01-12T17:45:002021-02-03T15:13:002021-01-122021-07-29 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441384104413842021-01-12T17:50:002021-07-062021-01-12T17:50:002021-06-08T15:41:002021-01-122021-07-06 1044374169 Hartman, Aaron N. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571376105713762020-12-07T10:39:002021-06-282020-12-07T10:39:002021-01-04T13:53:002020-12-072021-06-28 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571377105713772020-12-07T14:52:002021-08-252020-12-07T14:52:002020-12-28T11:14:002020-12-072021-08-25 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571378105713782020-12-07T15:18:002021-08-252020-12-07T15:18:002020-12-28T11:17:002020-12-072021-08-25 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571379105713792020-12-07T16:33:002021-07-062020-12-07T16:33:002021-06-04T11:35:002020-12-072021-07-06 1057350735 Chalhoub, Fadi (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571380105713802020-12-08T09:51:002021-07-232020-12-08T09:51:002021-01-04T09:00:002020-12-082021-07-23 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571382105713822020-12-08T16:32:002021-09-022020-12-08T16:32:002021-01-05T10:27:002020-12-082021-09-02 1057350735 Chalhoub, Fadi (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571383105713832020-12-08T15:54:002021-08-192020-12-08T15:54:002021-06-11T12:00:002020-12-082021-08-19 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571384105713842020-12-08T16:25:002021-08-172020-12-08T16:25:002021-07-20T10:42:002020-12-082021-08-17 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571385105713852020-12-08T16:45:002021-07-222020-12-08T16:45:002020-12-28T14:43:002020-12-082021-07-22 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571386105713862020-12-08T16:44:002021-06-222020-12-08T16:44:002020-12-29T15:54:002020-12-082021-06-22 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571387105713872020-12-09T14:03:002021-08-052020-12-09T14:03:002021-06-23T16:12:002020-12-092021-08-05 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571388105713882020-12-09T14:22:002021-07-122020-12-09T14:22:002020-12-28T10:57:002020-12-092021-07-12 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571389105713892020-12-09T14:27:002021-07-122020-12-09T14:27:002021-01-04T16:42:002020-12-092021-07-12 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571390105713902020-12-09T14:45:002021-07-302020-12-09T14:45:002020-12-28T14:50:002020-12-092021-07-30 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571391105713912020-12-09T14:50:002021-04-142020-12-09T14:50:002021-03-17T15:44:002020-12-09 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571392105713922020-12-09T16:00:002021-07-222020-12-09T16:00:002020-12-28T14:03:002020-12-092021-07-22 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571393105713932020-12-09T16:14:002021-07-132020-12-09T16:14:002021-06-15T16:10:002020-12-092021-07-13 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571394105713942020-12-09T16:31:002021-07-082020-12-09T16:31:002021-06-08T15:53:002020-12-092021-07-08 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571395105713952020-12-09T16:39:002021-06-162020-12-09T16:39:002021-01-14T16:16:002020-12-092021-06-16 1057350735 Chalhoub, Fadi (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571396105713962020-12-10T14:42:002021-08-252020-12-10T14:42:002020-12-28T14:05:002020-12-10 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571397105713972020-12-10T16:10:002021-06-232020-12-10T16:10:002020-12-30T15:37:002020-12-10 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571398105713982020-12-10T16:17:002021-07-012020-12-10T16:17:002021-06-03T13:58:002020-12-102021-07-01 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571399105713992020-12-10T16:35:002021-06-232020-12-10T16:35:002020-12-29T15:10:002020-12-102021-06-23 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571400105714002020-12-11T10:55:002021-08-042020-12-11T10:55:002021-06-07T15:17:002020-12-112021-08-04 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571401105714012020-12-11T12:14:002021-06-142020-12-11T12:14:002020-12-30T13:58:002020-12-112021-06-14 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571402105714022020-12-14T16:12:002021-04-212020-12-14T16:12:002021-03-24T15:57:002020-12-14 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571403105714032020-12-14T16:37:002021-06-282020-12-14T16:37:002021-01-04T14:00:002020-12-142021-06-28 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571404105714042020-12-16T11:22:002021-08-192020-12-16T11:22:002021-07-21T14:30:002020-12-162021-08-19 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571405105714052020-12-16T16:35:002021-08-172020-12-16T16:35:002021-01-05T16:02:002020-12-16 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571406105714062020-12-16T16:40:002021-07-052020-12-16T16:40:002021-06-07T13:53:002020-12-16 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571407105714072020-12-17T14:30:002021-04-302020-12-17T14:30:002021-04-02T10:48:002020-12-17 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571408105714082020-12-17T14:38:002021-07-142020-12-17T14:38:002021-06-16T14:30:002020-12-172021-07-14 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571409105714092020-12-17T14:09:002021-06-292020-12-17T14:09:002021-01-05T15:58:002020-12-172021-06-29 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571410105714102020-12-17T16:10:002021-07-072020-12-17T16:10:002021-06-09T09:50:002020-12-172021-07-07 1057350735 Chalhoub, Fadi (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571411105714112020-12-17T16:42:002021-06-252020-12-17T16:42:002021-01-06T09:52:002020-12-172021-06-25 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571412105714122020-12-17T16:43:002021-07-212020-12-17T16:43:002021-01-06T09:53:002020-12-172021-07-21 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571413105714132020-12-21 2020-12-21 2020-12-212020-12-21 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) NOTTRT Not Treated USAC4591001DMC4591001 1057 10571414105714142020-12-21T15:20:002021-06-082020-12-21T15:20:002021-01-12T15:40:002020-12-212021-06-08 1057350735 Chalhoub, Fadi (b)(6)AYEARSFMULTIPLE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571415105714152020-12-21T15:22:002021-08-062020-12-21T15:22:002021-07-09T11:57:002020-12-212021-08-06 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571416105714162020-12-21T15:30:002021-07-192020-12-21T15:30:002021-01-13T15:50:002020-12-212021-07-19 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571417105714172020-12-21T15:38:002021-07-122020-12-21T15:38:002021-06-14T14:40:002020-12-212021-07-12 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571418105714182020-12-22T15:27:002021-08-272020-12-22T15:27:002021-01-11T14:26:002020-12-222021-08-27 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571419105714192020-12-22T15:35:002021-05-142020-12-22T15:35:002021-01-11T11:53:002020-12-22 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571420105714202020-12-23T11:13:002021-02-242020-12-23T11:13:002021-01-11T11:47:002020-12-232021-02-24 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571421105714212020-12-23T14:36:002021-07-092020-12-23T14:36:002021-01-11T15:45:002020-12-232021-07-09 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571422105714222020-12-23T15:50:002021-07-082020-12-23T15:50:002021-01-13T15:52:002020-12-232021-07-08 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571423105714232020-12-24T09:47:002021-07-122020-12-24T09:47:002021-01-15T10:07:002020-12-242021-07-12 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571424105714242020-12-24T09:42:002021-07-082020-12-24T09:42:002021-06-09T09:45:002020-12-242021-07-08 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571425105714252020-12-24T11:08:002021-07-152020-12-24T11:08:002021-01-12T14:01:002020-12-242021-07-15 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571426105714262020-12-24T11:18:002021-08-022020-12-24T11:18:002021-01-21T16:24:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571427105714272020-12-24T11:24:002021-08-022020-12-24T11:24:002021-01-21T16:17:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571428105714282020-12-24T11:40:002021-08-022020-12-24T11:40:002021-01-21T16:24:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571429105714292020-12-24T11:44:002021-08-022020-12-24T11:44:002021-01-21T16:15:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571430105714302020-12-29T14:37:002021-05-142020-12-29T14:37:002021-01-18T14:05:002020-12-29 1057350735 Chalhoub, Fadi (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571431105714312020-12-30T14:25:002021-07-192020-12-30T14:25:002021-06-21T15:21:002020-12-302021-07-19 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571432105714322020-12-30T14:39:002021-06-292020-12-30T14:39:002021-06-01T15:48:002020-12-302021-06-29 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571433105714332020-12-30T16:28:002021-07-162020-12-30T16:28:002021-01-22T08:45:002020-12-302021-07-16 1057350735 Chalhoub, Fadi (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571434105714342020-12-31T11:15:002021-07-272020-12-31T11:15:002021-06-29T11:51:002020-12-312021-07-27 1057350735 Chalhoub, Fadi (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571435105714352021-01-04T14:34:002021-07-212021-01-04T14:34:002021-01-25T09:40:002021-01-042021-07-21 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571436105714362021-01-04T14:38:002021-08-172021-01-04T14:38:002021-08-17T15:49:002021-01-04 1057350735 Chalhoub, Fadi (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571437105714372021-01-04T16:15:002021-08-102021-01-04T16:15:002021-08-10T10:54:002021-01-04 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571438105714382021-01-04T16:26:002021-07-202021-01-04T16:26:002021-01-25T15:41:002021-01-042021-07-20 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571439105714392021-01-06T14:15:002021-07-052021-01-06T14:15:002021-06-07T14:46:002021-01-062021-07-05 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571440105714402021-01-06T16:06:002021-07-192021-01-06T16:06:002021-01-27T14:33:002021-01-062021-07-19 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571441105714412021-01-06T16:21:002021-07-072021-01-06T16:21:002021-06-09T16:45:002021-01-062021-07-07 1057350735 Chalhoub, Fadi (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571442105714422021-01-07T11:27:002021-08-192021-01-07T11:27:002021-07-22T10:04:002021-01-072021-08-19 1057350735 Chalhoub, Fadi (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571443105714432021-01-08T11:21:002021-08-112021-01-08T11:21:002021-01-28T14:38:002021-01-082021-08-11 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571444105714442021-01-08T11:28:002021-08-112021-01-08T11:28:002021-01-28T14:49:002021-01-082021-08-11 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571445105714452021-01-11T11:07:002021-08-032021-01-11T11:07:002021-02-01T12:01:002021-01-112021-08-03 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571446105714462021-01-11T14:22:002021-09-012021-01-11T14:22:002021-02-01T15:57:002021-01-112021-09-01 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571447105714472021-01-11T16:34:002021-07-052021-01-11T16:34:002021-06-07T08:56:002021-01-112021-07-05 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571448105714482021-01-11T16:43:002021-07-262021-01-11T16:43:002021-02-01T15:50:002021-01-112021-07-26 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571449105714492021-01-12T11:14:002021-07-062021-01-12T11:14:002021-06-08T15:48:002021-01-122021-07-06 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571450105714502021-01-12T11:20:002021-08-262021-01-12T11:20:002021-02-02T13:59:002021-01-122021-08-26 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571451105714512021-01-12T14:27:002021-07-272021-01-12T14:27:002021-02-02T14:07:002021-01-122021-07-27 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571452105714522021-01-12T14:32:002021-07-282021-01-12T14:32:002021-02-03T15:10:002021-01-122021-07-28 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571453105714532021-01-12T16:00:002021-07-052021-01-12T16:00:002021-06-07T13:38:002021-01-122021-07-05 1057350735 Chalhoub, Fadi (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571454105714542021-01-12T15:58:002021-08-022021-01-12T15:58:002021-02-03T14:45:002021-01-122021-08-02 1057350735 Chalhoub, Fadi (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661394106613942020-12-09T11:15:002021-07-152020-12-09T11:15:002021-06-15T13:31:002020-12-012021-07-15 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661395106613952020-12-01T14:38:002021-06-152020-12-01T14:38:002020-12-21T12:40:002020-12-012021-06-15 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661397106613972020-12-01T17:27:002021-07-072020-12-01T17:27:002021-06-09T11:52:002020-12-012021-07-07 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661401106614012020-12-02T15:00:002021-07-082020-12-02T15:00:002021-06-07T08:34:002020-12-022021-07-08 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661402106614022020-12-02T15:50:002021-06-172020-12-02T15:50:002020-12-21T15:50:002020-12-022021-06-17 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661403106614032020-12-03T11:41:002021-07-072020-12-03T11:41:002021-06-09T09:27:002020-12-032021-07-07 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661404106614042020-12-03T11:40:002021-06-162020-12-03T11:40:002020-12-23T10:42:002020-12-032021-06-16 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661405106614052020-12-03T16:18:002021-07-052020-12-03T16:18:002021-06-07T14:37:002020-12-032021-07-05 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661407106614072020-12-04T10:50:002021-06-172020-12-04T10:50:002020-12-22T09:10:002020-12-042021-06-17 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661408106614082020-12-08T16:33:002021-08-022020-12-08T16:33:002020-12-28T13:50:002020-12-082021-08-02 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661409106614092020-12-08T16:35:002021-06-222020-12-08T16:35:002020-12-28T13:51:002020-12-082021-06-22 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661410106614102020-12-09T13:50:002021-07-082020-12-09T13:50:002021-06-08T12:21:002020-12-092021-07-08 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661411106614112020-12-09T16:47:002021-06-232020-12-09T16:47:002020-12-29T13:41:002020-12-092021-06-23 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661412106614122020-12-09T16:45:002021-07-202020-12-09T16:45:002021-06-09T14:11:002020-12-092021-07-20 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661414106614142020-12-14T15:50:002021-06-282020-12-14T15:50:002021-01-04T12:04:002020-12-142021-06-28 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661415106614152020-12-14T15:42:002021-08-232020-12-14T15:42:002021-07-26T10:38:002020-12-142021-08-23 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661416106614162020-12-15T16:25:002021-07-142020-12-15T16:25:002021-06-16T09:22:002020-12-152021-07-14 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661417106614172020-12-16T14:55:002021-08-182020-12-16T14:55:002021-01-06T15:20:002020-12-162021-08-18 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661418106614182020-12-16T15:17:002021-07-202020-12-16T15:17:002021-06-17T09:29:002020-12-162021-07-20 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661419106614192020-12-16T16:00:002021-07-192020-12-16T16:00:002021-01-06T13:50:002020-12-162021-07-19 1066270090 Butuk, David J. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661420106614202020-12-17T15:28:002021-03-082020-12-17T15:28:002021-01-05T16:00:002020-12-17 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661421106614212020-12-22T10:35:002021-07-152020-12-22T10:35:002021-06-17T10:17:002020-12-222021-07-15 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661422106614222020-12-22T10:37:002021-07-082020-12-22T10:37:002021-01-13T10:03:002020-12-222021-07-08 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661423106614232020-12-30T08:20:002021-07-122020-12-30T08:20:002021-06-14T12:25:002020-12-302021-07-12 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661424106614242020-12-30T10:18:002021-07-282020-12-30T10:18:002021-01-20T11:36:002020-12-302021-07-28 1066270090 Butuk, David J. (b)(6)AYEARSMNATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERHISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661425106614252021-01-05T16:01:002021-07-082021-01-05T16:01:002021-06-08T10:35:002021-01-052021-07-08 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661426106614262021-01-06T11:05:002021-07-052021-01-06T11:05:002021-06-07T09:18:002021-01-062021-07-05 1066270090 Butuk, David J. (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661427106614272021-01-06T11:06:002021-07-212021-01-06T11:06:002021-01-27T10:24:002021-01-062021-07-21 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661428106614282021-01-06T13:00:002021-05-032021-01-06T13:00:002021-04-05T13:11:002021-01-062021-05-03 1066270090 Butuk, David J. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661429106614292021-01-06T15:50:002021-08-162021-01-06T15:50:002021-08-16T15:33:002021-01-06 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661430106614302021-01-07T08:00:002021-07-272021-01-07T08:00:002021-01-26T07:20:002021-01-072021-07-27 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661431106614312021-01-07T12:05:002021-07-282021-01-07T12:05:002021-01-27T07:57:002021-01-072021-07-28 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661432106614322021-01-07T12:20:002021-07-142021-01-07T12:20:002021-06-09T13:21:002021-01-072021-07-14 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661433106614332021-01-07T16:00:002021-07-082021-01-07T16:00:002021-06-07T12:04:002021-01-072021-07-08 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661434106614342021-01-12T12:25:002021-07-302021-01-12T12:25:002021-02-02T11:25:002021-01-122021-07-30 1066270090 Butuk, David J. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661435106614352021-01-12T12:24:002021-07-302021-01-12T12:24:002021-02-02T11:26:002021-01-122021-07-30 1066270090 Butuk, David J. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771274107712742020-12-03T15:02:002021-06-152020-12-03T15:02:002020-12-22T16:39:002020-12-032021-06-15 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771275107712752020-12-03T15:03:002021-07-072020-12-03T15:03:002021-06-07T13:48:002020-12-032021-07-07 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771277107712772020-12-04T09:47:002021-07-202020-12-04T09:47:002021-06-16T12:15:002020-12-042021-07-20 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771278107712782020-12-04T09:45:002021-06-162020-12-04T09:45:002020-12-23T10:09:002020-12-042021-06-16 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771279107712792020-12-14T09:13:002021-06-302020-12-14T09:13:002021-01-04T09:15:002020-12-142021-06-30 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771280107712802020-12-14T09:10:002021-07-162020-12-14T09:10:002021-06-18T10:59:002020-12-142021-07-16 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771281107712812020-12-14T09:55:002021-07-082020-12-14T09:55:002021-01-04T15:07:002020-12-142021-07-08 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771282107712822020-12-14T17:08:002021-05-172020-12-14T17:08:002021-01-05T16:33:002020-12-142021-05-17 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771283107712832020-12-15T09:18:002021-07-072020-12-15T09:18:002021-06-08T08:23:002020-12-152021-07-07 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771284107712842020-12-15T09:16:002021-06-282020-12-15T09:16:002021-01-06T08:07:002020-12-152021-06-28 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771285107712852020-12-15T09:20:002021-07-072020-12-15T09:20:002021-06-07T08:50:002020-12-152021-07-07 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771286107712862020-12-15T14:03:002021-07-022020-12-15T14:03:002021-01-04T11:15:002020-12-152021-07-02 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771287107712872020-12-15T14:25:002021-07-062020-12-15T14:25:002021-01-06T12:12:002020-12-152021-07-06 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771288107712882020-12-16T15:30:002021-07-122020-12-16T15:30:002021-01-06T10:47:002020-12-162021-07-12 107774381 Patel, Suchet R. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771289107712892020-12-18T15:05:002021-05-142020-12-18T15:05:002021-01-08T14:36:002020-12-182021-05-14 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771290107712902020-12-18T15:06:002021-05-142020-12-18T15:06:002021-01-08T14:38:002020-12-182021-05-14 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771291107712912020-12-18T16:10:002021-06-302020-12-18T16:10:002021-01-06T12:29:002020-12-182021-06-30 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771292107712922020-12-18T16:11:002021-05-182020-12-18T16:11:002021-01-06T12:30:002020-12-182021-05-18 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771293107712932020-12-18 2020-12-18 2020-12-182020-12-18 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo NOTTRT Not Treated USAC4591001DMC4591001 1077 10771294107712942020-12-28T13:31:002021-07-162020-12-28T13:31:002021-06-18T14:10:002020-12-282021-07-16 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771295107712952020-12-28T14:07:002021-08-232020-12-28T14:07:002021-03-17T13:50:002020-12-28 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771296107712962020-12-29T12:00:002021-07-072020-12-29T12:00:002021-01-20T11:10:002020-12-292021-07-07 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771297107712972021-01-06T14:46:002021-07-302021-01-06T14:46:002021-01-28T15:50:002021-01-062021-07-30 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771298107712982021-01-07T12:20:002021-07-072021-01-07T12:20:002021-06-04T15:53:002021-01-072021-07-07 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771299107712992021-01-07T14:29:002021-07-212021-01-07T14:29:002021-01-27T13:42:002021-01-072021-07-21 107774381 Patel, Suchet R. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771300107713002021-01-07T16:38:002021-07-222021-01-07T16:38:002021-01-27T16:16:002021-01-072021-07-22 107774381 Patel, Suchet R. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841541108415412020-12-11T10:05:002021-08-302020-12-11T10:05:002020-12-30T15:45:002020-12-112021-08-30 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841542108415422020-12-11T12:05:002021-07-012020-12-11T12:05:002020-12-30T15:30:002020-12-112021-07-01 1084215414 Denham, Douglas Scott (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841543108415432020-12-18T16:31:002021-07-052020-12-18T16:31:002021-06-07T15:36:002020-12-182021-07-05 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841544108415442020-12-18T17:19:002021-06-302020-12-18T17:19:002021-01-06T16:29:002020-12-182021-06-30 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841545108415452020-12-18T17:25:002021-07-062020-12-18T17:25:002021-06-09T09:04:002020-12-182021-07-06 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841546108415462020-12-18T17:30:002021-06-302020-12-18T17:30:002021-01-06T16:36:002020-12-182021-06-30 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841547108415472020-12-21T10:00:002021-07-072020-12-21T10:00:002021-06-09T11:14:002020-12-212021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841548108415482020-12-21T14:36:002021-07-092020-12-21T14:36:002021-01-13T15:55:002020-12-212021-07-09 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841549108415492020-12-21T11:52:002021-07-122020-12-21T11:52:002021-01-11T10:34:002020-12-212021-07-12 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841550108415502020-12-21T14:41:002021-08-252020-12-21T14:41:002021-08-25T10:13:002020-12-212021-08-25 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841551108415512020-12-21T14:47:002021-08-022020-12-21T14:47:002021-01-13T15:38:002020-12-212021-08-02 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841552108415522020-12-21T14:53:002021-07-132020-12-21T14:53:002021-06-11T13:21:002020-12-212021-07-13 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841553108415532020-12-21T16:13:002021-07-072020-12-21T16:13:002021-01-11T11:06:002020-12-21 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841555108415552020-12-21T16:30:002021-08-202020-12-21T16:30:002021-08-20T10:28:002020-12-21 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841556108415562020-12-28T11:10:002021-07-192020-12-28T11:10:002021-01-18T09:12:002020-12-282021-07-19 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841557108415572020-12-28T10:31:002021-05-132020-12-28T10:31:002021-01-18T09:21:002020-12-282021-05-13 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841558108415582020-12-28T13:14:002021-07-122020-12-28T13:14:002021-01-18T10:11:002020-12-282021-07-12 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841559108415592020-12-28T13:43:002021-07-122020-12-28T13:43:002021-01-18T10:02:002020-12-282021-07-12 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841560108415602020-12-28T12:50:002021-07-192020-12-28T12:50:002021-06-21T11:26:002020-12-282021-07-19 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841561108415612020-12-28T13:52:002021-07-052020-12-28T13:52:002021-06-07T14:09:002020-12-282021-07-05 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841562108415622020-12-28T16:00:002021-07-122020-12-28T16:00:002021-01-18T10:50:002020-12-282021-07-12 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841563108415632020-12-30T11:06:002021-07-122020-12-30T11:06:002021-01-18T11:23:002020-12-302021-07-12 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841564108415642020-12-30T11:09:002021-08-052020-12-30T11:09:002021-06-11T14:37:002020-12-302021-08-05 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841565108415652020-12-30T12:11:002021-07-072020-12-30T12:11:002021-06-11T14:40:002020-12-302021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841566108415662020-12-30T13:41:002021-07-262020-12-30T13:41:002021-01-18T10:42:002020-12-302021-07-26 1084215414 Denham, Douglas Scott (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841567108415672020-12-30T14:19:002021-07-122020-12-30T14:19:002021-01-18T15:36:002020-12-302021-07-12 1084215414 Denham, Douglas Scott (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841568108415682020-12-30T15:21:002021-06-152020-12-30T15:21:002021-01-18T10:54:002020-12-302021-06-15 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841569108415692020-12-30T16:33:002021-07-072020-12-30T16:33:002021-06-11T11:05:002020-12-302021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841570108415702020-12-30T16:36:002021-07-072020-12-30T16:36:002021-06-11T11:07:002020-12-302021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841571108415712020-12-30T16:43:002021-09-012020-12-30T16:43:002021-08-04T17:30:002020-12-302021-09-01 1084215414 Denham, Douglas Scott (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841572108415722021-01-04T10:12:002021-07-162021-01-04T10:12:002021-06-18T14:35:002021-01-04 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841573108415732021-01-04T16:30:002021-07-282021-01-04T16:30:002021-01-27T15:42:002021-01-042021-07-28 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841574108415742021-01-04T16:38:002021-07-282021-01-04T16:38:002021-01-27T15:31:002021-01-042021-07-28 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841575108415752021-01-04T16:57:002021-06-302021-01-04T16:57:002021-05-07T16:21:002021-01-04 1084215414 Denham, Douglas Scott (b)(6)AYEARSMASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841576108415762021-01-06T09:58:002021-07-192021-01-06T09:58:002021-01-25T09:09:002021-01-062021-07-19 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841577108415772021-01-06T12:51:002021-07-072021-01-06T12:51:002021-06-09T10:17:002021-01-062021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841578108415782021-01-06T12:53:002021-07-282021-01-06T12:53:002021-01-27T16:08:002021-01-062021-07-28 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841579108415792021-01-06T14:17:002021-05-242021-01-06T14:17:002021-01-27T17:05:002021-01-062021-05-24 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841580108415802021-01-06T14:20:002021-07-232021-01-06T14:20:002021-01-27T17:16:002021-01-062021-07-23 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841581108415812021-01-06T15:40:002021-08-042021-01-06T15:40:002021-06-07T15:58:002021-01-062021-08-04 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841582108415822021-01-06T15:54:002021-07-262021-01-06T15:54:002021-01-27T17:26:002021-01-062021-07-26 1084215414 Denham, Douglas Scott (b)(6)AYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841583108415832021-01-08T10:47:002021-08-042021-01-08T10:47:002021-01-27T16:46:002021-01-082021-08-04 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841584108415842021-01-08T11:20:002021-07-262021-01-08T11:20:002021-01-29T14:20:002021-01-082021-07-26 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841586108415862021-01-08T12:16:002021-07-072021-01-08T12:16:002021-06-11T09:07:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841587108415872021-01-08T13:01:002021-07-072021-01-08T13:01:002021-06-09T10:13:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841588108415882021-01-08T13:42:002021-07-072021-01-08T13:42:002021-06-11T10:43:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841589108415892021-01-08T13:24:002021-07-232021-01-08T13:24:002021-01-29T11:14:002021-01-08 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841590108415902021-01-08T14:59:002021-07-072021-01-08T14:59:002021-06-07T09:55:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841591108415912021-01-08T14:56:002021-07-232021-01-08T14:56:002021-01-29T10:01:002021-01-082021-07-23 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841592108415922021-01-08T14:29:002021-07-302021-01-08T14:29:002021-01-27T11:14:002021-01-082021-07-30 1084215414 Denham, Douglas Scott (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841593108415932021-01-08T15:29:002021-07-232021-01-08T15:29:002021-01-29T11:49:002021-01-082021-07-23 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841594108415942021-01-08T16:21:002021-07-302021-01-08T16:21:002021-01-29T12:03:002021-01-082021-07-30 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841595108415952021-01-08T16:29:002021-07-052021-01-08T16:29:002021-06-07T14:52:002021-01-082021-07-05 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841596108415962021-01-08T16:35:002021-07-062021-01-08T16:35:002021-06-07T09:48:002021-01-082021-07-06 1084215414 Denham, Douglas Scott (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841597108415972021-01-08T16:42:002021-06-292021-01-08T16:42:002021-05-28T15:36:002021-01-082021-06-29 1084215414 Denham, Douglas Scott (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911394109113942020-12-02T13:29:002021-06-172020-12-02T13:29:002020-12-21T12:44:002020-12-022021-06-17 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911395109113952020-12-02T13:27:002021-06-172020-12-02T13:27:002020-12-21T12:46:002020-12-02 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911396109113962020-12-02T16:14:002021-07-012020-12-02T16:14:002021-06-01T11:02:002020-12-022021-07-01 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911399109113992020-12-04T10:55:002021-07-212020-12-04T10:55:002021-01-07T16:30:002020-12-042021-07-21 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911400109114002020-12-04T11:26:002021-08-242020-12-04T11:26:002021-07-06T15:27:002020-12-042021-08-24 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911402109114022020-12-07T10:08:002021-06-302020-12-07T10:08:002020-12-29T10:40:002020-12-072021-06-30 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911403109114032020-12-07T11:39:002021-06-222020-12-07T11:39:002020-12-29T09:07:002020-12-072021-06-22 1091110670 Arora, Samir (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911404109114042020-12-07T13:39:002021-07-142020-12-07T13:39:002020-12-28T11:59:002020-12-072021-07-14 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911405109114052020-12-07T15:54:002021-07-212020-12-07T15:54:002021-06-16T12:17:002020-12-072021-07-21 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911406109114062020-12-07T16:37:002021-06-152020-12-07T16:37:002020-12-28T11:33:002020-12-072021-06-15 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911407109114072020-12-08T15:53:002021-08-312020-12-08T15:53:002021-08-03T12:48:002020-12-082021-08-31 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911408109114082020-12-08T15:55:002021-06-282020-12-08T15:55:002020-12-30T13:58:002020-12-082021-06-28 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911409109114092020-12-09T10:43:002021-05-262020-12-09T10:43:002020-12-28T09:36:002020-12-092021-05-26 1091110670 Arora, Samir (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911410109114102020-12-09T11:54:002021-06-242020-12-09T11:54:002020-12-28T11:29:002020-12-092021-06-24 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911411109114112020-12-09T11:58:002021-08-032020-12-09T11:58:002021-06-24T11:17:002020-12-092021-08-03 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911412109114122020-12-09T16:17:002021-06-232020-12-09T16:17:002020-12-30T15:47:002020-12-092021-06-23 1091110670 Arora, Samir (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911413109114132020-12-09T16:13:002021-07-012020-12-09T16:13:002021-01-07T13:20:002020-12-092021-07-01 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911414109114142020-12-09T16:15:002021-07-012020-12-09T16:15:002021-05-25T17:25:002020-12-092021-07-01 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911415109114152020-12-10T11:03:002021-07-222020-12-10T11:03:002021-06-22T15:40:002020-12-102021-07-22 1091110670 Arora, Samir (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911416109114162020-12-10T12:48:002021-07-072020-12-10T12:48:002020-12-30T15:00:002020-12-102021-07-07 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911417109114172020-12-10T12:49:002021-08-042020-12-10T12:49:002021-06-09T13:56:002020-12-102021-08-04 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911418109114182020-12-10T12:08:002021-08-172020-12-10T12:08:002021-06-07T12:14:002020-12-102021-08-17 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911419109114192020-12-10T15:49:002021-06-232020-12-10T15:49:002020-12-30T12:34:002020-12-102021-06-23 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911420109114202020-12-10T15:45:002021-06-282020-12-10T15:45:002020-12-30T16:33:002020-12-102021-06-28 1091110670 Arora, Samir (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911421109114212020-12-10T15:46:002021-07-062020-12-10T15:46:002021-06-08T16:20:002020-12-102021-07-06 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911422109114222020-12-14T10:31:002021-07-062020-12-14T10:31:002021-01-06T08:38:002020-12-142021-07-06 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911423109114232020-12-14T10:32:002021-08-232020-12-14T10:32:002021-07-21T15:42:002020-12-142021-08-23 1091110670 Arora, Samir (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911424109114242020-12-15T11:29:002021-07-072020-12-15T11:29:002021-06-07T08:17:002020-12-152021-07-07 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911425109114252020-12-15T12:35:002021-07-122020-12-15T12:35:002021-06-14T11:13:002020-12-152021-07-12 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911426109114262020-12-16T13:28:002021-07-012020-12-16T13:28:002021-01-07T14:10:002020-12-162021-07-01 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911427109114272020-12-16T14:39:002021-07-092020-12-16T14:39:002021-01-06T11:51:002020-12-162021-07-09 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911428109114282020-12-16T14:41:002021-06-302020-12-16T14:41:002021-01-06T11:49:002020-12-162021-06-30 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911429109114292020-12-16T15:26:002021-05-272020-12-16T15:26:002021-04-27T16:31:002020-12-162021-05-27 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911430109114302020-12-16T15:59:002021-07-072020-12-16T15:59:002021-06-07T09:29:002020-12-162021-07-07 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911431109114312020-12-17T10:29:002021-07-012020-12-17T10:29:002021-01-12T08:04:002020-12-172021-07-01 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911432109114322020-12-17T10:27:002021-06-212020-12-17T10:27:002021-01-06T14:13:002020-12-172021-06-21 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911433109114332020-12-17T15:30:002021-05-252020-12-17T15:30:002021-01-07T16:33:002020-12-172021-05-25 1091110670 Arora, Samir (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911434109114342020-12-17T15:28:002021-07-122020-12-17T15:28:002021-06-10T10:16:002020-12-172021-07-12 1091110670 Arora, Samir (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911435109114352020-12-17T16:50:002021-07-012020-12-17T16:50:002021-01-07T16:43:002020-12-172021-07-01 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911436109114362020-12-17T16:53:002021-06-302020-12-17T16:53:002021-01-06T09:41:002020-12-172021-06-30 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911437109114372020-12-17T16:54:002021-07-142020-12-17T16:54:002021-06-15T16:09:002020-12-17 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911438109114382020-12-18T10:42:002021-07-062020-12-18T10:42:002021-01-08T09:22:002020-12-182021-07-06 1091110670 Arora, Samir (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911439109114392020-12-18T10:44:002021-07-212020-12-18T10:44:002021-06-23T14:33:002020-12-182021-07-21 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911440109114402020-12-18T11:05:002021-07-062020-12-18T11:05:002021-01-08T09:35:002020-12-182021-07-06 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911441109114412020-12-18T11:08:002021-06-082020-12-18T11:08:002021-06-08T08:47:002020-12-182021-06-08 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911442109114422020-12-18T11:10:002021-06-082020-12-18T11:10:002021-06-08T08:49:002020-12-182021-06-08 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911443109114432020-12-21T15:14:002021-08-122020-12-21T15:14:002021-01-15T09:05:002020-12-212021-08-12 1091110670 Arora, Samir (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911444109114442020-12-21T14:51:002021-07-122020-12-21T14:51:002021-01-11T10:20:002020-12-212021-07-12 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911445109114452020-12-21T15:16:002021-07-122020-12-21T15:16:002021-06-14T15:11:002020-12-212021-07-12 1091110670 Arora, Samir (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911446109114462020-12-22T09:38:002021-08-312020-12-22T09:38:002021-01-13T08:36:002020-12-222021-08-31 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911447109114472020-12-22T10:41:002021-07-082020-12-22T10:41:002021-01-14T11:25:002020-12-222021-07-08 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911448109114482020-12-22T10:42:002021-07-062020-12-22T10:42:002021-06-07T08:13:002020-12-222021-07-06 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911449109114492020-12-22T11:29:002021-05-142020-12-22T11:29:002021-01-11T14:11:002020-12-222021-05-14 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911450109114502020-12-22T15:22:002021-07-072020-12-22T15:22:002021-06-09T09:10:002020-12-222021-07-07 1091110670 Arora, Samir (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911451109114512020-12-22 2021-01-04 2020-12-222021-01-04 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) NOTTRT Not Treated USAC4591001DMC4591001 1091 10911452109114522020-12-22T16:41:002021-07-122020-12-22T16:41:002021-06-14T12:23:002020-12-222021-07-12 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911453109114532020-12-22T16:13:002021-07-132020-12-22T16:13:002021-01-12T10:18:002020-12-222021-07-13 1091110670 Arora, Samir (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911454109114542020-12-28T15:55:002021-07-212020-12-28T15:55:002021-01-18T11:05:002020-12-282021-07-21 1091110670 Arora, Samir (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911455109114552020-12-29T10:38:002021-07-262020-12-29T10:38:002021-01-19T09:13:002020-12-292021-07-26 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911456109114562020-12-29T16:52:002021-07-152020-12-29T16:52:002021-01-18T14:35:002020-12-292021-07-15 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911457109114572020-12-29T16:53:002021-07-152020-12-29T16:53:002021-01-18T14:37:002020-12-292021-07-15 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911458109114582020-12-29T16:48:002021-07-132020-12-29T16:48:002021-01-19T12:13:002020-12-292021-07-13 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911459109114592020-12-29T16:49:002021-07-132020-12-29T16:49:002021-06-10T10:28:002020-12-292021-07-13 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911460109114602020-12-30T12:15:002021-07-132020-12-30T12:15:002021-01-19T14:17:002020-12-302021-07-13 1091110670 Arora, Samir (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911461109114612020-12-30T12:16:002021-07-132020-12-30T12:16:002021-01-19T14:19:002020-12-302021-07-13 1091110670 Arora, Samir (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911462109114622021-01-04T11:30:002021-07-272021-01-04T11:30:002021-01-27T11:18:002021-01-042021-07-27 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911463109114632021-01-04T16:35:002021-07-072021-01-04T16:35:002021-06-07T09:27:002021-01-042021-07-07 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911464109114642021-01-04T16:37:002021-07-292021-01-04T16:37:002021-01-27T15:41:002021-01-042021-07-29 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911465109114652021-01-05T11:32:002021-08-022021-01-05T11:32:002021-01-27T10:25:002021-01-052021-08-02 1091110670 Arora, Samir (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911466109114662021-01-11T15:19:002021-07-202021-01-11T15:19:002021-06-07T15:38:002021-01-112021-07-20 1091110670 Arora, Samir (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231422112314222020-12-01T09:44:002021-06-092020-12-01T09:44:002020-12-21T09:44:002020-12-012021-06-09 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231425112314252020-12-02T09:38:002021-06-282020-12-02T09:38:002020-12-21T09:17:002020-12-022021-06-28 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231428112314282020-12-03T15:10:002021-06-152020-12-03T15:10:002020-12-22T09:19:002020-12-032021-06-15 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231431112314312020-12-04T09:41:002021-07-072020-12-04T09:41:002021-06-07T10:04:002020-12-042021-07-07 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231432112314322020-12-04T09:39:002021-06-182020-12-04T09:39:002020-12-23T12:00:002020-12-042021-06-18 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231434112314342020-12-07T10:15:002021-05-132020-12-07T10:15:002020-12-28T09:18:002020-12-072021-05-13 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231438112314382020-12-08T10:33:002021-06-152020-12-08T10:33:002021-01-06T10:08:002020-12-082021-06-15 1123113680 Essink, Brandon James (b)(6)AYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231439112314392020-12-08T10:31:002021-07-072020-12-08T10:31:002021-01-06T10:23:002020-12-082021-07-07 1123113680 Essink, Brandon James (b)(6)AYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231440112314402020-12-09T09:38:002021-06-282020-12-09T09:38:002020-12-28T09:16:002020-12-092021-06-28 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231441112314412020-12-09T11:58:002021-05-102020-12-09T11:58:002021-01-04T14:12:002020-12-092021-05-10 1123113680 Essink, Brandon James (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231442112314422020-12-09T12:33:002021-07-232020-12-09T12:33:002021-06-22T13:52:002020-12-092021-07-23 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231443112314432020-12-09T12:31:002021-07-062020-12-09T12:31:002021-01-04T13:51:002020-12-092021-07-06 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231445112314452020-12-09T14:35:002021-06-102020-12-09T14:35:002020-12-30T15:30:002020-12-092021-06-10 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231446112314462020-12-09T14:55:002021-06-302020-12-09T14:55:002020-12-30T15:32:002020-12-092021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231447112314472020-12-10T15:13:002021-06-302020-12-10T15:13:002020-12-29T10:43:002020-12-102021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231448112314482020-12-11T09:05:002021-04-202020-12-11T09:05:002020-12-30T09:24:002020-12-112021-04-20 1123113680 Essink, Brandon James (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231449112314492020-12-11T10:14:002021-08-272020-12-11T10:14:002020-12-30T16:23:002020-12-112021-08-27 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231450112314502020-12-11T10:43:002021-07-142020-12-11T10:43:002021-06-16T09:21:002020-12-112021-07-14 1123113680 Essink, Brandon James (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231451112314512020-12-15T09:45:002021-06-282020-12-15T09:45:002021-01-04T16:17:002020-12-152021-06-28 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231452112314522020-12-15T14:58:002021-06-302020-12-15T14:58:002021-05-26T14:08:002020-12-152021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231453112314532020-12-15T15:13:002021-07-132020-12-15T15:13:002021-01-07T15:26:002020-12-152021-07-13 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231454112314542020-12-15T15:15:002021-04-122020-12-15T15:15:002021-03-15T14:48:002020-12-15 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231455112314552020-12-15T17:09:002021-06-292020-12-15T17:09:002021-01-04T16:50:002020-12-152021-06-29 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231456112314562020-12-16T09:53:002021-07-062020-12-16T09:53:002021-06-08T09:02:002020-12-162021-07-06 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231457112314572020-12-16T12:56:002021-07-022020-12-16T12:56:002021-06-04T09:49:002020-12-162021-07-02 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231458112314582020-12-16T14:41:002021-08-112020-12-16T14:41:002021-01-04T16:01:002020-12-16 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231459112314592020-12-16T15:43:002021-07-122020-12-16T15:43:002021-01-04T15:01:002020-12-162021-07-12 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231460112314602020-12-17T12:41:002021-04-082020-12-17T12:41:002021-03-10T15:41:002020-12-17 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231461112314612020-12-17T12:59:002021-06-292020-12-17T12:59:002021-01-05T09:31:002020-12-17 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231462112314622020-12-17T15:18:002021-07-022020-12-17T15:18:002021-01-08T15:26:002020-12-172021-07-02 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231463112314632020-12-18T12:52:002021-07-162020-12-18T12:52:002021-06-17T11:36:002020-12-182021-07-16 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231465112314652020-12-18T14:38:002021-07-072020-12-18T14:38:002021-06-09T14:05:002020-12-182021-07-07 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231466112314662020-12-18T15:24:002021-06-302020-12-18T15:24:002021-01-06T14:38:002020-12-182021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231467112314672020-12-21T09:18:002021-06-302020-12-21T09:18:002021-06-02T09:10:002020-12-212021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231468112314682020-12-21T09:21:002021-08-132020-12-21T09:21:002021-06-23T09:56:002020-12-212021-08-13 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231469112314692020-12-21T11:29:002021-07-162020-12-21T11:29:002021-01-12T10:25:002020-12-212021-07-16 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231470112314702020-12-21T12:14:002021-07-152020-12-21T12:14:002021-06-15T10:55:002020-12-212021-07-15 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231472112314722020-12-21T12:49:002021-07-062020-12-21T12:49:002021-01-12T09:28:002020-12-212021-07-06 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231473112314732020-12-21T12:53:002021-07-062020-12-21T12:53:002021-06-08T12:06:002020-12-212021-07-06 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231474112314742020-12-21T15:03:002021-07-182020-12-21T15:03:002021-01-11T08:54:002020-12-212021-07-18 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231475112314752020-12-21T15:01:002021-07-182020-12-21T15:01:002021-01-11T08:52:002020-12-212021-07-18 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231476112314762020-12-21T15:35:002021-06-302020-12-21T15:35:002021-06-02T12:10:002020-12-212021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231477112314772020-12-21T16:33:002021-07-192020-12-21T16:33:002021-01-11T11:02:002020-12-212021-07-19 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231478112314782020-12-21T16:35:002021-06-092020-12-21T16:35:002021-01-11T11:01:002020-12-212021-06-09 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231479112314792020-12-21T15:58:002021-05-142020-12-21T15:58:002021-01-11T14:45:002020-12-212021-05-14 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231481112314812020-12-21T17:02:002021-08-032020-12-21T17:02:002021-01-12T12:30:002020-12-212021-08-03 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231482112314822020-12-22T09:20:002021-07-092020-12-22T09:20:002021-01-11T15:14:002020-12-222021-07-09 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231483112314832020-12-22T09:54:002021-06-102020-12-22T09:54:002021-01-11T09:41:002020-12-222021-06-10 1123113680 Essink, Brandon James (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231484112314842020-12-22T10:18:002021-07-162020-12-22T10:18:002021-01-12T09:35:002020-12-222021-07-16 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231485112314852020-12-22T11:19:002021-07-232020-12-22T11:19:002021-06-23T15:19:002020-12-222021-07-23 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231486112314862020-12-22T11:43:002021-07-212020-12-22T11:43:002021-01-11T14:05:002020-12-222021-07-21 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231487112314872020-12-22T11:22:002021-07-152020-12-22T11:22:002021-06-15T15:10:002020-12-222021-07-15 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231488112314882020-12-22T14:48:002021-07-122020-12-22T14:48:002021-01-13T11:35:002020-12-222021-07-12 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231489112314892020-12-22T15:22:002021-07-252020-12-22T15:22:002021-01-11T12:14:002020-12-222021-07-25 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231491112314912020-12-22T16:02:002021-06-092020-12-22T16:02:002021-01-11T11:46:002020-12-222021-06-09 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231492112314922020-12-23T10:13:002021-07-072020-12-23T10:13:002021-06-07T13:41:002020-12-23 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231493112314932020-12-23T10:51:002021-07-142020-12-23T10:51:002021-01-15T14:23:002020-12-232021-07-14 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231494112314942020-12-23T11:28:002021-07-122020-12-23T11:28:002021-01-14T15:36:002020-12-232021-07-12 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231495112314952020-12-23T12:04:002021-07-152020-12-23T12:04:002021-01-13T14:37:002020-12-232021-07-15 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231496112314962020-12-23T12:03:002021-07-142020-12-23T12:03:002021-06-16T10:46:002020-12-23 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231497112314972020-12-23T12:53:002021-07-202020-12-23T12:53:002021-06-18T14:11:002020-12-232021-07-20 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231499112314992020-12-28T10:13:002021-06-302020-12-28T10:13:002021-06-02T09:50:002020-12-282021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231500112315002020-12-28T10:39:002021-06-152020-12-28T10:39:002021-01-18T10:00:002020-12-282021-06-15 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231501112315012020-12-28T12:31:002021-07-092020-12-28T12:31:002021-06-11T13:42:002020-12-282021-07-09 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231502112315022020-12-28T12:33:002021-07-132020-12-28T12:33:002021-01-19T16:22:002020-12-282021-07-13 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231503112315032020-12-28T12:20:002021-07-082020-12-28T12:20:002021-06-09T14:07:002020-12-282021-07-08 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231504112315042020-12-28T15:30:002021-07-192020-12-28T15:30:002021-01-18T09:35:002020-12-282021-07-19 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231505112315052020-12-28T15:31:002021-07-202020-12-28T15:31:002021-06-22T10:31:002020-12-282021-07-20 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231506112315062020-12-28T16:01:002021-08-312020-12-28T16:01:002021-01-18T11:20:002020-12-282021-08-31 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231507112315072020-12-28T16:52:002021-05-262020-12-28T16:52:002021-01-18T11:50:002020-12-282021-05-26 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231508112315082020-12-28T16:53:002021-07-142020-12-28T16:53:002021-01-20T09:22:002020-12-282021-07-14 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231509112315092020-12-29T12:04:002021-07-152020-12-29T12:04:002021-06-17T14:56:002020-12-292021-07-15 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231510112315102020-12-29T12:42:002021-07-152020-12-29T12:42:002021-06-15T11:52:002020-12-29 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231511112315112020-12-30T10:16:002021-05-102020-12-30T10:16:002021-01-19T15:38:002020-12-302021-05-10 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231512112315122020-12-30T10:17:002021-05-102020-12-30T10:17:002021-01-19T15:39:002020-12-302021-05-10 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231513112315132020-12-30T10:40:002021-07-282020-12-30T10:40:002021-06-30T10:09:002020-12-302021-07-28 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231514112315142020-12-30T14:10:002021-07-152020-12-30T14:10:002021-06-15T10:54:002020-12-302021-07-15 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231515112315152020-12-30T15:53:002021-05-282020-12-30T15:53:002021-01-18T14:03:002020-12-302021-05-28 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231516112315162020-12-30T16:18:002021-08-122020-12-30T16:18:002021-07-08T16:05:002020-12-302021-08-12 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231517112315172020-12-30T15:35:002021-07-142020-12-30T15:35:002021-01-18T12:50:002020-12-302021-07-14 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231518112315182020-12-30T16:17:002021-07-142020-12-30T16:17:002021-01-20T14:52:002020-12-302021-07-14 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231519112315192020-12-30T16:57:002021-07-142020-12-30T16:57:002021-01-20T11:15:002020-12-302021-07-14 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231520112315202020-12-30T17:14:002021-07-122020-12-30T17:14:002021-06-11T09:46:002020-12-302021-07-12 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231521112315212020-12-30T17:14:002021-07-122020-12-30T17:14:002021-01-18T12:47:002020-12-302021-07-12 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231522112315222021-01-05T13:59:002021-07-072021-01-05T13:59:002021-06-08T13:38:002021-01-052021-07-07 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231523112315232021-01-05T13:59:002021-07-072021-01-05T13:59:002021-06-08T13:39:002021-01-052021-07-07 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231524112315242021-01-05T15:44:002021-07-222021-01-05T15:44:002021-01-28T16:12:002021-01-052021-07-22 1123113680 Essink, Brandon James (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231525112315252021-01-07T16:34:002021-07-282021-01-07T16:34:002021-01-29T15:31:002021-01-072021-07-28 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231526112315262021-01-08T09:33:002021-06-302021-01-08T09:33:002021-05-25T15:52:002021-01-082021-06-30 1123113680 Essink, Brandon James (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241236112412362020-12-14T11:17:002021-06-012020-12-14T11:17:002021-01-04T10:50:002020-12-142021-06-01 112428769 Fried, David L. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241238112412382020-12-14T15:16:002021-06-302020-12-14T15:16:002021-01-06T15:48:002020-12-142021-06-30 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241239112412392020-12-14T15:21:002021-06-302020-12-14T15:21:002021-01-06T16:21:002020-12-142021-06-30 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241240112412402020-12-14T15:58:002021-07-142020-12-14T15:58:002021-06-09T16:07:002020-12-142021-07-14 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241241112412412020-12-14T15:57:002021-07-142020-12-14T15:57:002021-06-09T16:09:002020-12-142021-07-14 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241242112412422020-12-14T17:03:002021-06-212020-12-14T17:03:002021-01-05T14:49:002020-12-142021-06-21 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241243112412432020-12-15T13:39:002021-06-292020-12-15T13:39:002021-01-05T16:39:002020-12-152021-06-29 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241244112412442020-12-15T14:29:002021-06-292020-12-15T14:29:002021-01-05T14:00:002020-12-152021-06-29 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241245112412452020-12-15T17:12:002021-07-142020-12-15T17:12:002021-01-06T17:54:002020-12-152021-07-14 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241246112412462020-12-15T17:10:002021-06-302020-12-15T17:10:002021-01-06T17:56:002020-12-152021-06-30 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241247112412472020-12-16T09:40:002021-07-222020-12-16T09:40:002021-07-22T16:19:002020-12-16 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241248112412482020-12-16T10:40:002021-07-082020-12-16T10:40:002021-06-09T15:41:002020-12-162021-07-08 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241249112412492020-12-16T14:24:002021-07-212020-12-16T14:24:002021-01-04T16:07:002020-12-162021-07-21 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241250112412502020-12-17T16:15:002021-07-062020-12-17T16:15:002021-06-07T16:18:002020-12-172021-07-06 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241251112412512020-12-18T09:49:002021-07-162020-12-18T09:49:002021-01-08T11:45:002020-12-182021-07-16 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241252112412522020-12-18T09:42:002021-07-082020-12-18T09:42:002021-06-08T14:07:002020-12-182021-07-08 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241253112412532020-12-18T14:56:002021-07-232020-12-18T14:56:002021-01-08T11:53:002020-12-182021-07-23 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241254112412542020-12-18T14:53:002021-07-302020-12-18T14:53:002021-01-08T11:51:002020-12-182021-07-30 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241255112412552020-12-18T16:52:002021-07-122020-12-18T16:52:002021-06-09T15:27:002020-12-182021-07-12 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241256112412562020-12-21T12:23:002021-05-212020-12-21T12:23:002021-01-13T15:50:002020-12-212021-05-21 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241257112412572020-12-22T16:08:002021-07-072020-12-22T16:08:002021-06-08T16:26:002020-12-222021-07-07 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241258112412582020-12-23T11:55:002021-07-062020-12-23T11:55:002021-06-08T15:45:002020-12-232021-07-06 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241259112412592020-12-23T11:51:002021-07-142020-12-23T11:51:002021-01-14T16:10:002020-12-232021-07-14 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241260112412602020-12-23T12:00:002021-07-092020-12-23T12:00:002021-01-13T15:56:002020-12-232021-07-09 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241261112412612020-12-23T12:42:002021-06-232020-12-23T12:42:002021-01-13T15:54:002020-12-232021-06-23 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241262112412622020-12-23T14:42:002021-07-092020-12-23T14:42:002021-01-11T16:40:002020-12-232021-07-09 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241263112412632020-12-29T10:04:002021-07-122020-12-29T10:04:002021-06-10T15:05:002020-12-292021-07-12 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241264112412642020-12-29T10:05:002021-07-122020-12-29T10:05:002021-06-10T15:05:002020-12-292021-07-12 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241265112412652020-12-29T12:24:002021-07-202020-12-29T12:24:002021-01-18T09:51:002020-12-292021-07-20 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241266112412662020-12-29T12:28:002021-07-192020-12-29T12:28:002021-01-18T09:49:002020-12-292021-07-19 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241267112412672020-12-29T12:31:002021-07-062020-12-29T12:31:002021-06-07T16:17:002020-12-292021-07-06 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241268112412682021-01-04T13:56:002021-07-062021-01-04T13:56:002021-06-08T15:29:002021-01-042021-07-06 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241269112412692021-01-04T16:28:002021-07-202021-01-04T16:28:002021-01-25T15:19:002021-01-042021-07-20 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241270112412702021-01-05T16:03:002021-04-132021-01-05T16:03:002021-03-16T15:20:002021-01-052021-04-13 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241271112412712021-01-05T16:53:002021-07-212021-01-05T16:53:002021-01-26T16:23:002021-01-052021-07-21 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241272112412722021-01-05T17:10:002021-07-132021-01-05T17:10:002021-06-09T14:58:002021-01-052021-07-13 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241273112412732021-01-06T17:37:002021-07-212021-01-06T17:37:002021-01-27T16:58:002021-01-062021-07-21 112428769 Fried, David L. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241274112412742021-01-06T17:34:002021-07-142021-01-06T17:34:002021-06-09T16:59:002021-01-062021-07-14 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241275112412752021-01-08T15:18:002021-08-112021-01-08T15:18:002021-01-27T16:40:002021-01-082021-08-11 112428769 Fried, David L. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251241112512412020-12-07T09:06:002021-06-252020-12-07T09:06:002020-12-30T09:29:002020-12-072021-06-25 1125399369 Harper, Charles Harold (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251242112512422020-12-07T09:29:002021-07-122020-12-07T09:29:002021-06-07T16:50:002020-12-072021-07-12 1125399369 Harper, Charles Harold (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251244112512442020-12-08T18:31:002021-08-062020-12-08T18:31:002021-07-09T18:06:002020-12-082021-08-06 1125399369 Harper, Charles Harold (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251246112512462020-12-10T10:10:002021-06-232020-12-10T10:10:002020-12-30T12:45:002020-12-102021-06-23 1125399369 Harper, Charles Harold (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251248112512482020-12-11T14:25:002021-07-012020-12-11T14:25:002020-12-30T13:35:002020-12-112021-07-01 1125399369 Harper, Charles Harold (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251249112512492020-12-11T15:05:002021-07-122020-12-11T15:05:002021-06-08T14:56:002020-12-112021-07-12 1125399369 Harper, Charles Harold (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251250112512502020-12-14T12:01:002021-06-302020-12-14T12:01:002021-01-06T16:47:002020-12-142021-06-30 1125399369 Harper, Charles Harold (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251251112512512020-12-14T12:31:002021-06-302020-12-14T12:31:002021-01-06T14:18:002020-12-142021-06-30 1125399369 Harper, Charles Harold (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251252112512522020-12-16T14:46:002021-07-082020-12-16T14:46:002021-01-13T08:40:002020-12-162021-07-08 1125399369 Harper, Charles Harold (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251253112512532020-12-16T16:06:002021-07-202020-12-16T16:06:002021-06-15T09:08:002020-12-162021-07-20 1125399369 Harper, Charles Harold (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251254112512542020-12-28T11:54:002021-07-122020-12-28T11:54:002021-06-08T16:29:002020-12-282021-07-12 1125399369 Harper, Charles Harold (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251255112512552021-01-06T17:04:002021-07-262021-01-06T17:04:002021-01-27T16:49:002021-01-062021-07-26 1125399369 Harper, Charles Harold (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261229112612292020-11-30T13:43:002021-06-162020-11-30T13:43:002020-12-21T10:39:002020-11-302021-06-16 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261230112612302020-11-30T16:10:002021-08-262020-11-30T16:10:002020-12-21T14:27:002020-11-302021-08-26 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261233112612332020-12-01T11:55:002021-07-072020-12-01T11:55:002021-06-09T13:42:002020-12-012021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261235112612352020-12-01T15:41:002021-07-092020-12-01T15:41:002021-06-08T11:41:002020-12-012021-07-09 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261239112612392020-12-02T10:00:002021-07-122020-12-02T10:00:002021-06-07T09:58:002020-12-022021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261240112612402020-12-02T10:01:002021-07-122020-12-02T10:01:002021-06-10T13:04:002020-12-022021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261241112612412020-12-02T11:23:002021-08-132020-12-02T11:23:002020-12-21T12:16:002020-12-022021-08-13 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261243112612432020-12-02T12:37:002021-07-282020-12-02T12:37:002020-12-21T09:40:002020-12-022021-07-28 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261246112612462020-12-02T15:19:002021-06-222020-12-02T15:19:002020-12-23T10:23:002020-12-022021-06-22 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261249112612492020-12-02T17:48:002021-06-182020-12-02T17:48:002020-12-22T14:15:002020-12-022021-06-18 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261250112612502020-12-02T17:51:002021-07-162020-12-02T17:51:002021-06-15T16:10:002020-12-022021-07-16 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261253112612532020-12-03T12:39:002021-07-062020-12-03T12:39:002021-06-08T09:43:002020-12-032021-07-06 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261254112612542020-12-03T15:42:002021-08-192020-12-03T15:42:002021-07-12T09:59:002020-12-032021-08-19 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261255112612552020-12-03T15:46:002021-08-032020-12-03T15:46:002020-12-23T11:22:002020-12-032021-08-03 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261258112612582020-12-03T17:45:002021-08-312020-12-03T17:45:002020-12-22T09:40:002020-12-032021-08-31 1126280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261262112612622020-12-04T16:09:002021-07-192020-12-04T16:09:002021-03-03T12:25:002020-12-04 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261263112612632020-12-04T16:51:002021-06-242020-12-04T16:51:002020-12-23T15:39:002020-12-042021-06-24 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261264112612642020-12-04T17:51:002021-06-252020-12-04T17:51:002020-12-23T14:22:002020-12-042021-06-25 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261265112612652020-12-14T18:09:002021-07-122020-12-14T18:09:002021-06-14T12:06:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261266112612662020-12-14T09:34:002021-07-122020-12-14T09:34:002021-06-14T12:08:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261267112612672020-12-14T10:18:002021-07-122020-12-14T10:18:002021-06-11T09:44:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261268112612682020-12-14T11:08:002021-07-072020-12-14T11:08:002021-01-05T16:05:002020-12-142021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261269112612692020-12-14T13:04:002021-07-122020-12-14T13:04:002021-01-06T11:41:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261270112612702020-12-14T14:48:002021-07-082020-12-14T14:48:002021-06-10T09:55:002020-12-142021-07-08 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261271112612712020-12-14T16:16:002021-07-162020-12-14T16:16:002021-01-06T14:15:002020-12-142021-07-16 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261273112612732020-12-14T17:54:002021-07-132020-12-14T17:54:002021-01-06T16:54:002020-12-142021-07-13 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261274112612742020-12-15T12:09:002021-07-132020-12-15T12:09:002021-06-10T19:39:002020-12-152021-07-13 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261275112612752020-12-15T16:25:002021-08-262020-12-15T16:25:002021-03-03T13:23:002020-12-152021-08-26 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261276112612762020-12-15T16:26:002021-08-262020-12-15T16:26:002021-03-03T13:22:002020-12-15 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261277112612772020-12-15T17:02:002021-07-132020-12-15T17:02:002021-01-05T14:37:002020-12-152021-07-13 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261278112612782020-12-15T17:53:002021-07-132020-12-15T17:53:002021-01-05T14:39:002020-12-152021-07-13 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261279112612792020-12-16T09:55:002021-07-092020-12-16T09:55:002021-06-11T13:04:002020-12-162021-07-09 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261280112612802020-12-16T09:58:002021-07-092020-12-16T09:58:002021-06-11T13:05:002020-12-162021-07-09 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261281112612812020-12-16T11:43:002021-07-152020-12-16T11:43:002021-01-07T16:23:002020-12-162021-07-15 1126280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261282112612822020-12-16T12:10:002021-06-302020-12-16T12:10:002021-01-06T11:24:002020-12-162021-06-30 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261283112612832020-12-16T14:19:002021-07-072020-12-16T14:19:002021-06-09T14:53:002020-12-162021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261284112612842020-12-16T15:04:002021-07-092020-12-16T15:04:002021-06-07T15:12:002020-12-162021-07-09 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261285112612852020-12-16T17:02:002021-06-302020-12-16T17:02:002021-01-06T10:13:002020-12-162021-06-30 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261286112612862020-12-16T17:06:002021-07-072020-12-16T17:06:002021-01-13T13:28:002020-12-162021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261287112612872020-12-16T17:08:002021-07-082020-12-16T17:08:002021-06-10T11:27:002020-12-162021-07-08 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261288112612882020-12-16T17:25:002021-07-062020-12-16T17:25:002021-01-06T11:49:002020-12-162021-07-06 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261289112612892020-12-17T13:19:002021-07-072020-12-17T13:19:002021-06-09T14:49:002020-12-172021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261290112612902020-12-17T16:12:002021-07-162020-12-17T16:12:002021-06-09T14:08:002020-12-172021-07-16 1126280164 Klein, Nicola P. (b)(6)AYEARSMNOT REPORTED NOT REPORTED PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261291112612912020-12-17T15:34:002021-07-152020-12-17T15:34:002021-01-07T15:24:002020-12-172021-07-15 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261292112612922020-12-17T17:21:002021-07-082020-12-17T17:21:002021-06-07T11:34:002020-12-172021-07-08 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261293112612932020-12-18T09:08:002021-07-172020-12-18T09:08:002021-01-08T17:04:002020-12-182021-07-17 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261294112612942020-12-18T11:53:002021-08-062020-12-18T11:53:002021-08-06T10:25:002020-12-18 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261295112612952020-12-18T13:45:002021-07-072020-12-18T13:45:002021-01-08T15:35:002020-12-182021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261296112612962020-12-18T15:35:002021-05-242020-12-18T15:35:002021-04-26T15:15:002020-12-182021-05-24 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261297112612972020-12-18T15:34:002021-07-142020-12-18T15:34:002021-06-09T15:54:002020-12-182021-07-14 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261298112612982020-12-18T16:16:002021-07-012020-12-18T16:16:002021-01-07T16:50:002020-12-182021-07-01 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261299112612992020-12-21T12:31:002021-07-192020-12-21T12:31:002021-01-12T15:25:002020-12-212021-07-19 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261300112613002020-12-22T08:30:002021-07-092020-12-22T08:30:002021-06-11T15:01:002020-12-222021-07-09 1126280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261301112613012020-12-22T13:30:002021-07-082020-12-22T13:30:002021-01-14T15:48:002020-12-222021-07-08 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261302112613022020-12-23T13:43:002021-07-092020-12-23T13:43:002021-06-11T14:03:002020-12-23 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261303112613032020-12-29T11:14:002021-07-122020-12-29T11:14:002021-01-18T16:10:002020-12-292021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261304112613042020-12-29T11:21:002021-07-122020-12-29T11:21:002021-01-18T16:12:002020-12-292021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261305112613052020-12-30T11:37:002021-04-162020-12-30T11:37:002021-03-17T10:19:002020-12-30 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261306112613062020-12-30T11:40:002021-07-062020-12-30T11:40:002021-06-08T09:45:002020-12-302021-07-06 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261307112613072021-01-04T16:26:002021-07-212021-01-04T16:26:002021-01-25T15:10:002021-01-042021-07-21 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261308112613082021-01-04T16:31:002021-08-062021-01-04T16:31:002021-07-09T13:08:002021-01-042021-08-06 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261309112613092021-01-04T16:34:002021-08-092021-01-04T16:34:002021-01-25T15:13:002021-01-042021-08-09 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261310112613102021-01-05T10:23:002021-07-202021-01-05T10:23:002021-01-26T11:01:002021-01-05 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261311112613112021-01-05T15:11:002021-07-222021-01-05T15:11:002021-06-21T09:39:002021-01-052021-07-22 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261312112613122021-01-05T15:43:002021-07-122021-01-05T15:43:002021-06-09T09:40:002021-01-052021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261313112613132021-01-06T14:31:002021-07-262021-01-06T14:31:002021-01-28T15:19:002021-01-062021-07-26 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261314112613142021-01-06T14:20:002021-07-072021-01-06T14:20:002021-06-07T16:10:002021-01-062021-07-07 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261315112613152021-01-06T17:48:002021-07-232021-01-06T17:48:002021-01-29T14:02:002021-01-062021-07-23 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261316112613162021-01-07T09:54:002021-07-232021-01-07T09:54:002021-01-27T08:19:002021-01-072021-07-23 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261317112613172021-01-07T09:57:002021-08-302021-01-07T09:57:002021-06-09T15:49:002021-01-072021-08-30 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261318112613182021-01-07T13:15:002021-08-242021-01-07T13:15:002021-08-24T16:11:002021-01-07 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261319112613192021-01-07T15:20:002021-08-042021-01-07T15:20:002021-01-27T11:52:002021-01-072021-08-04 1126280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261320112613202021-01-07T16:55:002021-07-062021-01-07T16:55:002021-06-08T14:07:002021-01-072021-07-06 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261321112613212021-01-07T17:55:002021-07-222021-01-07T17:55:002021-01-28T16:13:002021-01-072021-07-22 1126280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261322112613222021-01-07T17:57:002021-07-122021-01-07T17:57:002021-06-14T09:42:002021-01-072021-07-12 1126280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261323112613232021-01-08T16:46:002021-07-262021-01-08T16:46:002021-01-28T16:46:002021-01-082021-07-26 1126280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261324112613242021-01-08T16:48:002021-07-262021-01-08T16:48:002021-01-28T16:44:002021-01-082021-07-26 1126280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261325112613252021-01-08T17:29:002021-07-062021-01-08T17:29:002021-06-08T14:12:002021-01-082021-07-06 1126280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311275113112752020-12-04T11:17:002021-08-312020-12-04T11:17:002020-12-23T12:21:002020-12-042021-08-31 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311277113112772020-12-08T12:32:002021-07-012020-12-08T12:32:002020-12-29T13:03:002020-12-082021-07-01 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311278113112782020-12-08T17:15:002021-06-282020-12-08T17:15:002020-12-30T15:17:002020-12-082021-06-28 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311279113112792020-12-21T14:16:002021-07-122020-12-21T14:16:002021-01-11T16:49:002020-12-172021-07-12 1131220331 Randall, William (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311280113112802020-12-17T18:24:002021-09-022020-12-17T18:24:002021-08-03T10:43:002020-12-172021-09-02 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311281113112812020-12-21T16:23:002021-07-092020-12-21T16:23:002021-01-11T16:16:002020-12-212021-07-09 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311282113112822020-12-22T11:01:002021-07-132020-12-22T11:01:002021-01-14T14:20:002020-12-222021-07-13 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311283113112832020-12-22T16:59:002021-07-162020-12-22T16:59:002021-06-17T16:34:002020-12-222021-07-16 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311285113112852020-12-23T11:47:002021-08-042020-12-23T11:47:002021-07-07T14:24:002020-12-232021-08-04 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311286113112862020-12-29T10:32:002021-07-122020-12-29T10:32:002021-01-18T11:25:002020-12-292021-07-12 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311287113112872020-12-29T11:35:002021-07-142020-12-29T11:35:002021-06-16T10:53:002020-12-29 1131220331 Randall, William (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311288113112882020-12-29T11:37:002021-07-142020-12-29T11:37:002021-06-16T10:52:002020-12-292021-07-14 1131220331 Randall, William (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311289113112892020-12-30T12:23:002021-08-312020-12-30T12:23:002021-01-21T10:07:002020-12-302021-08-31 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311290113112902020-12-30T12:46:002021-07-142020-12-30T12:46:002021-01-20T17:02:002020-12-302021-07-14 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311291113112912020-12-30T14:45:002021-07-142020-12-30T14:45:002021-01-20T10:09:002020-12-302021-07-14 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311292113112922021-01-04T16:05:002021-08-302021-01-04T16:05:002021-08-30T12:37:002021-01-042021-08-30 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311293113112932021-01-04T17:20:002021-09-022021-01-04T17:20:002021-08-03T10:41:002021-01-042021-09-02 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311294113112942021-01-05T18:13:002021-07-202021-01-05T18:13:002021-01-26T17:32:002021-01-052021-07-20 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311295113112952021-01-07T14:07:002021-07-122021-01-07T14:07:002021-06-14T15:19:002021-01-072021-07-12 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311296113112962021-01-08T11:40:002021-05-282021-01-08T11:40:002021-04-30T12:27:002021-01-082021-05-28 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311297113112972021-01-08T11:43:002021-08-022021-01-08T11:43:002021-01-27T12:36:002021-01-082021-08-02 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311298113112982021-01-08T11:43:002021-07-232021-01-08T11:43:002021-01-29T15:42:002021-01-082021-07-23 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311299113112992021-01-08T17:45:002021-08-312021-01-08T17:45:002021-06-10T10:41:002021-01-08 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311300113113002021-01-08T17:47:002021-07-082021-01-08T17:47:002021-06-10T10:43:002021-01-08 1131220331 Randall, William (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311301113113012021-01-11T14:50:002021-08-092021-01-11T14:50:002021-02-05T14:06:002021-01-112021-08-09 1131220331 Randall, William (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311302113113022021-01-11T17:49:002021-08-052021-01-11T17:49:002021-02-01T11:09:002021-01-112021-08-05 1131220331 Randall, William (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391144113911442020-12-11T15:51:002021-06-242020-12-11T15:51:002020-12-30T13:20:002020-12-012021-06-24 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391145113911452020-12-01T11:33:002021-06-292020-12-01T11:33:002020-12-21T13:16:002020-12-012021-06-29 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391151113911512020-12-04T14:27:002021-06-182020-12-04T14:27:002020-12-23T12:15:002020-12-042021-06-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391152113911522020-12-04T17:25:002021-07-012020-12-04T17:25:002021-06-03T13:45:002020-12-042021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391154113911542020-12-04T17:34:002021-07-012020-12-04T17:34:002021-06-03T16:20:002020-12-042021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391155113911552020-12-04T17:38:002021-08-172020-12-04T17:38:002020-12-28T15:25:002020-12-042021-08-17 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391156113911562020-12-07T11:03:002021-06-222020-12-07T11:03:002020-12-29T15:30:002020-12-072021-06-22 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391157113911572020-12-08T11:25:002021-05-042020-12-08T11:25:002021-04-06T13:15:002020-12-082021-05-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391158113911582020-12-08T15:18:002021-07-012020-12-08T15:18:002021-06-03T14:14:002020-12-082021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391159113911592020-12-08T14:58:002021-08-122020-12-08T14:58:002021-06-10T12:45:002020-12-082021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391161113911612020-12-08T16:07:002021-06-232020-12-08T16:07:002020-12-29T12:18:002020-12-082021-06-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391162113911622020-12-08T16:11:002021-06-222020-12-08T16:11:002020-12-29T13:24:002020-12-082021-06-22 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391163113911632020-12-08T16:15:002021-07-082020-12-08T16:15:002021-06-04T15:06:002020-12-082021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391165113911652020-12-11T15:59:002021-06-082020-12-11T15:59:002020-12-30T14:18:002020-12-112021-06-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391166113911662020-12-11T16:06:002021-04-142020-12-11T16:06:002021-03-11T13:19:002020-12-11 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391168113911682020-12-11T16:15:002021-08-122020-12-11T16:15:002021-06-10T16:16:002020-12-112021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391169113911692020-12-15T11:13:002021-07-082020-12-15T11:13:002021-01-14T12:59:002020-12-152021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391170113911702020-12-15T11:18:002021-07-082020-12-15T11:18:002021-01-14T12:59:002020-12-152021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391171113911712020-12-15T11:24:002021-08-272020-12-15T11:24:002021-01-05T12:43:002020-12-152021-08-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391172113911722020-12-15T15:48:002021-05-312020-12-15T15:48:002021-01-05T12:36:002020-12-152021-05-31 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391173113911732020-12-15T17:24:002021-07-162020-12-15T17:24:002021-01-07T17:05:002020-12-152021-07-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391174113911742020-12-15T17:28:002021-08-182020-12-15T17:28:002021-07-16T14:22:002020-12-152021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391175113911752020-12-15T17:15:002021-07-012020-12-15T17:15:002021-06-03T12:32:002020-12-152021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391177113911772020-12-17T11:50:002021-07-192020-12-17T11:50:002021-01-15T14:15:002020-12-17 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391178113911782020-12-18T12:58:002021-08-272020-12-18T12:58:002021-01-08T15:52:002020-12-182021-08-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391179113911792020-12-18T15:03:002021-08-282020-12-18T15:03:002021-01-08T15:40:002020-12-182021-08-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391180113911802020-12-18T15:20:002021-07-072020-12-18T15:20:002021-06-03T12:19:002020-12-182021-07-07 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391181113911812020-12-18T15:02:002021-04-082020-12-18T15:02:002021-03-08T13:02:002020-12-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391182113911822020-12-18T15:27:002021-07-082020-12-18T15:27:002021-06-04T12:20:002020-12-182021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391183113911832020-12-18T16:56:002021-07-152020-12-18T16:56:002021-01-08T14:04:002020-12-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391185113911852020-12-18T17:00:002021-07-072020-12-18T17:00:002021-06-03T12:25:002020-12-182021-07-07 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391186113911862020-12-21T11:53:002021-07-092020-12-21T11:53:002021-01-11T14:51:002020-12-212021-07-09 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391187113911872020-12-21T11:58:002021-08-122020-12-21T11:58:002021-06-11T12:54:002020-12-212021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391188113911882020-12-21T12:15:002021-07-192020-12-21T12:15:002021-01-12T15:27:002020-12-212021-07-19 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391189113911892020-12-21T16:15:002021-05-132020-12-21T16:15:002021-01-11T14:28:002020-12-212021-05-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391190113911902020-12-21T16:32:002021-07-152020-12-21T16:32:002021-01-11T15:16:002020-12-212021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391191113911912020-12-21T16:37:002021-07-152020-12-21T16:37:002021-01-11T15:20:002020-12-212021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391192113911922020-12-21T16:27:002021-07-142020-12-21T16:27:002021-01-11T14:36:002020-12-212021-07-14 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391193113911932020-12-21T16:21:002021-07-012020-12-21T16:21:002021-06-03T15:03:002020-12-212021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391195113911952020-12-21T16:43:002021-07-272020-12-21T16:43:002021-06-11T12:37:002020-12-212021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391196113911962020-12-21T16:49:002021-07-272020-12-21T16:49:002021-06-03T13:45:002020-12-212021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391197113911972020-12-22T12:05:002021-07-122020-12-22T12:05:002021-01-12T16:05:002020-12-222021-07-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391198113911982020-12-22T11:55:002021-08-132020-12-22T11:55:002021-06-11T13:27:002020-12-222021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391199113911992020-12-22T11:48:002021-07-082020-12-22T11:48:002021-01-14T14:32:002020-12-222021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391200113912002020-12-22T12:01:002021-07-062020-12-22T12:01:002021-01-12T16:57:002020-12-222021-07-06 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391201113912012020-12-22T15:02:002021-08-042020-12-22T15:02:002021-01-12T16:30:002020-12-222021-08-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391202113912022020-12-22T15:06:002021-08-122020-12-22T15:06:002021-06-17T16:07:002020-12-222021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391203113912032020-12-22T16:50:002021-04-272020-12-22T16:50:002021-04-06T15:00:002020-12-222021-04-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391204113912042020-12-22T16:55:002021-05-122020-12-22T16:55:002021-01-12T15:51:002020-12-222021-05-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391205113912052020-12-22T16:29:002021-08-182020-12-22T16:29:002021-07-16T15:05:002020-12-222021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391206113912062020-12-22T16:34:002021-07-152020-12-22T16:34:002021-01-12T17:12:002020-12-222021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391207113912072020-12-22T16:39:002021-08-122020-12-22T16:39:002021-06-10T12:22:002020-12-222021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391208113912082020-12-22T16:44:002021-08-122020-12-22T16:44:002021-06-10T12:22:002020-12-222021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391209113912092020-12-23T10:40:002021-07-282020-12-23T10:40:002021-01-14T13:47:002020-12-222021-07-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391210113912102020-12-28T12:21:002021-08-122020-12-28T12:21:002021-06-18T12:50:002020-12-282021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391211113912112020-12-28T13:05:002021-07-142020-12-28T13:05:002021-01-19T12:57:002020-12-282021-07-14 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391212113912122020-12-28T12:59:002021-04-142020-12-28T12:59:002021-03-15T16:10:002020-12-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391213113912132020-12-28T13:48:002021-08-032020-12-28T13:48:002021-01-19T15:32:002020-12-282021-08-03 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391214113912142020-12-28T15:13:002021-07-192020-12-28T15:13:002021-01-21T11:45:002020-12-282021-07-19 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391215113912152020-12-29T12:05:002021-07-062020-12-29T12:05:002021-06-04T13:36:002020-12-292021-07-06 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391216113912162020-12-29T12:01:002021-08-042020-12-29T12:01:002021-01-19T14:46:002020-12-292021-08-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391217113912172020-12-29T12:59:002021-07-082020-12-29T12:59:002021-06-08T15:33:002020-12-292021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391218113912182020-12-29T15:48:002021-08-182020-12-29T15:48:002021-01-19T10:45:002020-12-292021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391219113912192020-12-29T15:42:002021-07-022020-12-29T15:42:002021-06-03T13:55:002020-12-292021-07-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391220113912202020-12-29T15:52:002021-08-132020-12-29T15:52:002021-06-10T13:04:002020-12-292021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391221113912212021-01-04T13:06:002021-08-022021-01-04T13:06:002021-01-26T13:42:002021-01-042021-08-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391222113912222021-01-04T13:32:002021-08-132021-01-04T13:32:002021-06-11T15:56:002021-01-042021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391223113912232021-01-04T12:57:002021-07-202021-01-04T12:57:002021-01-26T14:13:002021-01-042021-07-20 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391224113912242021-01-04T14:43:002021-07-072021-01-04T14:43:002021-06-03T16:08:002021-01-042021-07-07 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391225113912252021-01-04T13:26:002021-08-022021-01-04T13:26:002021-01-28T14:25:002021-01-042021-08-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391226113912262021-01-05T12:12:002021-08-052021-01-05T12:12:002021-01-28T14:09:002021-01-052021-08-05 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391227113912272021-01-05T12:15:002021-07-162021-01-05T12:15:002021-06-11T12:49:002021-01-052021-07-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391228113912282021-01-05T12:31:002021-08-132021-01-05T12:31:002021-06-11T13:12:002021-01-052021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391229113912292021-01-05T12:21:002021-08-132021-01-05T12:21:002021-06-10T14:30:002021-01-052021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391230113912302021-01-05T12:27:002021-07-272021-01-05T12:27:002021-01-26T12:57:002021-01-052021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391231113912312021-01-05T16:28:002021-07-212021-01-05T16:28:002021-01-26T15:34:002021-01-052021-07-21 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391232113912322021-01-05T16:33:002021-08-232021-01-05T16:33:002021-01-26T15:27:002021-01-052021-08-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391233113912332021-01-05T16:38:002021-07-212021-01-05T16:38:002021-01-26T15:30:002021-01-052021-07-21 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391235113912352021-01-05T16:47:002021-04-052021-01-05T16:47:002021-03-08T12:44:002021-01-05 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391236113912362021-01-05T16:52:002021-07-282021-01-05T16:52:002021-01-25T14:10:002021-01-052021-07-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391237113912372021-01-07T16:46:002021-07-152021-01-07T16:46:002021-06-17T15:44:002021-01-072021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391238113912382021-01-07T16:38:002021-07-162021-01-07T16:38:002021-01-29T14:53:002021-01-072021-07-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391239113912392021-01-07T16:52:002021-08-162021-01-07T16:52:002021-06-11T14:48:002021-01-072021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391240113912402021-01-08T13:57:002021-07-302021-01-08T13:57:002021-01-28T13:59:002021-01-082021-07-30 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391241113912412021-01-08T16:24:002021-08-162021-01-08T16:24:002021-06-11T16:06:002021-01-082021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391242113912422021-01-08T16:42:002021-08-232021-01-08T16:42:002021-01-29T13:40:002021-01-082021-08-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391243113912432021-01-08T16:32:002021-07-122021-01-08T16:32:002021-06-10T14:39:002021-01-082021-07-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391244113912442021-01-08T16:36:002021-08-182021-01-08T16:36:002021-01-29T16:11:002021-01-082021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391245113912452021-01-08T17:24:002021-08-112021-01-08T17:24:002021-02-02T14:45:002021-01-082021-08-11 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391246113912462021-01-08T16:52:002021-08-162021-01-08T16:52:002021-06-10T11:51:002021-01-082021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391247113912472021-01-08T17:04:002021-07-012021-01-08T17:04:002021-06-03T15:50:002021-01-082021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391248113912482021-01-08T17:09:002021-07-232021-01-08T17:09:002021-01-29T16:45:002021-01-082021-07-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391249113912492021-01-11T14:19:002021-08-252021-01-11T14:19:002021-02-01T12:07:002021-01-112021-08-25 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391250113912502021-01-11T15:47:002021-06-082021-01-11T15:47:002021-05-11T15:51:002021-01-112021-06-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391251113912512021-01-11T13:41:002021-08-222021-01-11T13:41:002021-02-01T12:48:002021-01-11 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391252113912522021-01-11T13:46:002021-07-012021-01-11T13:46:002021-06-03T13:35:002021-01-112021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391253113912532021-01-11T15:53:002021-07-302021-01-11T15:53:002021-02-01T13:56:002021-01-112021-07-30 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391254113912542021-01-11T15:58:002021-07-232021-01-11T15:58:002021-06-04T15:06:002021-01-112021-07-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391255113912552021-01-11T16:07:002021-07-262021-01-11T16:07:002021-02-01T12:34:002021-01-112021-07-26 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391256113912562021-01-12T14:38:002021-07-272021-01-12T14:38:002021-02-01T14:52:002021-01-122021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391257113912572021-01-12T12:35:002021-08-162021-01-12T12:35:002021-06-11T12:44:002021-01-122021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391258113912582021-01-12T16:12:002021-07-232021-01-12T16:12:002021-06-04T12:07:002021-01-122021-07-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391259113912592021-01-12T12:43:002021-08-022021-01-12T12:43:002021-02-02T14:25:002021-01-122021-08-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391260113912602021-01-12T16:22:002021-08-162021-01-12T16:22:002021-06-11T13:32:002021-01-122021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391261113912612021-01-12T16:08:002021-08-032021-01-12T16:08:002021-02-02T13:02:002021-01-122021-08-03 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391262113912622021-01-12T17:00:002021-08-042021-01-12T17:00:002021-02-04T15:41:002021-01-122021-08-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391263113912632021-01-12T17:12:002021-04-122021-01-12T17:12:002021-03-12T15:23:002021-01-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401323114013232020-12-10T14:15:002021-07-092020-12-10T14:15:002021-01-09T12:28:002020-12-102021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401324114013242020-12-10T14:20:002021-07-092020-12-10T14:20:002021-06-11T14:31:002020-12-102021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401325114013252020-12-10T15:02:002021-08-232020-12-10T15:02:002021-08-23T12:02:002020-12-10 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401326114013262020-12-10T15:07:002021-07-022020-12-10T15:07:002021-01-07T12:01:002020-12-102021-07-02 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401327114013272020-12-11T14:46:002021-07-122020-12-11T14:46:002021-06-08T14:37:002020-12-112021-07-12 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401328114013282020-12-14T14:08:002021-06-302020-12-14T14:08:002021-01-05T13:49:002020-12-142021-06-30 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401329114013292020-12-14T15:53:002021-07-122020-12-14T15:53:002021-01-05T15:24:002020-12-142021-07-12 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401330114013302020-12-15T10:32:002021-07-062020-12-15T10:32:002021-06-08T16:18:002020-12-152021-07-06 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401331114013312020-12-16T11:21:002021-08-272020-12-16T11:21:002021-01-06T11:40:002020-12-162021-08-27 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401332114013322020-12-16T11:25:002021-08-022020-12-16T11:25:002021-01-06T11:42:002020-12-162021-08-02 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401333114013332020-12-16T16:03:002021-07-072020-12-16T16:03:002021-06-08T15:54:002020-12-162021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401334114013342020-12-16T16:07:002021-07-072020-12-16T16:07:002021-06-08T15:56:002020-12-162021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401335114013352020-12-17T13:29:002021-07-072020-12-17T13:29:002021-06-07T09:36:002020-12-172021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401336114013362020-12-17T13:54:002021-07-092020-12-17T13:54:002021-01-08T14:03:002020-12-172021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401337114013372020-12-17T15:23:002021-06-292020-12-17T15:23:002021-01-05T11:12:002020-12-172021-06-29 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401338114013382020-12-17T16:09:002021-07-072020-12-17T16:09:002021-06-07T09:47:002020-12-172021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401340114013402020-12-21T09:29:002021-07-072020-12-21T09:29:002021-06-09T12:08:002020-12-212021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401343114013432020-12-21T15:19:002021-07-162020-12-21T15:19:002021-01-13T15:32:002020-12-212021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSFAMERICAN INDIAN OR ALASKA NATIVE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401344114013442020-12-21T15:21:002021-07-162020-12-21T15:21:002021-01-13T15:35:002020-12-212021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401345114013452020-12-22T09:36:002021-07-062020-12-22T09:36:002021-06-07T14:38:002020-12-222021-07-06 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401346114013462020-12-22 2020-12-22 2020-12-222020-12-22 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) NOTTRT Not Treated USAC4591001DMC4591001 1140 11401347114013472020-12-22T10:08:002021-07-072020-12-22T10:08:002021-06-09T11:10:002020-12-222021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401348114013482020-12-22T10:12:002021-07-072020-12-22T10:12:002021-06-09T11:08:002020-12-222021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401349114013492020-12-22T10:33:002021-07-142020-12-22T10:33:002021-01-12T08:53:002020-12-222021-07-14 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401350114013502020-12-22T12:21:002021-07-132020-12-22T12:21:002021-01-13T12:20:002020-12-222021-07-13 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401351114013512020-12-22T12:24:002021-08-232020-12-22T12:24:002021-08-23T12:05:002020-12-22 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401352114013522020-12-22T12:27:002021-07-132020-12-22T12:27:002021-01-13T12:24:002020-12-222021-07-13 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401353114013532020-12-22T14:58:002021-07-282020-12-22T14:58:002021-06-11T10:38:002020-12-222021-07-28 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401354114013542020-12-23T09:56:002021-07-072020-12-23T09:56:002021-01-13T14:52:002020-12-232021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401356114013562020-12-23T13:30:002021-07-152020-12-23T13:30:002021-06-11T11:12:002020-12-232021-07-15 11401449872Thomas, Stephen (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401357114013572020-12-23T14:07:002021-05-142020-12-23T14:07:002021-01-11T14:58:002020-12-232021-05-14 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401358114013582020-12-23T15:49:002021-07-072020-12-23T15:49:002021-01-13T13:15:002020-12-232021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401359114013592020-12-23T15:45:002021-07-192020-12-23T15:45:002021-01-13T15:11:002020-12-232021-07-19 11401449872Thomas, Stephen (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401361114013612020-12-28T11:58:002021-07-152020-12-28T11:58:002021-01-19T10:40:002020-12-282021-07-15 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401362114013622020-12-28T12:04:002021-07-072020-12-28T12:04:002021-06-07T10:39:002020-12-282021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401363114013632020-12-28T12:59:002021-07-092020-12-28T12:59:002021-06-11T15:47:002020-12-282021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401364114013642020-12-28T14:08:002021-07-082020-12-28T14:08:002021-06-09T14:56:002020-12-282021-07-08 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401365114013652020-12-28T14:05:002021-07-302020-12-28T14:05:002021-01-19T14:06:002020-12-282021-07-30 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401366114013662020-12-28T14:12:002021-07-082020-12-28T14:12:002021-06-09T14:58:002020-12-282021-07-08 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401367114013672020-12-28T15:38:002021-07-162020-12-28T15:38:002021-01-20T09:39:002020-12-282021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401369114013692020-12-29T11:11:002021-07-062020-12-29T11:11:002021-06-07T15:47:002020-12-292021-07-06 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401370114013702020-12-29T12:12:002021-07-162020-12-29T12:12:002021-01-21T11:41:002020-12-292021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401371114013712020-12-29T12:31:002021-07-192020-12-29T12:31:002021-01-20T12:45:002020-12-292021-07-19 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401372114013722020-12-29T12:34:002021-07-082020-12-29T12:34:002021-06-09T09:32:002020-12-292021-07-08 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401373114013732020-12-29T12:56:002021-07-162020-12-29T12:56:002021-01-20T12:59:002020-12-292021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401374114013742020-12-29T13:38:002021-07-192020-12-29T13:38:002021-06-18T12:40:002020-12-292021-07-19 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401375114013752020-12-29T15:00:002021-07-072020-12-29T15:00:002021-06-09T10:42:002020-12-292021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401376114013762020-12-29T14:52:002021-07-142020-12-29T14:52:002021-01-20T14:20:002020-12-292021-07-14 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401377114013772020-12-29T14:56:002021-07-072020-12-29T14:56:002021-06-09T10:40:002020-12-292021-07-07 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401378114013782020-12-29T15:20:002021-07-142020-12-29T15:20:002021-01-20T12:22:002020-12-292021-07-14 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401379114013792020-12-30T10:03:002021-07-092020-12-30T10:03:002021-06-07T16:24:002020-12-302021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401380114013802020-12-30T10:13:002021-08-022020-12-30T10:13:002021-01-19T14:59:002020-12-302021-08-02 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401381114013812020-12-30T11:14:002021-07-162020-12-30T11:14:002021-01-21T14:54:002020-12-302021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401382114013822020-12-30T11:17:002021-07-162020-12-30T11:17:002021-01-21T14:56:002020-12-302021-07-16 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401383114013832020-12-30T11:33:002021-07-122020-12-30T11:33:002021-06-11T10:21:002020-12-302021-07-12 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401384114013842020-12-30T12:17:002021-07-082020-12-30T12:17:002021-06-09T15:56:002020-12-302021-07-08 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401385114013852021-01-06T14:09:002021-07-232021-01-06T14:09:002021-01-27T15:02:002020-12-302021-07-23 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401386114013862021-01-05T12:17:002021-08-012021-01-05T12:17:002021-01-27T11:45:002020-12-302021-08-01 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401387114013872021-01-07T14:09:002021-07-092021-01-07T14:09:002021-06-09T13:15:002020-12-302021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401388114013882021-01-05T14:24:002021-07-122021-01-05T14:24:002021-06-10T13:55:002021-01-052021-07-12 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401389114013892021-01-05T14:27:002021-07-122021-01-05T14:27:002021-06-10T13:53:002021-01-052021-07-12 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401390114013902021-01-05T15:35:002021-07-232021-01-05T15:35:002021-01-27T14:14:002021-01-052021-07-23 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401391114013912021-01-06T09:21:002021-07-272021-01-06T09:21:002021-01-28T09:05:002021-01-062021-07-27 11401449872Thomas, Stephen (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401392114013922021-01-06T10:20:002021-07-012021-01-06T10:20:002021-06-09T13:37:002021-01-062021-07-01 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401393114013932021-01-06T14:27:002021-07-272021-01-06T14:27:002021-01-27T14:28:002021-01-062021-07-27 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401394114013942021-01-06T15:44:002021-08-062021-01-06T15:44:002021-01-28T14:21:002021-01-062021-08-06 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401395114013952021-01-07T12:37:002021-07-262021-01-07T12:37:002021-06-11T09:52:002021-01-072021-07-26 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401396114013962021-01-07T15:17:002021-07-082021-01-07T15:17:002021-06-10T11:55:002021-01-072021-07-08 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401397114013972021-01-08T10:14:002021-07-092021-01-08T10:14:002021-06-07T16:01:002021-01-082021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401398114013982021-01-08T13:08:002021-08-042021-01-08T13:08:002021-01-28T13:09:002021-01-082021-08-04 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401399114013992021-01-08T13:11:002021-08-042021-01-08T13:11:002021-01-28T13:12:002021-01-082021-08-04 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401400114014002021-01-08T13:46:002021-08-042021-01-08T13:46:002021-06-11T15:31:002021-01-082021-08-04 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401401114014012021-01-08T13:35:002021-07-302021-01-08T13:35:002021-01-28T13:41:002021-01-082021-07-30 11401449872Thomas, Stephen (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401402114014022021-01-08T16:17:002021-07-092021-01-08T16:17:002021-06-09T11:41:002021-01-082021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401403114014032021-01-08T16:21:002021-07-092021-01-08T16:21:002021-06-09T11:43:002021-01-082021-07-09 11401449872Thomas, Stephen (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421318114213182020-12-01T12:20:002021-05-142020-12-01T12:20:002020-12-21T10:38:002020-12-01 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421319114213192020-12-01T13:35:002021-06-162020-12-01T13:35:002020-12-21T13:57:002020-12-012021-06-16 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421321114213212020-12-02T10:22:002021-06-212020-12-02T10:22:002020-12-21T09:24:002020-12-022021-06-21 1142281273 Rupp, Richard Earl (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421323114213232020-12-03T11:12:002021-08-202020-12-03T11:12:002021-08-20T10:39:002020-12-03 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421324114213242020-12-03T11:05:002021-06-172020-12-03T11:05:002020-12-22T15:42:002020-12-032021-06-17 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421325114213252020-12-03T15:48:002021-07-142020-12-03T15:48:002021-06-14T13:23:002020-12-032021-07-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421326114213262020-12-03T15:44:002021-07-142020-12-03T15:44:002021-06-14T13:20:002020-12-032021-07-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421327114213272020-12-03T14:31:002021-08-172020-12-03T14:31:002020-12-22T15:54:002020-12-032021-08-17 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421329114213292020-12-04T10:31:002021-08-102020-12-04T10:31:002021-06-04T10:21:002020-12-042021-08-10 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421330114213302020-12-04T10:34:002021-07-212020-12-04T10:34:002020-12-23T09:35:002020-12-042021-07-21 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421333114213332020-12-18T09:52:002021-08-112020-12-18T09:52:002021-01-07T13:45:002020-12-182021-08-11 1142281273 Rupp, Richard Earl (b)(6)AYEARSMNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421335114213352020-12-04T14:30:002021-08-202020-12-04T14:30:002021-08-20T12:34:002020-12-04 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421340114213402020-12-07T10:46:002021-07-062020-12-07T10:46:002020-12-28T09:22:002020-12-072021-07-06 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421341114213412020-12-07T10:47:002021-06-232020-12-07T10:47:002020-12-28T09:28:002020-12-072021-06-23 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421342114213422020-12-07T12:36:002021-06-112020-12-07T12:36:002021-04-27T15:38:002020-12-072021-06-11 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421343114213432020-12-08T10:13:002021-06-212020-12-08T10:13:002020-12-28T09:20:002020-12-082021-06-21 1142281273 Rupp, Richard Earl (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421344114213442020-12-08T13:10:002021-08-232020-12-08T13:10:002021-08-23T14:58:002020-12-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSFNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421345114213452020-12-08T13:16:002021-08-312020-12-08T13:16:002021-08-31T13:34:002020-12-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSFNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421346114213462020-12-10T10:47:002021-06-252020-12-10T10:47:002020-12-29T10:25:002020-12-10 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421348114213482020-12-10T10:46:002021-06-252020-12-10T10:46:002020-12-31T12:03:002020-12-102021-06-25 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421349114213492020-12-10T13:23:002021-08-202020-12-10T13:23:002021-08-20T14:58:002020-12-10 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421350114213502020-12-10T12:56:002021-07-022020-12-10T12:56:002020-12-30T11:40:002020-12-102021-07-02 1142281273 Rupp, Richard Earl (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421351114213512020-12-11T10:40:002021-08-202020-12-11T10:40:002021-08-20T11:31:002020-12-11 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421352114213522020-12-11T15:06:002021-08-202020-12-11T15:06:002021-08-20T13:12:002020-12-11 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421353114213532020-12-11T15:10:002021-07-012020-12-11T15:10:002020-12-31T09:39:002020-12-112021-07-01 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421354114213542020-12-11T15:14:002021-06-302020-12-11T15:14:002020-12-30T16:11:002020-12-112021-06-30 1142281273 Rupp, Richard Earl (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421355114213552020-12-14T10:45:002021-08-162020-12-14T10:45:002021-08-16T13:52:002020-12-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421356114213562020-12-14T11:00:002021-08-162020-12-14T11:00:002021-08-16T13:54:002020-12-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421358114213582020-12-15T10:52:002021-07-142020-12-15T10:52:002021-01-05T16:50:002020-12-152021-07-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421359114213592020-12-15T13:42:002021-07-142020-12-15T13:42:002021-06-09T15:00:002020-12-152021-07-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421360114213602020-12-15T13:35:002021-08-132020-12-15T13:35:002021-01-04T13:49:002020-12-152021-08-13 1142281273 Rupp, Richard Earl (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421361114213612020-12-16T10:13:002021-08-202020-12-16T10:13:002021-08-20T14:55:002020-12-16 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421362114213622020-12-16T10:28:002021-06-292020-12-16T10:28:002021-01-04T12:36:002020-12-162021-06-29 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421363114213632020-12-16T14:06:002021-08-302020-12-16T14:06:002021-02-03T09:15:002020-12-162021-08-30 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421364114213642020-12-18T13:07:002021-07-132020-12-18T13:07:002021-01-08T16:06:002020-12-182021-07-13 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421365114213652020-12-18T15:13:002021-08-102020-12-18T15:13:002021-07-07T09:14:002020-12-182021-08-10 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421366114213662020-12-21T11:10:002021-08-162020-12-21T11:10:002021-08-16T15:42:002020-12-21 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421367114213672020-12-21T11:15:002021-07-132020-12-21T11:15:002021-01-11T15:10:002020-12-212021-07-13 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421368114213682020-12-21T10:48:002021-07-082020-12-21T10:48:002021-06-09T13:29:002020-12-212021-07-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421369114213692020-12-21T14:04:002021-07-202020-12-21T14:04:002021-01-15T15:06:002020-12-212021-07-20 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421370114213702020-12-21T14:10:002021-08-302020-12-21T14:10:002021-08-30T16:14:002020-12-212021-08-30 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421371114213712020-12-21T14:11:002021-07-122020-12-21T14:11:002021-01-11T15:35:002020-12-212021-07-12 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421372114213722020-12-22T10:32:002021-07-132020-12-22T10:32:002021-01-11T14:47:002020-12-222021-07-13 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421373114213732020-12-22T10:40:002021-07-132020-12-22T10:40:002021-06-04T11:30:002020-12-222021-07-13 1142281273 Rupp, Richard Earl (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421374114213742020-12-22T10:45:002021-07-132020-12-22T10:45:002021-01-12T15:56:002020-12-222021-07-13 1142281273 Rupp, Richard Earl (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421375114213752020-12-22T13:28:002021-07-082020-12-22T13:28:002021-06-04T13:57:002020-12-222021-07-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421376114213762020-12-22T13:19:002021-07-082020-12-22T13:19:002021-01-14T15:37:002020-12-222021-07-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421377114213772020-12-22T13:27:002021-07-112020-12-22T13:27:002021-06-04T15:22:002020-12-222021-07-11 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421379114213792020-12-28T10:22:002021-07-162020-12-28T10:22:002021-06-11T15:01:002020-12-282021-07-16 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421380114213802020-12-28T13:32:002021-08-162020-12-28T13:32:002021-08-16T16:01:002020-12-28 1142281273 Rupp, Richard Earl (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421383114213832020-12-29T10:20:002021-07-142020-12-29T10:20:002021-01-19T15:21:002020-12-292021-07-14 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421384114213842020-12-29T14:34:002021-08-052020-12-29T14:34:002021-01-20T15:54:002020-12-292021-08-05 1142281273 Rupp, Richard Earl (b)(6)AYEARSFNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421385114213852020-12-31T10:42:002021-07-262020-12-31T10:42:002021-01-22T09:57:002020-12-312021-07-26 1142281273 Rupp, Richard Earl (b)(6)AYEARSMNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421386114213862020-12-31T10:50:002021-07-202020-12-31T10:50:002021-06-02T09:27:002020-12-312021-07-20 1142281273 Rupp, Richard Earl (b)(6)AYEARSMNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421388114213882021-01-05T10:17:002021-05-202021-01-05T10:17:002021-01-26T11:01:002021-01-052021-05-20 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421389114213892021-01-06T10:32:002021-08-022021-01-06T10:32:002021-01-27T09:30:002021-01-062021-08-02 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421390114213902021-01-06T10:42:002021-07-202021-01-06T10:42:002021-01-26T15:57:002021-01-06 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421391114213912021-01-06T13:00:002021-07-082021-01-06T13:00:002021-06-09T13:32:002021-01-062021-07-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421392114213922021-01-08T10:19:002021-07-282021-01-08T10:19:002021-01-29T16:01:002021-01-082021-07-28 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421393114213932021-01-08T13:37:002021-08-312021-01-08T13:37:002021-08-31T12:34:002021-01-08 1142281273 Rupp, Richard Earl (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421394114213942021-01-11T10:52:002021-07-272021-01-11T10:52:002021-02-02T09:43:002021-01-112021-07-27 1142281273 Rupp, Richard Earl (b)(6)AYEARSMNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421395114213952021-01-11T11:01:002021-08-042021-01-11T11:01:002021-02-01T10:10:002021-01-112021-08-04 1142281273 Rupp, Richard Earl (b)(6)AYEARSMMULTIPLE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421396114213962021-01-11T12:58:002021-08-262021-01-11T12:58:002021-08-26T12:02:002021-01-112021-08-26 1142281273 Rupp, Richard Earl (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471261114712612020-12-12T13:55:002021-07-022020-12-12T13:55:002021-01-04T11:20:002020-12-012021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471262114712622020-12-12T09:09:002021-07-022020-12-12T09:09:002021-01-04T10:25:002020-12-012021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471263114712632020-12-05T10:38:002021-06-282020-12-05T10:38:002020-12-28T12:32:002020-12-052021-06-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471264114712642020-12-05T11:37:002021-07-072020-12-05T11:37:002021-06-04T08:58:002020-12-052021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471268114712682020-12-05T13:28:002021-06-302020-12-05T13:28:002020-12-28T11:00:002020-12-052021-06-30 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471269114712692020-12-05T13:56:002021-04-192020-12-05T13:56:002021-03-19T09:15:002020-12-05 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471270114712702020-12-05T13:58:002021-04-192020-12-05T13:58:002021-03-19T09:20:002020-12-05 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471271114712712020-12-05T13:46:002021-04-192020-12-05T13:46:002021-03-19T09:23:002020-12-05 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471273114712732020-12-05T14:45:002021-06-212020-12-05T14:45:002020-12-28T10:39:002020-12-052021-06-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471274114712742020-12-05T15:10:002021-06-212020-12-05T15:10:002020-12-28T11:19:002020-12-052021-06-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471275114712752020-12-05T15:27:002021-07-072020-12-05T15:27:002021-06-04T09:48:002020-12-052021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471277114712772020-12-08T18:15:002021-06-222020-12-08T18:15:002020-12-28T12:15:002020-12-082021-06-22 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471278114712782020-12-08T18:25:002021-07-162020-12-08T18:25:002021-06-14T09:12:002020-12-082021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471279114712792020-12-08T18:13:002021-07-022020-12-08T18:13:002020-12-28T15:23:002020-12-082021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471280114712802021-01-04T09:40:002021-07-162021-01-04T09:40:002021-06-14T09:07:002020-12-082021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471281114712812020-12-12T10:44:002021-07-072020-12-12T10:44:002021-06-03T10:32:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471282114712822020-12-12T11:21:002021-06-282020-12-12T11:21:002021-01-04T12:30:002020-12-122021-06-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471283114712832020-12-12T11:39:002021-06-252020-12-12T11:39:002021-01-04T09:45:002020-12-122021-06-25 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471284114712842020-12-12T11:53:002021-08-092020-12-12T11:53:002021-01-04T14:20:002020-12-122021-08-09 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471285114712852020-12-12T11:22:002021-06-302020-12-12T11:22:002021-05-31T12:52:002020-12-122021-06-30 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471286114712862020-12-12T14:20:002021-07-072020-12-12T14:20:002021-06-03T09:39:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471287114712872020-12-12T14:31:002021-07-072020-12-12T14:31:002021-01-04T14:22:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471288114712882020-12-12T15:06:002021-07-072020-12-12T15:06:002021-06-03T11:56:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471289114712892020-12-19T10:10:002021-07-122020-12-19T10:10:002021-01-09T14:02:002020-12-192021-07-12 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471290114712902020-12-19T11:21:002021-07-072020-12-19T11:21:002021-06-03T09:34:002020-12-19 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471291114712912020-12-19T10:10:002021-06-182020-12-19T10:10:002021-05-20T11:30:002020-12-192021-06-18 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471292114712922020-12-19T10:57:002021-07-062020-12-19T10:57:002021-06-08T09:51:002020-12-192021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471294114712942020-12-19T10:48:002021-07-072020-12-19T10:48:002021-01-09T09:10:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471295114712952020-12-19T11:44:002021-07-072020-12-19T11:44:002021-06-03T15:44:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471296114712962020-12-19T11:53:002021-07-022020-12-19T11:53:002021-01-09T12:01:002020-12-192021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471297114712972020-12-19T11:20:002021-07-062020-12-19T11:20:002021-01-09T12:55:002020-12-192021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471298114712982020-12-19T12:08:002021-06-302020-12-19T12:08:002021-06-02T10:54:002020-12-192021-06-30 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471299114712992020-12-19T12:51:002021-07-072020-12-19T12:51:002021-01-09T09:49:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471300114713002020-12-19T12:40:002021-08-172020-12-19T12:40:002021-06-14T10:24:002020-12-192021-08-17 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471301114713012020-12-19T13:09:002021-07-072020-12-19T13:09:002021-01-09T13:27:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471302114713022020-12-19T14:26:002021-07-072020-12-19T14:26:002021-01-09T10:16:002020-12-19 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471303114713032020-12-21T09:50:002021-07-062020-12-21T09:50:002021-01-09T09:24:002020-12-212021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471304114713042020-12-21T10:05:002021-07-142020-12-21T10:05:002021-01-09T09:07:002020-12-212021-07-14 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471305114713052020-12-21T10:34:002021-07-072020-12-21T10:34:002021-01-11T17:00:002020-12-212021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471306114713062020-12-21T10:45:002021-07-062020-12-21T10:45:002021-06-04T08:48:002020-12-212021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471307114713072020-12-21T10:53:002021-07-072020-12-21T10:53:002021-06-03T15:00:002020-12-212021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471308114713082020-12-21T12:31:002021-07-012020-12-21T12:31:002021-06-04T14:39:002020-12-212021-07-01 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471309114713092020-12-21T12:53:002021-07-062020-12-21T12:53:002021-01-09T13:35:002020-12-212021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471310114713102020-12-21T13:52:002021-07-192020-12-21T13:52:002021-01-09T14:17:002020-12-212021-07-19 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471311114713112020-12-21T13:50:002021-07-202020-12-21T13:50:002021-06-01T09:30:002020-12-212021-07-20 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471312114713122020-12-21T14:35:002021-07-072020-12-21T14:35:002021-06-04T11:39:002020-12-212021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471313114713132020-12-21T15:45:002021-08-132020-12-21T15:45:002021-01-09T12:57:002020-12-212021-08-13 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471314114713142020-12-21T15:53:002021-07-092020-12-21T15:53:002021-01-09T10:46:002020-12-212021-07-09 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471315114713152021-01-04T12:55:002021-07-272021-01-04T12:55:002021-01-23T12:03:002021-01-042021-07-27 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471316114713162021-01-04T13:02:002021-07-192021-01-04T13:02:002021-06-17T09:18:002021-01-042021-07-19 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471317114713172021-01-04T13:52:002021-09-012021-01-04T13:52:002021-01-23T10:35:002021-01-042021-09-01 1013347220 Dever, Michael Edward (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471318114713182021-01-04T17:25:002021-06-222021-01-04T17:25:002021-05-20T16:31:002021-01-042021-06-22 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471319114713192021-01-05T10:02:002021-07-282021-01-05T10:02:002021-01-28T10:44:002021-01-052021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471320114713202021-01-05T11:04:002021-07-212021-01-05T11:04:002021-01-27T10:05:002021-01-052021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471321114713212021-01-05T14:30:002021-08-122021-01-05T14:30:002021-06-07T10:39:002021-01-052021-08-12 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471322114713222021-01-05T14:51:002021-08-062021-01-05T14:51:002021-01-27T09:19:002021-01-05 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471323114713232021-01-05T16:23:002021-07-212021-01-05T16:23:002021-01-27T17:07:002021-01-052021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471324114713242021-01-05T16:26:002021-07-062021-01-05T16:26:002021-06-07T13:54:002021-01-052021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471325114713252021-01-05T16:20:002021-07-212021-01-05T16:20:002021-01-27T16:55:002021-01-052021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471326114713262021-01-05T15:05:002021-07-282021-01-05T15:05:002021-01-27T15:55:002021-01-052021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471327114713272021-01-05T17:10:002021-07-282021-01-05T17:10:002021-01-05T17:10:002021-01-052021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471328114713282021-01-05T17:00:002021-08-182021-01-05T17:00:002021-07-23T15:30:002021-01-052021-08-18 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471329114713292021-01-05T17:40:002021-07-162021-01-05T17:40:002021-06-11T13:01:002021-01-052021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471330114713302021-01-05T17:50:002021-07-162021-01-05T17:50:002021-06-14T15:27:002021-01-052021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471331114713312021-01-05T17:55:002021-05-272021-01-05T17:55:002021-01-28T17:02:002021-01-052021-05-27 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471332114713322021-01-06T10:52:002021-08-172021-01-06T10:52:002021-06-10T12:00:002021-01-062021-08-17 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471333114713332021-01-06T11:22:002021-07-282021-01-06T11:22:002021-02-03T16:39:002021-01-062021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471334114713342021-01-06T11:27:002021-07-212021-01-06T11:27:002021-01-27T09:00:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471335114713352021-01-06T11:31:002021-07-212021-01-06T11:31:002021-01-27T09:05:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471336114713362021-01-06T12:44:002021-07-122021-01-06T12:44:002021-01-27T11:28:002021-01-06 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471337114713372021-01-06T13:13:002021-07-212021-01-06T13:13:002021-01-27T15:45:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471338114713382021-01-06T14:32:002021-07-212021-01-06T14:32:002021-01-27T09:13:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471339114713392021-01-06T14:40:002021-08-042021-01-06T14:40:002021-06-29T12:05:002021-01-062021-08-04 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471340114713402021-01-06T16:20:002021-07-282021-01-06T16:20:002021-01-27T14:33:002021-01-062021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471341114713412021-01-06T17:07:002021-08-042021-01-06T17:07:002021-06-15T13:37:002021-01-062021-08-04 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471342114713422021-01-06T17:05:002021-08-042021-01-06T17:05:002021-06-15T13:40:002021-01-062021-08-04 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471343114713432021-01-06T16:57:002021-07-282021-01-06T16:57:002021-01-28T16:10:002021-01-062021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMNOT REPORTED NOT REPORTED B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471344114713442021-01-06T17:30:002021-08-132021-01-06T17:30:002021-02-12T16:55:002021-01-062021-08-13 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471345114713452021-01-06T17:38:002021-07-162021-01-06T17:38:002021-06-09T14:10:002021-01-062021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471346114713462021-01-06T18:03:002021-07-222021-01-06T18:03:002021-01-27T13:14:002021-01-062021-07-22 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471347114713472021-01-06T18:13:002021-07-222021-01-06T18:13:002021-01-28T16:15:002021-01-062021-07-22 114731313 Garcia-Diaz, Julia (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501118115011182020-10-15T09:16:002021-05-182020-10-15T09:16:002020-11-03T17:47:002020-10-152021-05-18 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501119115011192020-10-15T11:43:002021-05-132020-10-15T11:43:002020-11-05T14:12:002020-10-152021-05-13 115036056 Senders, Shelly David (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501120115011202020-10-15T13:24:002021-07-082020-10-15T13:24:002021-06-10T14:39:002020-10-152021-07-08 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501121115011212020-10-15T16:35:002021-07-122020-10-15T16:35:002021-06-10T17:14:002020-10-152021-07-12 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501123115011232020-10-16T11:57:002021-07-012020-10-16T11:57:002021-06-03T16:32:002020-10-162021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501124115011242020-10-19T09:35:002021-05-132020-10-19T09:35:002020-11-10T16:41:002020-10-192021-05-13 115036056 Senders, Shelly David (b)(6)AYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501125115011252020-10-19T11:35:002021-07-152020-10-19T11:35:002021-06-10T10:47:002020-10-192021-07-15 115036056 Senders, Shelly David (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501126115011262020-10-19T12:23:002021-08-052020-10-19T12:23:002020-11-09T17:03:002020-10-192021-08-05 115036056 Senders, Shelly David (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501127115011272020-10-19T13:57:002021-08-032020-10-19T13:57:002020-11-11T16:33:002020-10-192021-08-03 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501128115011282020-10-19T17:45:002021-07-052020-10-19T17:45:002021-06-07T13:38:002020-10-192021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501129115011292020-10-20T08:47:002021-07-072020-10-20T08:47:002021-06-01T16:36:002020-10-202021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501130115011302020-10-20T17:30:002021-05-142020-10-20T17:30:002020-11-09T09:50:002020-10-202021-05-14 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501131115011312020-10-20T17:34:002021-06-112020-10-20T17:34:002021-03-15T09:23:002020-10-20 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501132115011322020-10-20T17:33:002021-05-142020-10-20T17:33:002020-11-09T09:49:002020-10-202021-05-14 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501133115011332020-10-21T09:40:002021-05-112020-10-21T09:40:002020-11-10T13:43:002020-10-212021-05-11 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501134115011342020-10-21T12:36:002021-07-052020-10-21T12:36:002021-06-07T16:03:002020-10-21 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501135115011352020-10-21T12:47:002021-05-132020-10-21T12:47:002020-11-13T12:18:002020-10-21 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501136115011362020-10-21T16:14:002021-07-062020-10-21T16:14:002021-06-08T11:49:002020-10-21 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501166115011662020-11-30T11:25:002021-07-062020-11-30T11:25:002021-06-08T09:06:002020-11-302021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501168115011682020-12-02T14:10:002021-06-112020-12-02T14:10:002020-12-23T11:51:002020-12-022021-06-11 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501171115011712020-12-03T09:47:002021-06-172020-12-03T09:47:002020-12-24T10:50:002020-12-032021-06-17 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501176115011762020-12-04T10:57:002021-07-062020-12-04T10:57:002021-06-08T11:45:002020-12-042021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501178115011782020-12-07T12:41:002021-06-282020-12-07T12:41:002020-12-28T17:27:002020-12-072021-06-28 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501179115011792020-12-07T15:58:002021-07-022020-12-07T15:58:002021-06-04T11:39:002020-12-072021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501180115011802020-12-08T09:17:002021-06-282020-12-08T09:17:002020-12-30T09:42:002020-12-082021-06-28 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501182115011822020-12-08T12:51:002021-04-152020-12-08T12:51:002021-03-18T12:14:002020-12-082021-04-15 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501183115011832020-12-08T12:53:002021-06-252020-12-08T12:53:002020-12-28T10:52:002020-12-082021-06-25 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501185115011852020-12-08T17:00:002021-07-022020-12-08T17:00:002021-06-03T12:14:002020-12-082021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501186115011862020-12-09T11:27:002021-07-012020-12-09T11:27:002020-12-29T10:53:002020-12-092021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501187115011872020-12-09T14:13:002021-07-232020-12-09T14:13:002020-12-28T09:07:002020-12-092021-07-23 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501189115011892020-12-10T09:31:002021-07-072020-12-10T09:31:002021-06-07T17:47:002020-12-102021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501190115011902020-12-10T09:29:002021-07-072020-12-10T09:29:002021-06-07T17:46:002020-12-102021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501191115011912020-12-10T10:59:002021-06-302020-12-10T10:59:002020-12-30T12:20:002020-12-102021-06-30 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501192115011922020-12-10T12:55:002021-07-082020-12-10T12:55:002021-06-09T15:54:002020-12-102021-07-08 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501193115011932020-12-10T15:02:002021-06-302020-12-10T15:02:002021-06-01T08:25:002020-12-102021-06-30 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501194115011942020-12-10T17:07:002021-06-242020-12-10T17:07:002020-12-31T11:16:002020-12-102021-06-24 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501195115011952020-12-11T09:41:002021-07-062020-12-11T09:41:002021-06-07T17:37:002020-12-112021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501196115011962020-12-11T09:43:002021-07-062020-12-11T09:43:002021-06-07T17:39:002020-12-112021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501197115011972020-12-11T13:07:002021-06-232020-12-11T13:07:002020-12-30T13:58:002020-12-112021-06-23 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501198115011982020-12-11T13:08:002021-06-252020-12-11T13:08:002020-12-30T16:07:002020-12-112021-06-25 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501199115011992020-12-11T15:29:002021-05-192020-12-11T15:29:002020-12-30T09:18:002020-12-112021-05-19 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501200115012002020-12-11T15:57:002021-06-292020-12-11T15:57:002021-06-01T16:47:002020-12-112021-06-29 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501201115012012020-12-11T15:56:002021-06-242020-12-11T15:56:002020-12-31T12:46:002020-12-112021-06-24 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501202115012022020-12-14T08:59:002021-07-052020-12-14T08:59:002021-01-05T18:03:002020-12-142021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501203115012032020-12-14T09:30:002021-07-062020-12-14T09:30:002021-01-04T08:52:002020-12-142021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501204115012042020-12-14T09:32:002021-07-062020-12-14T09:32:002021-06-07T08:09:002020-12-142021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501205115012052020-12-14T11:23:002021-06-292020-12-14T11:23:002021-01-04T17:37:002020-12-142021-06-29 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501206115012062020-12-14T16:50:002021-07-122020-12-14T16:50:002021-06-14T16:40:002020-12-142021-07-12 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501207115012072020-12-14T17:13:002021-07-072020-12-14T17:13:002021-06-09T16:30:002020-12-142021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501208115012082020-12-14T17:14:002021-07-062020-12-14T17:14:002021-01-04T18:02:002020-12-142021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501209115012092020-12-15T10:21:002021-06-292020-12-15T10:21:002021-01-04T14:02:002020-12-15 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501210115012102020-12-15T15:10:002021-07-212020-12-15T15:10:002021-06-14T15:33:002020-12-152021-07-21 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501211115012112020-12-15T16:06:002021-07-092020-12-15T16:06:002021-01-07T08:32:002020-12-152021-07-09 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501212115012122020-12-15T16:05:002021-07-052020-12-15T16:05:002021-06-02T16:05:002020-12-152021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501213115012132020-12-15T18:03:002021-07-012020-12-15T18:03:002021-01-04T13:33:002020-12-15 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501214115012142020-12-15T18:11:002021-07-142020-12-15T18:11:002021-06-10T17:46:002020-12-152021-07-14 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501215115012152020-12-15T18:10:002021-07-142020-12-15T18:10:002021-06-10T17:47:002020-12-152021-07-14 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501216115012162020-12-16T11:43:002021-07-012020-12-16T11:43:002021-01-06T17:44:002020-12-162021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501217115012172020-12-16T17:07:002021-06-292020-12-16T17:07:002021-01-05T08:39:002020-12-162021-06-29 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501218115012182020-12-17T09:35:002021-07-062020-12-17T09:35:002021-06-08T09:43:002020-12-172021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501219115012192020-12-17T09:51:002021-07-072020-12-17T09:51:002021-01-05T13:52:002020-12-172021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501220115012202020-12-17T12:00:002021-07-062020-12-17T12:00:002021-06-07T12:07:002020-12-172021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501221115012212020-12-17T13:25:002021-06-222020-12-17T13:25:002021-01-08T13:23:002020-12-172021-06-22 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501222115012222020-12-17T14:27:002021-06-292020-12-17T14:27:002021-06-01T11:10:002020-12-172021-06-29 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501223115012232020-12-17T14:52:002021-07-062020-12-17T14:52:002021-06-07T09:00:002020-12-172021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501224115012242020-12-17T17:07:002021-07-052020-12-17T17:07:002021-06-07T15:45:002020-12-172021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501225115012252020-12-17T17:04:002021-07-022020-12-17T17:04:002021-01-08T16:44:002020-12-172021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501226115012262020-12-17T17:18:002021-07-052020-12-17T17:18:002021-01-08T17:09:002020-12-172021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501227115012272020-12-18T14:59:002021-06-302020-12-18T14:59:002021-01-06T13:07:002020-12-182021-06-30 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501228115012282020-12-18T15:52:002021-07-012020-12-18T15:52:002021-06-03T13:45:002020-12-182021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501229115012292020-12-20T09:36:002021-07-012020-12-20T09:36:002021-06-02T17:16:002020-12-202021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501230115012302020-12-20T11:23:002021-07-062020-12-20T11:23:002021-01-11T18:01:002020-12-202021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501231115012312020-12-20T13:27:002021-07-052020-12-20T13:27:002021-06-07T10:08:002020-12-202021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501232115012322020-12-21T09:16:002021-08-172020-12-21T09:16:002021-06-07T09:11:002020-12-212021-08-17 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501233115012332020-12-21T09:15:002021-07-262020-12-21T09:15:002021-01-11T08:31:002020-12-212021-07-26 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501234115012342020-12-21T11:20:002021-07-082020-12-21T11:20:002021-01-13T15:52:002020-12-212021-07-08 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501235115012352020-12-21T12:36:002021-07-052020-12-21T12:36:002021-06-07T11:47:002020-12-212021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501236115012362020-12-21T14:51:002021-09-022020-12-21T14:51:002021-01-12T08:40:002020-12-212021-09-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501237115012372020-12-21T17:21:002021-07-122020-12-21T17:21:002021-06-11T16:47:002020-12-212021-07-12 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501238115012382020-12-22T09:41:002021-08-172020-12-22T09:41:002021-01-14T16:11:002020-12-222021-08-17 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501239115012392020-12-22T15:53:002021-07-082020-12-22T15:53:002021-01-13T16:26:002020-12-222021-07-08 115036056 Senders, Shelly David (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501240115012402020-12-22T17:02:002021-06-302020-12-22T17:02:002021-06-02T17:15:002020-12-222021-06-30 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501241115012412020-12-22T19:08:002021-07-092020-12-22T19:08:002021-01-14T16:50:002020-12-222021-07-09 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501242115012422020-12-23T12:14:002021-05-032020-12-23T12:14:002021-04-05T11:42:002020-12-232021-05-03 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501243115012432020-12-23T14:40:002021-07-012020-12-23T14:40:002021-06-03T14:58:002020-12-232021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501244115012442020-12-28T09:13:002021-09-022020-12-28T09:13:002021-03-08T14:23:002020-12-282021-09-02 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501245115012452020-12-28T12:34:002021-09-022020-12-28T12:34:002021-01-19T17:19:002020-12-282021-09-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501246115012462020-12-28T16:38:002021-08-112020-12-28T16:38:002021-01-29T10:46:002020-12-282021-08-11 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501247115012472020-12-29T09:31:002021-07-132020-12-29T09:31:002021-01-19T11:38:002020-12-292021-07-13 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501248115012482020-12-29T11:28:002021-07-072020-12-29T11:28:002021-06-09T14:41:002020-12-292021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501249115012492020-12-29T14:10:002021-07-062020-12-29T14:10:002021-06-04T16:35:002020-12-292021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501250115012502020-12-29T14:08:002021-07-192020-12-29T14:08:002021-01-19T16:40:002020-12-292021-07-19 115036056 Senders, Shelly David (b)(6)AYEARSFNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501251115012512020-12-29T15:16:002021-06-302020-12-29T15:16:002021-06-02T09:15:002020-12-292021-06-30 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501252115012522020-12-29T15:43:002021-07-142020-12-29T15:43:002021-01-18T13:26:002020-12-292021-07-14 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501253115012532020-12-29T17:12:002021-07-222020-12-29T17:12:002021-01-18T11:45:002020-12-292021-07-22 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501254115012542020-12-29T17:41:002021-07-022020-12-29T17:41:002021-06-03T09:36:002020-12-292021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501255115012552020-12-30T12:08:002021-07-122020-12-30T12:08:002021-01-18T17:07:002020-12-302021-07-12 115036056 Senders, Shelly David (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501256115012562020-12-30T12:06:002021-07-122020-12-30T12:06:002021-01-18T15:05:002020-12-302021-07-12 115036056 Senders, Shelly David (b)(6)AYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501257115012572020-12-30T13:51:002021-06-302020-12-30T13:51:002021-06-02T10:19:002020-12-302021-06-30 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501258115012582020-12-30T16:31:002021-07-132020-12-30T16:31:002021-06-11T15:40:002020-12-302021-07-13 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501259115012592020-12-30T16:32:002021-07-132020-12-30T16:32:002021-06-11T15:41:002020-12-302021-07-13 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501260115012602020-12-30T18:00:002021-07-142020-12-30T18:00:002021-01-20T17:41:002020-12-302021-07-14 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501261115012612020-12-31T10:38:002021-07-052020-12-31T10:38:002021-06-03T10:34:002020-12-312021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501262115012622020-12-31T10:10:002021-08-052020-12-31T10:10:002021-01-20T17:06:002020-12-312021-08-05 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501263115012632021-01-04T09:11:002021-07-092021-01-04T09:11:002021-06-11T09:20:002021-01-042021-07-09 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501264115012642021-01-04T09:58:002021-07-132021-01-04T09:58:002021-06-15T17:59:002021-01-042021-07-13 115036056 Senders, Shelly David (b)(6)AYEARSFMULTIPLE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501265115012652021-01-04T12:01:002021-07-222021-01-04T12:01:002021-01-25T16:56:002021-01-042021-07-22 115036056 Senders, Shelly David (b)(6)AYEARSFNATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERNOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501266115012662021-01-04T12:26:002021-07-202021-01-04T12:26:002021-01-26T15:42:002021-01-042021-07-20 115036056 Senders, Shelly David (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501267115012672021-01-04T17:22:002021-07-062021-01-04T17:22:002021-05-05T15:05:002021-01-042021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501268115012682021-01-04T16:53:002021-07-302021-01-04T16:53:002021-01-25T15:08:002021-01-042021-07-30 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501269115012692021-01-04T17:00:002021-08-042021-01-04T17:00:002021-01-26T16:14:002021-01-042021-08-04 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501270115012702021-01-04T17:09:002021-07-062021-01-04T17:09:002021-06-08T09:18:002021-01-042021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501271115012712021-01-05T09:05:002021-07-022021-01-05T09:05:002021-06-02T15:43:002021-01-052021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501272115012722021-01-05T09:03:002021-07-022021-01-05T09:03:002021-06-02T15:43:002021-01-052021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501273115012732021-01-05T09:18:002021-07-292021-01-05T09:18:002021-01-26T08:43:002021-01-052021-07-29 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501274115012742021-01-05T13:59:002021-07-202021-01-05T13:59:002021-01-25T17:13:002021-01-052021-07-20 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501275115012752021-01-05T14:13:002021-08-062021-01-05T14:13:002021-01-27T16:42:002021-01-052021-08-06 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501276115012762021-01-05T16:09:002021-07-222021-01-05T16:09:002021-01-26T16:38:002021-01-052021-07-22 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501277115012772021-01-05T16:53:002021-07-062021-01-05T16:53:002021-06-08T10:15:002021-01-052021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501278115012782021-01-05T17:53:002021-07-192021-01-05T17:53:002021-06-21T16:18:002021-01-052021-07-19 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501279115012792021-01-06T09:04:002021-08-022021-01-06T09:04:002021-01-25T13:45:002021-01-062021-08-02 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501280115012802021-01-06T11:13:002021-07-082021-01-06T11:13:002021-06-10T16:43:002021-01-062021-07-08 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501281115012812021-01-06T13:24:002021-07-282021-01-06T13:24:002021-01-27T15:48:002021-01-062021-07-28 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501282115012822021-01-06T15:40:002021-07-072021-01-06T15:40:002021-06-09T08:41:002021-01-062021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501283115012832021-01-06T16:43:002021-07-062021-01-06T16:43:002021-06-03T12:03:002021-01-062021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501284115012842021-01-07T11:14:002021-07-072021-01-07T11:14:002021-06-07T13:37:002021-01-072021-07-07 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501285115012852021-01-07T14:15:002021-07-212021-01-07T14:15:002021-01-27T12:37:002021-01-072021-07-21 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501286115012862021-01-07T14:17:002021-07-212021-01-07T14:17:002021-01-27T12:38:002021-01-072021-07-21 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501287115012872021-01-07T14:58:002021-07-282021-01-07T14:58:002021-01-28T16:35:002021-01-072021-07-28 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501288115012882021-01-08T09:39:002021-07-222021-01-08T09:39:002021-01-28T14:34:002021-01-082021-07-22 115036056 Senders, Shelly David (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501289115012892021-01-08T14:08:002021-07-012021-01-08T14:08:002021-06-03T16:07:002021-01-082021-07-01 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501290115012902021-01-11T09:24:002021-07-022021-01-11T09:24:002021-06-04T10:40:002021-01-112021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501291115012912021-01-11T11:34:002021-07-062021-01-11T11:34:002021-06-08T13:34:002021-01-112021-07-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501292115012922021-01-11T11:36:002021-07-282021-01-11T11:36:002021-02-03T15:37:002021-01-112021-07-28 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501293115012932021-01-11T11:56:002021-08-062021-01-11T11:56:002021-02-12T14:43:002021-01-112021-08-06 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501294115012942021-01-11T14:04:002021-07-152021-01-11T14:04:002021-06-16T16:11:002021-01-11 115036056 Senders, Shelly David (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501295115012952021-01-11T14:13:002021-07-202021-01-11T14:13:002021-02-01T16:48:002021-01-112021-07-20 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501296115012962021-01-11T17:04:002021-07-052021-01-11T17:04:002021-06-02T15:32:002021-01-112021-07-05 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501297115012972021-01-11T17:23:002021-08-052021-01-11T17:23:002021-02-02T17:18:002021-01-11 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501298115012982021-01-12T11:15:002021-06-292021-01-12T11:15:002021-06-01T09:32:002021-01-122021-06-29 115036056 Senders, Shelly David (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501299115012992021-01-12T14:26:002021-07-262021-01-12T14:26:002021-02-01T09:14:002021-01-122021-07-26 115036056 Senders, Shelly David (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501300115013002021-01-12T16:29:002021-07-022021-01-12T16:29:002021-06-04T16:01:002021-01-122021-07-02 115036056 Senders, Shelly David (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501301115013012021-01-12T16:40:002021-08-092021-01-12T16:40:002021-02-03T16:38:002021-01-122021-08-09 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501302115013022021-01-12T16:44:002021-05-242021-01-12T16:44:002021-04-26T15:49:002021-01-122021-05-24 115036056 Senders, Shelly David (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521604115216042020-12-02T15:10:002021-05-042020-12-02T15:10:002021-03-31T10:15:002020-12-022021-05-04 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521605115216052020-12-02T16:07:002021-06-152020-12-02T16:07:002020-12-22T10:37:002020-12-022021-06-15 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521607115216072020-12-03T11:41:002021-07-142020-12-03T11:41:002021-06-16T16:37:002020-12-032021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521608115216082020-12-03T11:32:002021-06-162020-12-03T11:32:002020-12-23T11:30:002020-12-032021-06-16 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521611115216112020-12-03T15:02:002021-06-152020-12-03T15:02:002020-12-22T13:55:002020-12-032021-06-15 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521612115216122020-12-03T14:44:002021-08-252020-12-03T14:44:002021-07-14T14:22:002020-12-032021-08-25 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521613115216132020-12-03T14:37:002021-08-252020-12-03T14:37:002021-07-14T14:32:002020-12-032021-08-25 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521614115216142020-12-03T15:45:002021-06-172020-12-03T15:45:002020-12-22T11:06:002020-12-032021-06-17 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521615115216152020-12-03T15:52:002021-07-082020-12-03T15:52:002021-06-10T09:38:002020-12-032021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521617115216172020-12-03T17:37:002021-07-142020-12-03T17:37:002020-12-28T09:03:002020-12-032021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521619115216192020-12-03T18:08:002021-06-212020-12-03T18:08:002020-12-22T15:51:002020-12-032021-06-21 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521625115216252020-12-04T10:04:002021-07-192020-12-04T10:04:002020-12-23T12:10:002020-12-042021-07-19 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521626115216262020-12-04T09:55:002021-08-192020-12-04T09:55:002021-07-22T14:18:002020-12-042021-08-19 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521628115216282020-12-04T10:43:002021-06-162020-12-04T10:43:002020-12-23T12:41:002020-12-042021-06-16 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521629115216292020-12-04T10:57:002021-07-212020-12-04T10:57:002021-01-25T09:33:002020-12-042021-07-21 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521633115216332020-12-07T10:42:002021-07-282020-12-07T10:42:002021-06-17T15:16:002020-12-072021-07-28 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521635115216352020-12-07T11:54:002021-06-302020-12-07T11:54:002020-12-28T11:19:002020-12-072021-06-30 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521636115216362020-12-07T12:01:002021-08-112020-12-07T12:01:002020-12-28T08:42:002020-12-072021-08-11 115211354 Brandon, Donald M. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521637115216372020-12-07T13:10:002021-07-082020-12-07T13:10:002021-06-09T15:16:002020-12-072021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521638115216382020-12-07T12:55:002021-05-192020-12-07T12:55:002021-04-21T14:48:002020-12-072021-05-19 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521639115216392020-12-07T15:06:002021-07-072020-12-07T15:06:002021-06-08T10:34:002020-12-072021-07-07 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521640115216402020-12-07T15:24:002021-05-262020-12-07T15:24:002020-12-28T12:30:002020-12-072021-05-26 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521641115216412020-12-07T15:35:002021-05-262020-12-07T15:35:002020-12-07T15:35:002020-12-072021-05-26 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521642115216422020-12-07T15:51:002021-07-072020-12-07T15:51:002021-06-09T16:12:002020-12-072021-07-07 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521644115216442020-12-07T17:09:002021-06-292020-12-07T17:09:002020-12-28T10:32:002020-12-072021-06-29 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521645115216452020-12-08T09:20:002021-08-182020-12-08T09:20:002021-08-18T16:58:002020-12-082021-08-18 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521646115216462020-12-08T12:48:002021-07-282020-12-08T12:48:002020-12-28T16:37:002020-12-082021-07-28 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521647115216472020-12-08T14:53:002021-07-162020-12-08T14:53:002021-06-18T08:41:002020-12-082021-07-16 115211354 Brandon, Donald M. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521648115216482020-12-08T15:15:002021-06-282020-12-08T15:15:002020-12-28T09:37:002020-12-082021-06-28 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521649115216492020-12-08T15:26:002021-09-012020-12-08T15:26:002021-08-03T12:03:002020-12-082021-09-01 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521650115216502020-12-08T16:16:002021-08-022020-12-08T16:16:002020-12-28T11:41:002020-12-082021-08-02 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521651115216512020-12-08T16:44:002021-07-092020-12-08T16:44:002021-06-07T11:23:002020-12-082021-07-09 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521652115216522020-12-08T17:12:002021-07-082020-12-08T17:12:002021-06-01T10:00:002020-12-082021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521653115216532020-12-09T10:59:002021-06-222020-12-09T10:59:002020-12-28T12:56:002020-12-092021-06-22 115211354 Brandon, Donald M. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521654115216542020-12-09T11:45:002021-08-162020-12-09T11:45:002021-07-19T10:08:002020-12-092021-08-16 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521655115216552020-12-09T12:21:002021-06-222020-12-09T12:21:002020-12-29T09:10:002020-12-092021-06-22 115211354 Brandon, Donald M. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521656115216562020-12-10T11:04:002021-07-072020-12-10T11:04:002021-01-04T13:44:002020-12-102021-07-07 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521657115216572020-12-10T14:52:002021-06-222020-12-10T14:52:002020-12-29T12:33:002020-12-102021-06-22 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521658115216582020-12-10T15:00:002021-07-192020-12-10T15:00:002021-07-19T10:42:002020-12-102021-07-19 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521659115216592020-12-10T16:00:002021-07-082020-12-10T16:00:002021-06-07T15:10:002020-12-102021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521660115216602020-12-10T15:51:002021-07-272020-12-10T15:51:002021-06-29T12:59:002020-12-102021-07-27 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521661115216612020-12-10T16:19:002021-07-142020-12-10T16:19:002021-06-16T15:19:002020-12-102021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521662115216622020-12-10T16:50:002021-06-222020-12-10T16:50:002020-12-29T11:58:002020-12-102021-06-22 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521663115216632020-12-10T17:11:002021-06-222020-12-10T17:11:002020-12-29T14:16:002020-12-102021-06-22 115211354 Brandon, Donald M. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521664115216642020-12-11T10:46:002021-08-202020-12-11T10:46:002021-07-21T09:58:002020-12-112021-08-20 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521665115216652020-12-11T10:37:002021-06-242020-12-11T10:37:002020-12-30T10:00:002020-12-112021-06-24 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521666115216662020-12-11T10:54:002021-08-112020-12-11T10:54:002021-07-14T09:24:002020-12-112021-08-11 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521667115216672020-12-11T11:46:002021-07-062020-12-11T11:46:002021-06-07T16:26:002020-12-112021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521668115216682020-12-11T11:37:002021-06-282020-12-11T11:37:002020-12-30T11:43:002020-12-112021-06-28 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521669115216692020-12-11T12:33:002021-07-142020-12-11T12:33:002021-06-16T16:45:002020-12-112021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521670115216702020-12-11T14:11:002021-08-052020-12-11T14:11:002020-12-30T09:39:002020-12-112021-08-05 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521671115216712020-12-14T14:59:002021-07-122020-12-14T14:59:002021-01-04T16:54:002020-12-142021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521672115216722020-12-14T15:33:002021-07-092020-12-14T15:33:002021-06-11T13:27:002020-12-142021-07-09 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521673115216732020-12-14T15:39:002021-08-312020-12-14T15:39:002021-01-04T14:22:002020-12-142021-08-31 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521674115216742020-12-14T16:14:002021-07-072020-12-14T16:14:002021-01-08T12:21:002020-12-142021-07-07 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521675115216752020-12-14T16:22:002021-07-302020-12-14T16:22:002021-06-14T10:52:002020-12-142021-07-30 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521676115216762020-12-14T17:26:002021-07-082020-12-14T17:26:002021-06-09T15:09:002020-12-142021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521677115216772020-12-15T11:57:002021-07-262020-12-15T11:57:002021-01-04T10:22:002020-12-152021-07-26 115211354 Brandon, Donald M. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521678115216782020-12-15T12:21:002021-07-132020-12-15T12:21:002021-06-15T11:44:002020-12-152021-07-13 115211354 Brandon, Donald M. (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521679115216792020-12-15T14:58:002021-06-302020-12-15T14:58:002021-01-05T14:49:002020-12-152021-06-30 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521680115216802020-12-15T15:42:002021-07-022020-12-15T15:42:002021-06-04T14:01:002020-12-152021-07-02 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521681115216812020-12-15T16:27:002021-08-272020-12-15T16:27:002021-08-27T13:12:002020-12-152021-08-27 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521682115216822020-12-15T16:35:002021-07-082020-12-15T16:35:002021-01-05T14:06:002020-12-152021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521683115216832020-12-15T17:06:002021-06-292020-12-15T17:06:002021-01-05T15:56:002020-12-152021-06-29 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521684115216842020-12-15T17:33:002021-07-072020-12-15T17:33:002021-01-05T17:06:002020-12-152021-07-07 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521685115216852020-12-15T17:43:002021-07-132020-12-15T17:43:002021-01-05T12:22:002020-12-152021-07-13 115211354 Brandon, Donald M. (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521686115216862020-12-16T12:01:002021-08-162020-12-16T12:01:002021-08-16T10:03:002020-12-162021-08-16 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521687115216872020-12-16T15:49:002021-07-122020-12-16T15:49:002021-06-14T17:18:002020-12-162021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521688115216882020-12-16T15:41:002021-07-122020-12-16T15:41:002021-06-14T16:19:002020-12-162021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521689115216892020-12-16T16:19:002021-06-292020-12-16T16:19:002021-01-05T15:27:002020-12-162021-06-29 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521690115216902020-12-16T16:40:002021-07-142020-12-16T16:40:002021-06-16T15:59:002020-12-162021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521691115216912020-12-16T16:29:002021-06-242020-12-16T16:29:002021-01-06T15:02:002020-12-162021-06-24 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521692115216922020-12-16T16:53:002021-08-052020-12-16T16:53:002021-01-06T13:40:002020-12-162021-08-05 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521693115216932020-12-16T17:14:002021-07-202020-12-16T17:14:002021-06-08T09:30:002020-12-162021-07-20 115211354 Brandon, Donald M. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521694115216942020-12-16T17:28:002021-06-302020-12-16T17:28:002021-01-06T11:20:002020-12-162021-06-30 115211354 Brandon, Donald M. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521695115216952020-12-16T17:40:002021-07-162020-12-16T17:40:002021-06-16T15:32:002020-12-162021-07-16 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521696115216962020-12-17T18:12:002021-08-022020-12-17T18:12:002021-06-14T15:34:002020-12-172021-08-02 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521697115216972020-12-18T15:20:002021-07-092020-12-18T15:20:002021-01-08T14:35:002020-12-182021-07-09 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521698115216982020-12-18T15:30:002021-05-182020-12-18T15:30:002021-01-08T14:19:002020-12-182021-05-18 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521699115216992020-12-18T15:57:002021-07-062020-12-18T15:57:002021-01-08T14:46:002020-12-182021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521700115217002020-12-18T16:07:002021-07-142020-12-18T16:07:002021-01-08T14:12:002020-12-182021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521701115217012020-12-18T16:20:002021-07-152020-12-18T16:20:002021-06-17T16:41:002020-12-182021-07-15 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521702115217022020-12-21T10:23:002021-07-062020-12-21T10:23:002021-01-12T16:12:002020-12-212021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT REPORTED B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521703115217032020-12-21T10:32:002021-07-262020-12-21T10:32:002021-06-28T10:18:002020-12-212021-07-26 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT REPORTED PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521704115217042020-12-21T11:21:002021-07-062020-12-21T11:21:002021-01-11T11:58:002020-12-212021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521705115217052020-12-21T11:45:002021-05-182020-12-21T11:45:002021-04-14T14:52:002020-12-212021-05-18 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521706115217062020-12-21T12:35:002021-07-212020-12-21T12:35:002021-06-16T16:18:002020-12-212021-07-21 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521707115217072020-12-21T14:17:002021-07-142020-12-21T14:17:002021-01-11T13:34:002020-12-212021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521708115217082020-12-21T15:29:002021-07-192020-12-21T15:29:002021-01-11T11:40:002020-12-21 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521709115217092020-12-22T10:26:002021-07-272020-12-22T10:26:002021-06-14T15:06:002020-12-222021-07-27 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521710115217102020-12-22T11:28:002021-07-142020-12-22T11:28:002021-06-11T10:44:002020-12-222021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521711115217112020-12-22T12:05:002021-07-062020-12-22T12:05:002021-01-12T14:00:002020-12-222021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521712115217122020-12-22T16:04:002021-07-282020-12-22T16:04:002021-06-16T14:31:002020-12-222021-07-28 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521713115217132020-12-23T14:33:002021-07-062020-12-23T14:33:002021-01-12T15:41:002020-12-232021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521714115217142020-12-23T15:18:002021-07-122020-12-23T15:18:002021-06-14T14:52:002020-12-232021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521715115217152020-12-23T16:10:002021-07-062020-12-23T16:10:002021-01-11T15:52:002020-12-232021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521716115217162020-12-28T16:27:002021-07-202020-12-28T16:27:002021-01-18T11:02:002020-12-282021-07-20 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521717115217172020-12-28T16:59:002021-07-082020-12-28T16:59:002021-06-07T15:48:002020-12-282021-07-08 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521718115217182020-12-29T11:20:002021-07-152020-12-29T11:20:002021-01-21T15:25:002020-12-292021-07-15 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521719115217192020-12-29T12:06:002021-07-062020-12-29T12:06:002021-06-07T10:25:002020-12-292021-07-06 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521720115217202020-12-29T15:42:002021-07-192020-12-29T15:42:002021-06-09T15:38:002020-12-292021-07-19 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521721115217212020-12-29T15:49:002021-07-282020-12-29T15:49:002021-01-19T15:56:002020-12-292021-07-28 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521722115217222020-12-30T12:25:002021-08-312020-12-30T12:25:002021-01-21T15:41:002020-12-302021-08-31 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521723115217232020-12-30T15:11:002021-07-162020-12-30T15:11:002021-06-18T11:36:002020-12-302021-07-16 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521724115217242020-12-30T16:52:002021-07-132020-12-30T16:52:002021-01-18T12:13:002020-12-302021-07-13 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521725115217252020-12-30T16:40:002021-07-142020-12-30T16:40:002021-06-16T10:17:002020-12-302021-07-14 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521726115217262020-12-30T17:44:002021-06-152020-12-30T17:44:002021-01-18T16:05:002020-12-302021-06-15 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521727115217272021-01-04T10:54:002021-07-192021-01-04T10:54:002021-01-25T09:26:002021-01-042021-07-19 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521728115217282021-01-04T11:09:002021-07-232021-01-04T11:09:002021-01-25T08:52:002021-01-042021-07-23 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521729115217292021-01-04T11:56:002021-07-122021-01-04T11:56:002021-06-14T14:23:002021-01-042021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521730115217302021-01-04T15:36:002021-07-292021-01-04T15:36:002021-01-27T15:26:002021-01-042021-07-29 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521731115217312021-01-04T17:03:002021-05-102021-01-04T17:03:002021-04-12T13:53:002021-01-042021-05-10 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521732115217322021-01-05T10:21:002021-07-212021-01-05T10:21:002021-01-27T11:22:002021-01-052021-07-21 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521733115217332021-01-05T16:16:002021-07-092021-01-05T16:16:002021-06-11T16:29:002021-01-052021-07-09 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521734115217342021-01-05T17:29:002021-07-282021-01-05T17:29:002021-01-27T16:38:002021-01-052021-07-28 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521735115217352021-01-05T17:34:002021-08-232021-01-05T17:34:002021-08-23T08:41:002021-01-052021-08-23 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521736115217362021-01-05T17:41:002021-07-192021-01-05T17:41:002021-01-25T13:38:002021-01-052021-07-19 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521737115217372021-01-06T11:29:002021-08-032021-01-06T11:29:002021-01-25T08:07:002021-01-062021-08-03 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521738115217382021-01-06T15:41:002021-08-162021-01-06T15:41:002021-07-19T16:01:002021-01-062021-08-16 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521739115217392021-01-07T15:42:002021-07-092021-01-07T15:42:002021-06-11T15:52:002021-01-072021-07-09 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521740115217402021-01-07T16:43:002021-07-122021-01-07T16:43:002021-06-14T11:40:002021-01-072021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521741115217412021-01-07T17:19:002021-07-122021-01-07T17:19:002021-06-14T11:47:002021-01-072021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521742115217422021-01-08T08:56:002021-07-222021-01-08T08:56:002021-01-28T09:00:002021-01-082021-07-22 115211354 Brandon, Donald M. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521743115217432021-01-08T09:35:002021-07-212021-01-08T09:35:002021-01-27T11:53:002021-01-082021-07-21 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521744115217442021-01-08T09:41:002021-07-212021-01-08T09:41:002021-01-27T11:59:002021-01-082021-07-21 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521745115217452021-01-08T15:30:002021-08-062021-01-08T15:30:002021-01-28T14:29:002021-01-082021-08-06 115211354 Brandon, Donald M. (b)(6)AYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521746115217462021-01-08T15:36:002021-08-262021-01-08T15:36:002021-08-26T13:38:002021-01-08 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521747115217472021-01-08T16:51:002021-07-262021-01-08T16:51:002021-05-20T15:56:002021-01-082021-07-26 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521748115217482021-01-08T16:59:002021-07-212021-01-08T16:59:002021-01-27T13:21:002021-01-082021-07-21 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521749115217492021-01-08T18:12:002021-07-222021-01-08T18:12:002021-01-28T15:35:002021-01-082021-07-22 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521750115217502021-01-08T19:05:002021-07-122021-01-08T19:05:002021-06-14T12:06:002021-01-082021-07-12 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521751115217512021-01-11T08:52:002021-05-182021-01-11T08:52:002021-02-02T09:04:002021-01-112021-05-18 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521752115217522021-01-11T09:45:002021-07-192021-01-11T09:45:002021-06-14T08:38:002021-01-112021-07-19 115211354 Brandon, Donald M. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521753115217532021-01-11T09:56:002021-07-272021-01-11T09:56:002021-02-02T08:47:002021-01-112021-07-27 115211354 Brandon, Donald M. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521754115217542021-01-11T16:46:002021-05-212021-01-11T16:46:002021-02-01T16:12:002021-01-112021-05-21 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521755115217552021-01-11T16:37:002021-08-092021-01-11T16:37:002021-02-01T15:44:002021-01-112021-08-09 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521756115217562021-01-11T18:24:002021-08-032021-01-11T18:24:002021-02-01T17:32:002021-01-112021-08-03 115211354 Brandon, Donald M. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521757115217572021-01-11T18:31:002021-07-072021-01-11T18:31:002021-06-09T09:08:002021-01-112021-07-07 115211354 Brandon, Donald M. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561243115612432020-10-15T15:57:002021-05-212020-10-15T15:57:002020-11-03T12:21:002020-10-152021-05-21 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561244115612442020-10-15T14:04:002021-07-132020-10-15T14:04:002021-06-15T12:31:002020-10-152021-07-13 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561245115612452020-10-15T14:07:002021-05-212020-10-15T14:07:002020-11-03T12:27:002020-10-152021-05-21 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561246115612462020-10-22T14:51:002021-07-082020-10-22T14:51:002021-06-11T16:44:002020-10-152021-07-08 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561247115612472020-10-16T10:29:002021-07-292020-10-16T10:29:002021-06-25T14:48:002020-10-162021-07-29 1156427723 Rodriguez, Hector A (b)(6)AYEARSMNOT REPORTED NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561248115612482020-10-16T12:27:002021-08-192020-10-16T12:27:002021-06-01T11:09:002020-10-162021-08-19 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561249115612492020-10-16T13:13:002021-06-032020-10-16T13:13:002020-11-04T13:07:002020-10-162021-06-03 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561250115612502020-10-16T15:41:002021-05-192020-10-16T15:41:002020-11-04T14:17:002020-10-16 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561253115612532020-10-19T12:11:002021-08-022020-10-19T12:11:002021-06-28T11:41:002020-10-192021-08-02 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561254115612542020-10-19T16:03:002021-08-102020-10-19T16:03:002021-07-09T13:31:002020-10-192021-08-10 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561255115612552020-10-20T11:44:002021-07-062020-10-20T11:44:002021-06-07T11:55:002020-10-202021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561256115612562020-10-20T11:47:002021-05-172020-10-20T11:47:002020-11-10T11:48:002020-10-202021-05-17 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561257115612572020-10-20T11:52:002021-05-202020-10-20T11:52:002020-11-12T14:44:002020-10-202021-05-20 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561259115612592020-10-20T17:14:002021-06-232020-10-20T17:14:002020-11-10T11:53:002020-10-202021-06-23 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561260115612602020-10-21T11:46:002021-05-172020-10-21T11:46:002021-04-15T11:14:002020-10-212021-05-17 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561262115612622020-10-21T13:59:002021-05-182020-10-21T13:59:002020-11-11T12:39:002020-10-212021-05-18 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561263115612632020-10-21T15:17:002021-07-122020-10-21T15:17:002021-06-14T11:29:002020-10-212021-07-12 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561264115612642020-10-22T11:51:002021-05-182020-10-22T11:51:002020-11-10T12:59:002020-10-22 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561265115612652020-10-22T14:41:002021-07-122020-10-22T14:41:002021-06-11T16:46:002020-10-222021-07-12 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561303115613032020-11-30T13:24:002021-06-222020-11-30T13:24:002020-12-22T11:51:002020-11-302021-06-22 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561304115613042020-11-30T14:59:002021-08-202020-11-30T14:59:002020-12-21T11:02:002020-11-302021-08-20 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561305115613052020-11-30T15:03:002021-08-232020-11-30T15:03:002021-07-19T13:58:002020-11-302021-08-23 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561306115613062020-12-01T11:10:002021-06-222020-12-01T11:10:002020-12-22T11:51:002020-12-012021-06-22 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561307115613072020-12-01T12:37:002021-08-162020-12-01T12:37:002021-07-15T13:43:002020-12-012021-08-16 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561308115613082020-12-01T12:39:002021-06-252020-12-01T12:39:002020-12-21T10:53:002020-12-012021-06-25 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561309115613092020-12-01T12:43:002021-08-132020-12-01T12:43:002021-07-15T13:44:002020-12-012021-08-13 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561310115613102020-12-01T16:39:002021-07-022020-12-01T16:39:002021-01-07T10:36:002020-12-012021-07-02 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561311115613112020-12-02T10:29:002021-07-292020-12-02T10:29:002021-01-05T13:57:002020-12-02 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561312115613122020-12-02T11:36:002021-08-092020-12-02T11:36:002021-07-06T11:29:002020-12-022021-08-09 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561313115613132020-12-02T15:25:002021-06-242020-12-02T15:25:002020-12-21T13:10:002020-12-022021-06-24 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561314115613142020-12-03T11:15:002021-06-162020-12-03T11:15:002020-12-23T10:52:002020-12-032021-06-16 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561316115613162020-12-03T12:21:002021-05-062020-12-03T12:21:002020-12-28T14:39:002020-12-032021-05-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561317115613172020-12-03T15:37:002021-06-282020-12-03T15:37:002020-12-28T15:49:002020-12-032021-06-28 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561318115613182020-12-04T12:48:002021-07-132020-12-04T12:48:002021-01-05T11:37:002020-12-042021-07-13 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561319115613192020-12-04T14:12:002021-08-192020-12-04T14:12:002021-07-22T12:56:002020-12-042021-08-19 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561320115613202020-12-04T15:48:002021-01-252020-12-04T15:48:002020-12-23T12:04:002020-12-042021-01-25 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561321115613212020-12-07T12:41:002021-06-282020-12-07T12:41:002020-12-28T12:11:002020-12-072021-06-28 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561322115613222020-12-07T13:53:002021-07-062020-12-07T13:53:002021-06-07T11:31:002020-12-072021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561323115613232020-12-07T13:56:002021-07-122020-12-07T13:56:002021-06-07T12:00:002020-12-072021-07-12 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561324115613242020-12-07T13:59:002021-06-252020-12-07T13:59:002020-12-30T14:03:002020-12-072021-06-25 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561325115613252020-12-08T16:21:002021-07-022020-12-08T16:21:002020-12-28T10:36:002020-12-082021-07-02 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561327115613272020-12-10T16:34:002021-07-012020-12-10T16:34:002021-06-03T11:02:002020-12-102021-07-01 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561328115613282020-12-14T11:42:002021-08-182020-12-14T11:42:002021-01-04T16:09:002020-12-142021-08-18 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561330115613302020-12-15T16:07:002021-06-302020-12-15T16:07:002021-06-02T15:25:002020-12-152021-06-30 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561331115613312020-12-17T15:50:002021-06-302020-12-17T15:50:002021-01-05T16:13:002020-12-172021-06-30 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561332115613322020-12-17T16:05:002021-08-192020-12-17T16:05:002021-07-22T11:19:002020-12-172021-08-19 1156427723 Rodriguez, Hector A (b)(6)AYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561333115613332020-12-18T13:43:002021-07-062020-12-18T13:43:002021-06-04T15:29:002020-12-182021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561334115613342020-12-18T14:51:002021-07-122020-12-18T14:51:002021-01-08T10:17:002020-12-182021-07-12 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561335115613352020-12-21T11:13:002021-08-162020-12-21T11:13:002021-08-16T13:42:002020-12-21 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561336115613362020-12-22T12:31:002021-06-082020-12-22T12:31:002021-01-11T11:51:002020-12-222021-06-08 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561337115613372020-12-22T16:54:002021-07-082020-12-22T16:54:002021-01-11T16:04:002020-12-222021-07-08 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561338115613382020-12-23T12:08:002021-07-092020-12-23T12:08:002021-01-11T16:21:002020-12-232021-07-09 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561339115613392020-12-28T12:23:002021-07-062020-12-28T12:23:002021-01-19T16:43:002020-12-282021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561340115613402020-12-28T13:03:002021-07-142020-12-28T13:03:002021-01-19T14:16:002020-12-282021-07-14 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561341115613412020-12-29T13:49:002021-07-062020-12-29T13:49:002021-06-04T11:55:002020-12-292021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561342115613422020-12-29T13:52:002021-07-152020-12-29T13:52:002021-01-19T16:51:002020-12-292021-07-15 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561343115613432021-01-04T12:12:002021-07-062021-01-04T12:12:002021-06-07T15:21:002021-01-042021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561344115613442021-01-04T16:22:002021-08-032021-01-04T16:22:002021-01-25T14:48:002021-01-04 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561345115613452021-01-05T11:35:002021-07-302021-01-05T11:35:002021-07-02T16:15:002021-01-052021-07-30 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561346115613462021-01-06T11:40:002021-07-222021-01-06T11:40:002021-01-28T11:08:002021-01-062021-07-22 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561347115613472021-01-06T13:41:002021-07-262021-01-06T13:41:002021-01-27T10:47:002021-01-062021-07-26 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561348115613482021-01-06T17:04:002021-07-122021-01-06T17:04:002021-06-14T15:35:002021-01-062021-07-12 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561349115613492021-01-06T16:58:002021-08-022021-01-06T16:58:002021-01-26T16:37:002021-01-062021-08-02 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561351115613512021-01-07T10:36:002021-07-122021-01-07T10:36:002021-06-14T11:25:002021-01-072021-07-12 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561352115613522021-01-07T14:07:002021-07-292021-01-07T14:07:002021-01-28T14:26:002021-01-072021-07-29 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561353115613532021-01-07T15:54:002021-07-092021-01-07T15:54:002021-05-17T17:18:002021-01-072021-07-09 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561354115613542021-01-07T15:58:002021-08-192021-01-07T15:58:002021-01-27T16:11:002021-01-072021-08-19 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561355115613552021-01-07T16:02:002021-08-132021-01-07T16:02:002021-08-13T13:36:002021-01-07 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561356115613562021-01-07T16:06:002021-08-062021-01-07T16:06:002021-01-29T16:33:002021-01-072021-08-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561357115613572021-01-07T17:03:002021-07-062021-01-07T17:03:002021-06-07T10:59:002021-01-072021-07-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561358115613582021-01-07T17:07:002021-08-062021-01-07T17:07:002021-01-29T16:13:002021-01-072021-08-06 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561359115613592021-01-08T10:59:002021-06-302021-01-08T10:59:002021-05-14T12:29:002021-01-082021-06-30 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561360115613602021-01-08T12:29:002021-09-012021-01-08T12:29:002021-01-27T10:44:002021-01-082021-09-01 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561361115613612021-01-08T13:28:002021-08-052021-01-08T13:28:002021-01-28T14:04:002021-01-082021-08-05 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561362115613622021-01-08T14:11:002021-08-182021-01-08T14:11:002021-08-18T14:21:002021-01-08 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561363115613632021-01-08T15:43:002021-08-202021-01-08T15:43:002021-08-20T15:16:002021-01-08 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561364115613642021-01-08T17:05:002021-08-032021-01-08T17:05:002021-01-29T16:39:002021-01-082021-08-03 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561365115613652021-01-11T11:40:002021-08-092021-01-11T11:40:002021-02-01T10:42:002021-01-112021-08-09 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561366115613662021-01-11T11:38:002021-08-092021-01-11T11:38:002021-02-01T10:45:002021-01-112021-08-09 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561367115613672021-01-11T14:41:002021-06-302021-01-11T14:41:002021-06-02T13:59:002021-01-112021-06-30 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561368115613682021-01-11T15:42:002021-07-282021-01-11T15:42:002021-02-01T10:32:002021-01-112021-07-28 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561369115613692021-01-11T15:46:002021-06-302021-01-11T15:46:002021-06-02T12:19:002021-01-112021-06-30 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561370115613702021-01-11T16:46:002021-08-182021-01-11T16:46:002021-02-01T16:01:002021-01-112021-08-18 1156427723 Rodriguez, Hector A (b)(6)AYEARSFASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561371115613712021-01-12T11:45:002021-05-032021-01-12T11:45:002021-04-05T11:02:002021-01-122021-05-03 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561372115613722021-01-12T11:43:002021-07-292021-01-12T11:43:002021-02-04T11:03:002021-01-122021-07-29 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561373115613732021-01-12T12:30:002021-07-072021-01-12T12:30:002021-06-03T11:06:002021-01-122021-07-07 1156427723 Rodriguez, Hector A (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561374115613742021-01-12T16:10:002021-07-272021-01-12T16:10:002021-02-02T12:37:002021-01-122021-07-27 1156427723 Rodriguez, Hector A (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561375115613752021-01-12T16:36:002021-05-192021-01-12T16:36:002021-02-02T16:51:002021-01-122021-05-19 1156427723 Rodriguez, Hector A (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231267122312672021-01-07T16:07:002021-07-232021-01-07T16:07:002021-01-27T15:39:002021-01-072021-07-23 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231268122312682021-01-07T16:11:002021-07-092021-01-07T16:11:002021-06-10T13:41:002021-01-07 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231269122312692021-01-07T17:34:002021-07-092021-01-07T17:34:002021-06-08T12:49:002021-01-072021-07-09 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231270122312702021-01-07T17:34:002021-08-252021-01-07T17:34:002021-01-29T15:58:002021-01-072021-08-25 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231271122312712021-01-08T16:00:002021-08-092021-01-08T16:00:002021-01-29T12:34:002021-01-082021-08-09 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231272122312722021-01-09T10:29:002021-07-092021-01-09T10:29:002021-06-10T10:02:002021-01-092021-07-09 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231273122312732021-01-09T10:25:002021-07-092021-01-09T10:25:002021-06-10T09:58:002021-01-092021-07-09 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231274122312742021-01-09T10:35:002021-08-242021-01-09T10:35:002021-01-29T14:57:002021-01-092021-08-24 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231275122312752021-01-09T11:03:002021-08-042021-01-09T11:03:002021-02-02T14:59:002021-01-092021-08-04 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231276122312762021-01-09T11:11:002021-07-082021-01-09T11:11:002021-06-08T15:27:002021-01-092021-07-08 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231277122312772021-01-09T11:07:002021-07-142021-01-09T11:07:002021-06-14T12:11:002021-01-092021-07-14 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231278122312782021-01-09T11:53:002021-08-192021-01-09T11:53:002021-02-02T17:45:002021-01-092021-08-19 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231279122312792021-01-09T11:57:002021-07-142021-01-09T11:57:002021-06-11T11:09:002021-01-092021-07-14 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231280122312802021-01-09T12:27:002021-08-302021-01-09T12:27:002021-01-28T14:51:002021-01-092021-08-30 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231281122312812021-01-09T12:56:002021-08-102021-01-09T12:56:002021-02-02T18:20:002021-01-09 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231283122312832021-01-09T13:29:002021-08-102021-01-09T13:29:002021-06-09T10:06:002021-01-092021-08-10 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231284122312842021-01-12T15:43:002021-08-302021-01-12T15:43:002021-02-02T15:17:002021-01-122021-08-30 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231285122312852021-01-12T15:39:002021-08-302021-01-12T15:39:002021-02-02T15:21:002021-01-122021-08-30 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231286122312862021-01-12T16:26:002021-07-122021-01-12T16:26:002021-06-11T10:02:002021-01-122021-07-12 1223349998 Ogbuagu, Onyema E. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351232123512322020-11-30T10:33:002021-07-142020-11-30T10:33:002021-06-15T11:28:002020-11-302021-07-14 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351233123512332020-11-30T10:40:002021-06-152020-11-30T10:40:002020-12-21T09:11:002020-11-302021-06-15 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351234123512342020-11-30T12:53:002021-06-182020-11-30T12:53:002020-12-22T11:26:002020-11-302021-06-18 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351235123512352020-11-30T14:06:002021-07-062020-11-30T14:06:002021-06-07T10:25:002020-11-302021-07-06 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351236123512362020-12-02T14:14:002021-08-272020-12-02T14:14:002021-06-07T14:40:002020-12-022021-08-27 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351238123512382020-12-07T10:29:002021-08-052020-12-07T10:29:002020-12-28T10:35:002020-12-072021-08-05 1235240230 Vanchiere, John A. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351239123512392020-12-07T11:28:002021-07-072020-12-07T11:28:002021-06-07T14:23:002020-12-072021-07-07 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351242123512422020-12-08T10:43:002021-06-212020-12-08T10:43:002020-12-28T08:37:002020-12-082021-06-21 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351243123512432020-12-08T12:48:002021-07-152020-12-08T12:48:002020-12-30T11:12:002020-12-082021-07-15 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351244123512442020-12-08T12:52:002021-07-152020-12-08T12:52:002020-12-30T11:02:002020-12-082021-07-15 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351245123512452020-12-08T14:10:002021-06-232020-12-08T14:10:002020-12-30T09:43:002020-12-082021-06-23 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351246123512462020-12-15T09:40:002021-07-092020-12-15T09:40:002021-01-05T09:50:002020-12-152021-07-09 1235240230 Vanchiere, John A. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351247123512472020-12-15T09:42:002021-07-092020-12-15T09:42:002021-01-05T09:53:002020-12-152021-07-09 1235240230 Vanchiere, John A. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351248123512482020-12-15T11:00:002021-07-122020-12-15T11:00:002021-06-08T10:33:002020-12-152021-07-12 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351249123512492020-12-15T13:17:002021-07-122020-12-15T13:17:002021-06-08T10:35:002020-12-152021-07-12 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351250123512502020-12-15T14:21:002021-06-302020-12-15T14:21:002021-01-05T13:42:002020-12-152021-06-30 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351251123512512020-12-18T10:00:002021-07-092020-12-18T10:00:002021-06-04T08:33:002020-12-182021-07-09 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351252123512522020-12-21T14:20:002021-07-062020-12-21T14:20:002021-06-08T10:01:002020-12-212021-07-06 1235240230 Vanchiere, John A. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351253123512532021-01-08T15:50:002021-07-222021-01-08T15:50:002021-01-28T11:36:002021-01-082021-07-22 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351254123512542021-01-08T15:53:002021-07-222021-01-08T15:53:002021-01-28T11:38:002021-01-08 1235240230 Vanchiere, John A. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701173127011732020-11-30T11:50:002021-06-292020-11-30T11:50:002021-06-01T11:43:002020-11-302021-06-29 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701174127011742020-11-30T11:50:002021-06-292020-11-30T11:50:002021-06-01T11:43:002020-11-302021-06-29 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701177127011772020-12-01T14:13:002021-06-232020-12-01T14:13:002020-12-21T15:51:002020-12-012021-06-23 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701180127011802020-12-02T13:23:002021-08-312020-12-02T13:23:002020-12-22T13:24:002020-12-022021-08-31 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701181127011812020-12-02T13:23:002021-05-042020-12-02T13:23:002021-04-06T13:50:002020-12-022021-05-04 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701184127011842020-12-02T15:51:002021-06-222020-12-02T15:51:002020-12-23T12:15:002020-12-02 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701187127011872020-12-03T08:33:002021-06-152020-12-03T08:33:002020-12-22T09:00:002020-12-032021-06-15 1270280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701188127011882020-12-03T08:35:002021-07-142020-12-03T08:35:002021-06-14T10:22:002020-12-032021-07-14 1270280164 Klein, Nicola P. (b)(6)AYEARSMASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701189127011892020-12-03T15:19:002021-06-212020-12-03T15:19:002020-12-22T14:47:002020-12-032021-06-21 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701191127011912020-12-03T16:49:002021-08-092020-12-03T16:49:002020-12-23T16:30:002020-12-032021-08-09 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701192127011922020-12-04T11:00:002021-07-072020-12-04T11:00:002021-06-07T10:50:002020-12-042021-07-07 1270280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701194127011942020-12-04T13:37:002021-07-142020-12-04T13:37:002021-06-16T11:58:002020-12-042021-07-14 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701198127011982020-12-07T12:12:002021-07-022020-12-07T12:12:002020-12-30T12:03:002020-12-072021-07-02 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701199127011992020-12-08T15:11:002021-07-082020-12-08T15:11:002021-06-07T08:42:002020-12-082021-07-08 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701200127012002020-12-10T16:12:002021-07-012020-12-10T16:12:002020-12-29T15:59:002020-12-10 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701201127012012020-12-11T10:08:002021-08-022020-12-11T10:08:002021-05-05T08:49:002020-12-11 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701202127012022020-12-11T14:01:002021-06-242020-12-11T14:01:002020-12-31T16:25:002020-12-11 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701203127012032020-12-11T13:55:002021-07-212020-12-11T13:55:002020-12-30T10:56:002020-12-112021-07-21 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701204127012042020-12-15T08:58:002021-07-122020-12-15T08:58:002021-06-07T14:20:002020-12-152021-07-12 1270280164 Klein, Nicola P. (b)(6)AYEARSMNOT REPORTED NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701205127012052020-12-15T14:22:002021-07-132020-12-15T14:22:002021-06-14T09:37:002020-12-152021-07-13 1270280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701206127012062020-12-15T15:04:002021-07-212020-12-15T15:04:002021-06-16T15:36:002020-12-152021-07-21 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701207127012072020-12-16T09:08:002021-06-292020-12-16T09:08:002021-01-05T13:53:002020-12-162021-06-29 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701208127012082020-12-16T12:46:002021-07-192020-12-16T12:46:002021-06-14T15:31:002020-12-162021-07-19 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701209127012092020-12-16T14:53:002021-07-012020-12-16T14:53:002021-01-04T11:49:002020-12-162021-07-01 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701210127012102020-12-16T15:53:002021-07-092020-12-16T15:53:002021-01-04T15:19:002020-12-162021-07-09 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701211127012112020-12-16T15:53:002021-07-092020-12-16T15:53:002021-01-04T15:19:002020-12-162021-07-09 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701212127012122020-12-16T16:28:002021-05-102020-12-16T16:28:002021-04-09T14:52:002020-12-162021-05-10 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701213127012132020-12-17T09:10:002021-07-192020-12-17T09:10:002021-06-14T11:30:002020-12-172021-07-19 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701214127012142020-12-17T11:13:002021-07-082020-12-17T11:13:002021-01-08T15:33:002020-12-172021-07-08 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701215127012152020-12-17T12:51:002021-07-092020-12-17T12:51:002021-01-14T13:44:002020-12-172021-07-09 1270280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701216127012162020-12-17T13:48:002021-08-272020-12-17T13:48:002021-06-07T11:25:002020-12-172021-08-27 1270280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701217127012172020-12-17T15:13:002021-07-142020-12-17T15:13:002021-06-16T11:58:002020-12-172021-07-14 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701218127012182020-12-17T16:24:002021-07-132020-12-17T16:24:002021-06-15T13:31:002020-12-17 1270280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701219127012192020-12-18T11:01:002021-07-072020-12-18T11:01:002021-01-08T11:43:002020-12-182021-07-07 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701220127012202020-12-18T11:03:002021-08-112020-12-18T11:03:002021-01-08T11:45:002020-12-182021-08-11 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701221127012212020-12-18T12:51:002021-07-122020-12-18T12:51:002021-06-14T15:08:002020-12-182021-07-12 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701222127012222020-12-18T16:30:002021-08-062020-12-18T16:30:002021-01-08T14:18:002020-12-182021-08-06 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701223127012232020-12-18T16:34:002021-08-232020-12-18T16:34:002021-06-15T09:41:002020-12-182021-08-23 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701224127012242020-12-21T13:05:002021-07-122020-12-21T13:05:002021-01-12T16:05:002020-12-21 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701225127012252020-12-29T10:51:002021-07-212020-12-29T10:51:002021-06-15T10:18:002020-12-292021-07-21 1270280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701226127012262021-01-04T16:07:002021-07-262021-01-04T16:07:002021-01-25T08:52:002021-01-042021-07-26 1270280164 Klein, Nicola P. (b)(6)AYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701227127012272021-01-05T09:06:002021-07-072021-01-05T09:06:002021-06-08T08:08:002021-01-052021-07-07 1270280164 Klein, Nicola P. (b)(6)AYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701228127012282021-01-05T10:50:002021-07-262021-01-05T10:50:002021-06-03T13:33:002021-01-052021-07-26 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701229127012292021-01-05T12:08:002021-07-202021-01-05T12:08:002021-01-26T11:46:002021-01-052021-07-20 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701230127012302021-01-05T13:27:002021-05-242021-01-05T13:27:002021-04-26T15:05:002021-01-052021-05-24 1270280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701231127012312021-01-05T13:27:002021-07-082021-01-05T13:27:002021-06-08T13:51:002021-01-052021-07-08 1270280164 Klein, Nicola P. (b)(6)AYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701232127012322021-01-05T15:31:002021-07-212021-01-05T15:31:002021-01-27T15:40:002021-01-052021-07-21 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701233127012332021-01-05T16:07:002021-08-232021-01-05T16:07:002021-01-26T15:40:002021-01-052021-08-23 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701234127012342021-01-06T09:12:002021-08-032021-01-06T09:12:002021-01-28T08:52:002021-01-062021-08-03 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701235127012352021-01-06T10:25:002021-08-032021-01-06T10:25:002021-01-28T08:58:002021-01-062021-08-03 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701236127012362021-01-06T15:18:002021-07-072021-01-06T15:18:002021-06-07T14:22:002021-01-06 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701237127012372021-01-07T09:43:002021-07-132021-01-07T09:43:002021-05-19T09:55:002021-01-072021-07-13 1270280164 Klein, Nicola P. (b)(6)AYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701238127012382021-01-07T12:04:002021-07-072021-01-07T12:04:002021-06-07T15:13:002021-01-072021-07-07 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701239127012392021-01-07T12:52:002021-07-262021-01-07T12:52:002021-01-28T13:31:002021-01-072021-07-26 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701240127012402021-01-07T15:10:002021-08-252021-01-07T15:10:002021-01-28T14:35:002021-01-072021-08-25 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701241127012412021-01-07T15:50:002021-07-212021-01-07T15:50:002021-06-14T14:54:002021-01-072021-07-21 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701242127012422021-01-08T12:59:002021-07-022021-01-08T12:59:002021-06-04T13:58:002021-01-082021-07-02 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701243127012432021-01-11T16:18:002021-07-302021-01-11T16:18:002021-02-02T13:47:002021-01-112021-07-30 1270280164 Klein, Nicola P. (b)(6)AYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701244127012442021-01-11T16:18:002021-07-192021-01-11T16:18:002021-06-07T16:02:002021-01-112021-07-19 1270280164 Klein, Nicola P. (b)(6)AYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USA